,Gene_set,Term,Overlap,P-value,Adjusted P-value,Old P-value,Old Adjusted P-value,Odds Ratio,Combined Score,Genes
0,BioPlanet_2019,T cell receptor regulation of apoptosis,49 of 603,5.974779025120183e-19,5.144284740628477e-16,0,0,5.4637178273924265,229.26617617844693,CDKN1A;BTG1;CXCL8;ILK;TNFAIP3;BZW1;BBC3;NAMPT;CASP4;MAP3K8;RAC1;JUNB;IER2;IER3;DUSP5;SERPINB1;HSP90AA1;HLA-B;TAP1;TNFRSF1A;PPA1;TRAF3;IRF1;PSME1;S100A6;PSME2;PTMA;ATF3;BIRC3;ABCB1;CEBPD;EPAS1;RELB;MCL1;EGR1;JUN;JUND;GADD45B;STAT1;HSPA2;CFLAR;SOD2;PSMB8;PNRC1;NFKB1;PSMB9;NFKBIA;BCL3;MAP3K14
1,BioPlanet_2019,Immune system,61 of 998,2.4962159729506167e-17,1.0746209763552407e-14,0,0,4.100072227073294,156.74236066780023,CD40;CDKN1A;RNF19B;TNFAIP3;UBE2L6;ADAR;IFI30;UBE2Z;CTSS;ICAM1;IFIH1;MT2A;PPP2R1B;KIF5B;CASP4;MAP3K8;RAC1;B2M;JAK1;DTX3L;IFNGR2;HLA-B;HLA-C;TAP1;TRAF2;HLA-A;HLA-F;YWHAZ;HLA-E;TAPBP;PSMA3;PSMA4;OAS1;TRAF3;IRF1;PSME1;PSME2;SQSTM1;BIRC3;PSMB10;RASGRP3;SOCS2;SOCS3;SOCS1;PSMB2;UBB;TNFRSF14;EGR1;CD74;JUN;UBE2B;STAT1;STAT3;PSMB8;NFKB1;PSMB9;NFKB2;NFKBIA;CYLD;TNIP2;MAP3K14
2,BioPlanet_2019,Antigen processing: cross presentation,18 of 79,2.3713478137452538e-15,6.80576822544888e-13,0,0,16.99411764705882,572.2823142563628,HLA-B;HLA-C;TAP1;HLA-A;HLA-F;CTSS;PSMB10;PSMB8;HLA-E;TAPBP;PSMB9;PSMA3;PSMA4;PSMB2;UBB;PSME1;PSME2;B2M
3,BioPlanet_2019,Antigen processing and presentation,18 of 81,3.808284190531725e-15,7.634591975096621e-13,0,0,16.45294117647059,546.2639331150971,CD74;HSP90AA1;HLA-B;HLA-C;TAP1;HLA-A;HSPA2;IFI30;HLA-F;CTSS;PSMB8;HLA-E;TAPBP;PSMB9;RFX5;PSME1;PSME2;B2M
4,BioPlanet_2019,BDNF signaling pathway,29 of 261,4.433560961147864e-15,7.634591975096621e-13,0,0,7.374620060790273,243.72804629597567,BTG2;CDKN1A;ABCB1;BTG1;HSPB1;ZFP36;PPP2R1B;H1FX;TIMP1;JUNB;CLIC1;IER2;S100A11;TMOD1;KLF10;EGR1;DUSP5;JUN;GCH1;EMP3;SLC39A14;RHOB;DNAJA1;GAP43;KLF6;MARCKS;SRSF5;B4GALT6;ATF3
5,BioPlanet_2019,"Immune system signaling by interferons, interleukins, prolactin, and growth hormones",29 of 280,2.8039494517933067e-14,4.023667463323395e-12,0,0,6.809709490306252,212.4980902700158,UBE2L6;ADAR;IFI30;ICAM1;SOCS2;SOCS3;MT2A;SOCS1;UBB;MAP3K8;B2M;JAK1;EGR1;STAT1;IFNGR2;STAT3;HLA-B;HLA-C;HLA-A;HLA-F;YWHAZ;PSMB8;NFKB1;HLA-E;NFKB2;OAS1;TNIP2;IRF1;SQSTM1
6,BioPlanet_2019,Proteasome degradation,15 of 63,2.597776977714667e-13,3.1952656825890403e-11,0,0,17.85167638483965,517.322839839457,UBE2B;HLA-B;HLA-C;HLA-A;HLA-F;PSMB10;PSMB8;HLA-E;PSMB9;PSMA3;PSMA4;PSMB2;UBB;PSME1;PSME2
7,BioPlanet_2019,Adaptive immune system,40 of 606,1.177219446593212e-12,1.2669824293959442e-10,0,0,4.239393737360269,116.4470985026768,CD40;CDKN1A;RNF19B;UBE2L6;IFI30;UBE2Z;PSMB10;CTSS;ICAM1;RASGRP3;SOCS3;SOCS1;PSMB2;UBB;PPP2R1B;KIF5B;MAP3K8;TNFRSF14;RAC1;B2M;CD74;UBE2B;DTX3L;HLA-B;HLA-C;TAP1;HLA-A;HLA-F;YWHAZ;PSMB8;NFKB1;PSMB9;HLA-E;TAPBP;NFKBIA;PSMA3;PSMA4;PSME1;PSME2;MAP3K14
8,BioPlanet_2019,Interferon-gamma signaling pathway,17 of 97,1.401811726949719e-12,1.3410665521152314e-10,0,0,12.190395894428152,332.71559131953563,STAT1;IFNGR2;STAT3;HLA-B;HLA-C;HLA-A;IFI30;HLA-F;ICAM1;HLA-E;SOCS3;MT2A;SOCS1;OAS1;IRF1;B2M;JAK1
9,BioPlanet_2019,TNF-alpha signaling pathway,17 of 101,2.7798085647702416e-12,2.3322737039790076e-10,0,0,11.60752688172043,308.86049308429733,JUN;HSP90AA1;STAT1;TNFAIP3;TRAF2;CFLAR;NFKB1;NFKB2;TNFRSF1A;NFKBIA;CYLD;MAP3K8;RAC1;GLUL;SQSTM1;MAP3K14;BIRC3
10,BioPlanet_2019,Interferon signaling,21 of 168,2.979676044572484e-12,2.3322737039790076e-10,0,0,8.264094955489615,219.32252281715049,EGR1;STAT1;IFNGR2;HLA-B;HLA-C;UBE2L6;ADAR;HLA-A;IFI30;HLA-F;PSMB8;ICAM1;HLA-E;SOCS3;MT2A;SOCS1;UBB;OAS1;IRF1;B2M;JAK1
11,BioPlanet_2019,Interleukin-2 signaling pathway,47 of 847,5.438101985447486e-12,3.7206115265309657e-10,0,0,3.559381028938907,92.32176939756732,BTG1;CXCL8;ABCB1;AHR;CTSS;ICAM1;BBC3;SOCS2;SOCS3;SLC9A3R1;MT2A;ZFP36;SOCS1;NAMPT;TNFSF10;RAB29;H1FX;TNFRSF14;S100A11;ZNF267;IER3;JAK1;DUSP5;JUN;HSP90AA1;JUND;WARS;STAT1;ACTN1;STAT3;TAP1;TRAFD1;EMP3;CFLAR;ATP1B1;NFKB1;EHD1;KLF6;IRF1;NINJ1;BHLHE40;PLXNB2;TAGLN2;TAX1BP3;TOP1;LY6E;BIRC3
12,BioPlanet_2019,Interferon alpha/beta signaling,14 of 64,5.7342972258849095e-12,3.7206115265309657e-10,0,0,15.946976744186047,412.7804111959608,EGR1;STAT1;HLA-B;HLA-C;ADAR;HLA-A;HLA-F;PSMB8;HLA-E;SOCS3;SOCS1;OAS1;IRF1;JAK1
13,BioPlanet_2019,"Antigen presentation: folding, assembly, and peptide loading of class I MHC proteins",25 of 255,6.04977483988775e-12,3.7206115265309657e-10,0,0,6.336336336336337,163.67390429121775,RNF19B;UBE2L6;UBE2Z;CTSS;PSMB10;SOCS3;SOCS1;PSMB2;UBB;B2M;UBE2B;DTX3L;HLA-B;HLA-C;TAP1;HLA-A;HLA-F;PSMB8;HLA-E;PSMB9;TAPBP;PSMA3;PSMA4;PSME1;PSME2
14,BioPlanet_2019,Apoptosis,24 of 242,1.2688013140939001e-11,7.282919542898984e-10,0,0,6.402461132780311,160.64007657403698,JUN;TRAF2;CFLAR;PSMB8;NFKB1;PSMB10;BBC3;PSMB9;TNFRSF1A;NFKBIA;PSMA3;PSMA4;PSMB2;FNTA;UBB;TRAF3;IRF1;CASP4;TNFSF10;PSME1;PSME2;MAP3K14;MCL1;BIRC3
15,BioPlanet_2019,Oncostatin M,27 of 311,1.4675480420062855e-11,7.897242901046324e-10,0,0,5.5600399982979445,138.69432490597617,CDKN1A;CXCL8;CEBPD;EPAS1;ICAM1;SOCS3;MT2A;SOCS1;KIF5B;NAMPT;CASP4;TIMP1;B2M;JUNB;IER3;TGM2;KLF10;JUN;SERPINB1;STAT1;STAT3;TPM1;SOD2;CLDN4;OAS1;IRF1;ATF3
16,BioPlanet_2019,Endosomal/vacuolar pathway,7 of 9,1.9387749006250248e-11,9.819324643753803e-10,0,0,195.84045584045583,4830.675052971153,HLA-B;HLA-C;HLA-A;HLA-F;B2M;CTSS;HLA-E
17,BioPlanet_2019,Interleukin-5 regulation of apoptosis,18 of 144,1.0951741812822588e-10,5.238583167133472e-09,0,0,8.2,188.0664875791961,EGR1;DUSP5;CXCL8;HSPA2;INHBA;SOD2;NFKB1;IL17RB;ICAM1;NFKB2;RELB;SOCS1;TRAF3;CASP4;IER2;IER3;NFE2L2;BIRC3
18,BioPlanet_2019,"TNF-alpha effects on cytokine activity, cell motility, and apoptosis",17 of 135,3.2327093979071127e-10,1.4649277850515917e-08,0,0,8.248620706794572,180.253234105284,DDR1;CD40;CXCL8;IFNGR2;TNFAIP3;INHBA;CFLAR;SOD2;ICAM1;NFKB2;RELB;NFKBIA;UBD;IRF1;TNFSF10;OPTN;BIRC3
19,BioPlanet_2019,Thymic stromal lymphopoietin (TSLP) pathway,14 of 90,7.11510909628359e-10,3.0630544659500864e-08,0,0,10.47750917992656,220.6943805143474,CD40;CXCL8;CD82;PSMB10;PSMB8;ICAM1;PSMB9;CLDN4;PSMA4;PSMB2;IRF1;BCL3;PSME1;PSME2
20,BioPlanet_2019,Type II interferon signaling (interferon-gamma),11 of 50,1.0377945847362086e-09,4.254957797418457e-08,0,0,15.933865366142022,329.61061532807275,SOCS3;SOCS1;OAS1;STAT1;IFNGR2;IRF1;HLA-B;TAP1;ICAM1;JAK1;PSMB9
21,BioPlanet_2019,Tumor necrosis factor (TNF) pathway,9 of 30,1.7524379058531835e-09,6.858404713361779e-08,0,0,24.0945558739255,485.8006502244341,NFKBIA;JUN;TNFAIP3;TRAF2;CFLAR;NFKB1;NFKB2;TNFRSF1A;BIRC3
22,BioPlanet_2019,CD40/CD40L signaling,9 of 31,2.4306586518644903e-09,8.949701778314152e-08,0,0,22.9981766084918,456.1712148625356,NFKBIA;CD40;JUN;TRAF3;TNFAIP3;TRAF2;MAP3K14;NFKB1;BIRC3
23,BioPlanet_2019,RANKL signaling pathway,11 of 54,2.4946903911677078e-09,8.949701778314152e-08,0,0,14.448696468065144,286.2156906474275,NFKBIA;JUN;TRAF3;TRAF2;RAC1;SQSTM1;PAPSS2;NFKB1;ICAM1;RELB;NFKB2
24,BioPlanet_2019,Interleukin-4 regulation of apoptosis,22 of 267,3.1587554885513763e-09,1.087875390257094e-07,0,0,5.183843537414966,101.46382428280003,TMOD1;JUN;CDKN1A;NNMT;CXCL8;GADD45B;STAT1;DENND4A;ACTN1;RNF19B;ARID5B;UBE2L6;SPINT2;INHBA;ELL2;HS3ST1;RASGRP3;DDIT4;NINJ1;TNFSF10;MAP3K14;FKBP5
25,BioPlanet_2019,Prolactin activation of MAPK signaling,12 of 75,8.545377465230812e-09,2.829834614447588e-07,0,0,10.778420038535646,200.24014391936015,SOCS2;NFKBIA;SOCS3;JUN;SOCS1;STAT1;IRF1;STAT3;RAC1;YWHAZ;NFKB1;JAK1
26,BioPlanet_2019,FSH regulation of apoptosis,21 of 263,1.2626170124775525e-08,4.026345362011751e-07,0,0,4.995463128724526,90.85495659471496,KLF10;STAT1;ITGA3;ACTN1;CTNND1;TPM1;RAB27A;ILK;CFLAR;PTPRF;PAPSS2;RHOB;TUBA1A;VGF;BCL3;CASP4;S100A6;STX4;TIMP1;ATP9A;IER3
27,BioPlanet_2019,Downstream signaling events Of B cell receptor (BCR),13 of 98,2.127358587620541e-08,6.541627656933162e-07,0,0,8.669769820971867,153.15841652585095,CDKN1A;NFKB1;PSMB10;PSMB8;RASGRP3;PSMB9;NFKBIA;PSMA3;PSMA4;UBB;PSMB2;PSME1;PSME2
28,BioPlanet_2019,Activation of NF-kappaB in B cells,11 of 68,3.1945295055522306e-08,9.317969125582204e-07,0,0,10.89210779109156,187.98951256467055,NFKBIA;PSMA3;PSMA4;PSMB2;UBB;PSME1;PSME2;PSMB10;NFKB1;PSMB8;PSMB9
29,BioPlanet_2019,Interleukin-1 regulation of extracellular matrix,14 of 120,3.2466791378335205e-08,9.317969125582204e-07,0,0,7.500658183413778,129.334209641382,JUN;CXCL8;HLA-B;TNFAIP3;INHBA;SOD2;NFKB1;ICAM1;RHOB;NFKBIA;MT2A;ZFP36;NAMPT;BIRC3
30,BioPlanet_2019,Toll-like receptor signaling pathway regulation,15 of 142,4.051835883825476e-08,1.1253647406366885e-06,0,0,6.71988705493446,114.38262914559178,JUN;CD40;CXCL8;STAT1;TRAFD1;TNFAIP3;NFKB1;NFKB2;NFKBIA;CYLD;SOCS1;TRAF3;MAP3K8;RAC1;SQSTM1
31,BioPlanet_2019,mRNA stability regulation by proteins that bind AU-rich elements,12 of 86,4.192499326585682e-08,1.1280443500594602e-06,0,0,9.171067020778004,155.79243432738383,ZFP36;PSMA3;PSMA4;PSMB2;UBB;PSME1;HSPB1;PSME2;YWHAZ;PSMB10;PSMB8;PSMB9
32,BioPlanet_2019,TWEAK signaling pathway,9 of 42,4.519362560430454e-08,1.1791427771304913e-06,0,0,15.323521750455848,259.1561468639848,NFKBIA;JUN;TNFRSF12A;TRAF3;TRAF2;RAC1;NFKB1;RELB;NFKB2
33,BioPlanet_2019,Interleukin-6 signaling pathway,11 of 71,5.0860007323868254e-08,1.2879548913485462e-06,0,0,10.34591738712776,173.75129128413562,SOCS3;JUN;CEBPD;STAT1;IRF1;STAT3;RAC1;TIMP1;JUNB;JAK1;MCL1
34,BioPlanet_2019,Interleukin-1 signaling pathway,14 of 125,5.480757199435756e-08,1.348266271061196e-06,0,0,7.160957469097004,119.72718068330482,JUN;CXCL8;UBE2B;HSPB1;TNFAIP3;UBE2L6;UBE2Z;NFKB1;NFKBIA;ZFP36;TNIP2;MAP3K8;SQSTM1;MAP3K14
35,BioPlanet_2019,RIG-I/MDA5-mediated induction of interferon-alpha/beta pathways,11 of 76,1.050315314444153e-07,2.5120041270455984e-06,0,0,9.547639104411438,153.42106272584593,IFIH1;NFKBIA;CYLD;UBB;TRAF3;IRF1;TNFAIP3;UBE2L6;TRAF2;NFKB1;NFKB2
36,BioPlanet_2019,TSH regulation of gene expression,12 of 97,1.638635265639996e-07,3.813148550583883e-06,0,0,7.979734784087046,124.67722685208082,PPP1R15A;VMP1;EGR1;JUN;CXCL8;GADD45B;TNFAIP3;HES1;AHR;CALM2;PTPRF;ICAM1
37,BioPlanet_2019,Apoptosis modulation and signaling,11 of 80,1.802706918757954e-07,4.08455436065947e-06,0,0,8.992315081652258,139.63991883924388,NFKBIA;JUN;TRAF3;TNFSF10;CFLAR;MAP3K14;NFKB1;BBC3;TNFRSF1A;BIRC3;MCL1
38,BioPlanet_2019,CD40L signaling pathway,6 of 16,2.1710783604564187e-07,4.793072995776863e-06,0,0,33.46363636363636,513.4282782229468,NFKBIA;CD40;TRAF3;TNFAIP3;MAP3K14;NFKB1
39,BioPlanet_2019,Destabilization of mRNA by AUF1 (hnRNP D0),10 of 66,2.58023245716768e-07,5.55395036405343e-06,0,0,10.05028735632184,152.46503162939783,PSMA3;PSMA4;PSMB2;UBB;PSME1;HSPB1;PSME2;PSMB10;PSMB8;PSMB9
40,BioPlanet_2019,TNFR2 signaling pathway,6 of 18,4.882699115124082e-07,1.0253668141760571e-05,0,0,27.883522727272727,405.214435600313,NFKBIA;TRAF3;TNFAIP3;TRAF2;MAP3K14;NFKB1
41,BioPlanet_2019,Cyclin A-Cdk2-associated events at S phase entry,10 of 72,5.962518058323526e-07,1.2223162019563228e-05,0,0,9.074898034853542,130.06690867640643,CDKN1A;PSMA3;PSMA4;PSMB2;UBB;PSME1;PSME2;PSMB10;PSMB8;PSMB9
42,BioPlanet_2019,EGFR1 pathway,14 of 152,6.295356442065191e-07,1.2605353247949137e-05,0,0,5.751937984496124,82.12780042340486,CDKN1A;GRN;BTG1;ITGA3;ARID5B;HSPB1;EHD1;CLDN4;PIK3IP1;NINJ1;MT1F;HPRT1;SQSTM1;IER3
43,BioPlanet_2019,Degradation of beta-catenin by the destruction complex,10 of 73,6.800289783661622e-07,1.3306930690301493e-05,0,0,8.930395913154534,126.82171710459264,PSMA3;PSMA4;PPP2R1B;PSMB2;UBB;PSME1;PSME2;PSMB10;PSMB8;PSMB9
44,BioPlanet_2019,ATF2 transcription factor network,9 of 59,9.743874891952597e-07,1.8426607279379235e-05,0,0,10.104756446991404,139.86454962910312,ACHE;DUSP5;SOCS3;JUN;CXCL8;JUND;HES1;JUNB;ATF3
45,BioPlanet_2019,Gastrin pathway,8 of 44,9.844645004081822e-07,1.8426607279379235e-05,0,0,12.448253968253969,172.17389191688872,CHGA;JUN;CXCL8;S100A6;HES1;NFKB1;IER3;BIRC3
46,BioPlanet_2019,MAPK signaling pathway,20 of 314,1.0846125373727123e-06,1.948585475594683e-05,0,0,3.894054663285433,53.48206723316586,DUSP5;JUN;JUND;GADD45B;H3F3B;STAT1;CACNA2D1;H3F3A;HSPB1;TRAF2;HSPA2;NFKB1;RELB;RASGRP3;NFKB2;TNFRSF1A;RRAS;MAP3K8;RAC1;MAP3K14
47,BioPlanet_2019,Toll receptor cascades,14 of 159,1.0863194289029592e-06,1.948585475594683e-05,0,0,5.472293504410586,75.14944844010077,JUN;UBE2B;TNFAIP3;UBE2L6;UBE2Z;NFKB1;CTSS;NFKB2;NFKBIA;PPP2R1B;UBB;TRAF3;MAP3K8;MAP3K14
48,BioPlanet_2019,Apoptosis regulation,10 of 78,1.2722917071035855e-06,2.235598285339158e-05,0,0,8.271636240703177,112.28490429369911,CDKN1A;PSMA3;PSMA4;PSMB2;UBB;PSME1;PSME2;PSMB10;PSMB8;PSMB9
49,BioPlanet_2019,TGF-beta regulation of extracellular matrix,28 of 565,1.3179881061002374e-06,2.269575518704609e-05,0,0,3.0186784041532646,40.87110690101927,CEBPD;TNFAIP3;PLOD2;SPINT2;AHR;PTPRF;UGCG;SDCBP;RRAS;TNFSF10;JUNB;S100A11;KLF10;TNFRSF12A;DENND4A;PLA2G4C;TAP1;INHBA;ATP1B1;TNFRSF1A;ELF3;PPA1;QPCT;NINJ1;RBP1;DDIT4;RAB13;ATF3
50,BioPlanet_2019,Alternative NF-kappaB pathway,4 of 6,1.471998602216662e-06,2.485079993154012e-05,0,0,110.96045197740114,1490.0756470586225,MAP3K14;NFKB1;NFKB2;RELB
51,BioPlanet_2019,Induction of apoptosis through DR3 and DR4/5 death receptors,7 of 34,1.9700658808980204e-06,3.2069345088317054e-05,0,0,14.48823467341986,190.33836550448072,NFKBIA;TNFSF10;TRAF2;CFLAR;MAP3K14;NFKB1;BIRC3
52,BioPlanet_2019,Ubiquitin-mediated degradation of phosphorylated Cdc25A,9 of 64,1.9740711842982627e-06,3.2069345088317054e-05,0,0,9.18379786402709,120.6329737809852,PSMA3;PSMA4;PSMB2;UBB;PSME1;PSME2;PSMB10;PSMB8;PSMB9
53,BioPlanet_2019,Regular glucocorticoid receptor pathway,10 of 82,2.030248371241736e-06,3.237118236368768e-05,0,0,7.810504469987229,102.37503468195844,EGR1;CDKN1A;HSP90AA1;JUN;CXCL8;STAT1;IRF1;NFKB1;ICAM1;FKBP5
54,BioPlanet_2019,Interleukin-12-mediated signaling events,9 of 65,2.255587633762005e-06,3.531019913943793e-05,0,0,9.019340974212035,117.27037352873457,SOCS1;GADD45B;STAT1;STAT3;HLA-A;B2M;NFKB1;RELB;NFKB2
55,BioPlanet_2019,Interferon gamma signaling regulation,5 of 14,3.1324862027691997e-06,4.816197536757644e-05,0,0,30.898646521875985,391.5996682876792,SOCS3;SOCS1;STAT1;IFNGR2;JAK1
56,BioPlanet_2019,HIV factor interactions with host,12 of 128,3.32057677907744e-06,5.0158186083959226e-05,0,0,5.837950966713176,73.64792352180538,PSMA3;PSMA4;UBB;PSMB2;PSME1;PSME2;HLA-A;RAC1;B2M;PSMB10;PSMB8;PSMB9
57,BioPlanet_2019,Signaling by the B cell receptor (BCR),13 of 151,3.382790645169021e-06,5.021694388776772e-05,0,0,5.325603864734299,67.08561764651562,CDKN1A;NFKB1;PSMB10;PSMB8;RASGRP3;PSMB9;NFKBIA;PSMA3;PSMA4;UBB;PSMB2;PSME1;PSME2
58,BioPlanet_2019,DNA replication pre-Initiation,10 of 88,3.895483421681434e-06,5.6847647899452784e-05,0,0,7.207486000589449,89.7742312886512,CDKN1A;PSMA3;PSMA4;PSMB2;UBB;PSME1;PSME2;PSMB10;PSMB8;PSMB9
59,BioPlanet_2019,AP-1 transcription factor network,9 of 70,4.242001169291296e-06,6.087271677933009e-05,0,0,8.277936962750717,102.40201577713836,EGR1;MT2A;JUN;CXCL8;JUND;TIMP1;HLA-A;JUNB;ATF3
60,BioPlanet_2019,Adipogenesis,12 of 133,4.95624823370714e-06,6.995622506921062e-05,0,0,5.595280179620695,68.34557249218948,SOCS3;CDKN1A;KLF6;SOCS1;GADD45B;CEBPD;EPAS1;STAT1;NAMPT;STAT3;CISD1;AHR
61,BioPlanet_2019,TNF/stress-related signaling,6 of 27,6.794354629173875e-06,9.435386025352752e-05,0,0,15.926136363636363,189.51176155447448,NFKBIA;JUN;TRAF2;MAP3K14;NFKB1;TNFRSF1A
62,BioPlanet_2019,p53 signaling pathway,12 of 139,7.822432831442653e-06,0.00010690658202971623,0,0,5.329297710618542,62.664626792782215,DUSP5;DDX5;JUN;BTG2;CDKN1A;CD82;SESN1;DDIT4;TAP1;ATF3;MCL1;BBC3
63,BioPlanet_2019,Autodegradation of Cdh1 by Cdh1-APC/C,8 of 58,8.561584535539363e-06,0.000115180066954678,0,0,8.956342857142857,104.50462610309494,PSMA3;PSMA4;PSMB2;PSME1;PSME2;PSMB10;PSMB8;PSMB9
64,BioPlanet_2019,Prolactin regulation of apoptosis,11 of 118,8.98767520825856e-06,0.00011905212852785567,0,0,5.787524576476609,67.24904664054884,SOCS2;SOCS3;EGR1;HSP90AA1;KLF6;PSMA4;FTH1;IRF1;BCL3;TRIB1;IER3
65,BioPlanet_2019,Insulin signaling pathway,17 of 277,1.136615125375252e-05,0.00014827660953758967,0,0,3.716377171215881,42.31047396666487,EGR1;JUN;PTPRF;RHOB;TNFRSF1A;EHD1;SOCS2;SOCS3;SOCS1;KIF5B;STX4;MAP3K8;RAC1;CALM2;GYG1;MAP3K14;RHOQ
66,BioPlanet_2019,Leptin signaling pathway,8 of 61,1.2553947728839403e-05,0.0001589551322725107,0,0,8.448086253369272,95.34066943558034,SOCS2;SOCS3;STAT1;CFL2;STAT3;RAC1;NFKB1;JAK1
67,BioPlanet_2019,Licensing factor removal from origins,8 of 61,1.2553947728839403e-05,0.0001589551322725107,0,0,8.448086253369272,95.34066943558034,PSMA3;PSMA4;PSMB2;PSME1;PSME2;PSMB10;PSMB8;PSMB9
68,BioPlanet_2019,APC/C-mediated degradation of cell cycle proteins,9 of 82,1.5833326561418866e-05,0.0001956823598141608,0,0,6.912941084115084,76.4114584825727,PSMA3;PSMA4;PSMB2;UBB;PSME1;PSME2;PSMB10;PSMB8;PSMB9
69,BioPlanet_2019,Alpha-V beta-3 integrin/OPN pathway,6 of 31,1.5909134944240714e-05,0.0001956823598141608,0,0,13.375227272727273,147.77776461363348,NFKBIA;JUN;ILK;RAC1;MAP3K14;NFKB1
70,BioPlanet_2019,NOD signaling pathway,9 of 85,2.122331083283524e-05,0.00025737000883198786,0,0,6.639043884783592,71.43883694873804,NFKBIA;CYLD;HSP90AA1;CXCL8;CASP4;TNFAIP3;RAC1;NFKB1;BIRC3
71,BioPlanet_2019,Negative regulators of RIG-I/MDA5 signaling,6 of 33,2.3220179125165185e-05,0.0002776746420384337,0,0,12.383207070707073,132.1348731914592,IFIH1;CYLD;UBB;TRAF3;TNFAIP3;UBE2L6
72,BioPlanet_2019,Signaling by interleukins,10 of 109,2.640265962511876e-05,0.0003114067114688664,0,0,5.672529896667828,59.80007002649049,SOCS3;STAT1;TNIP2;STAT3;MAP3K8;SQSTM1;YWHAZ;NFKB1;NFKB2;JAK1
73,BioPlanet_2019,HIF-1 degradation in normoxia,9 of 88,2.809840360368046e-05,0.0003269287230103902,0,0,6.385949004388669,66.92345429195194,HSP90AA1;PSMA3;PSMA4;PSMB2;PSME1;PSME2;PSMB10;PSMB8;PSMB9
74,BioPlanet_2019,Erythropoietin-mediated neuroprotection through NF-kB,4 of 11,3.016063972523326e-05,0.000344177371071147,0,0,31.694915254237287,329.9115109064604,NFKBIA;CDKN1A;SOD2;NFKB1
75,BioPlanet_2019,TGF-beta signaling pathway,13 of 185,3.0380348665978133e-05,0.000344177371071147,0,0,4.265419615773508,44.36767742442609,KLF10;PPP1R15A;JUN;JUND;STAT1;STAT3;INHBA;NFKB1;KLF6;RAC1;JUNB;ATF3;JAK1
76,BioPlanet_2019,Mitotic G1-G1/S phases,11 of 135,3.208805075562558e-05,0.0003588027493583588,0,0,4.989727619224691,51.628845638999344,CDKN1A;PSMA3;PSMA4;PPP2R1B;UBB;PSMB2;PSME1;PSME2;PSMB10;PSMB8;PSMB9
77,BioPlanet_2019,S phase,10 of 112,3.34270936508604e-05,0.0003689836876075744,0,0,5.504845616407483,56.73373051764877,CDKN1A;PSMA3;PSMA4;UBB;PSMB2;PSME1;PSME2;PSMB10;PSMB8;PSMB9
78,BioPlanet_2019,Epstein-Barr virus LMP1 signaling,5 of 22,3.6619556247395146e-05,0.0003941179741125902,0,0,16.351441426428927,167.0287991001042,HSP90AA1;CXCL8;MAP3K14;NFKB1;NFKB2
79,BioPlanet_2019,TRAF6 mediated NF-kB activation,5 of 22,3.6619556247395146e-05,0.0003941179741125902,0,0,16.351441426428927,167.0287991001042,IFIH1;NFKBIA;TRAF2;NFKB1;NFKB2
80,BioPlanet_2019,RIG-I-like receptor signaling pathway,8 of 71,3.883135171872669e-05,0.00040772919304663023,0,0,7.103492063492063,72.14507286947499,IFIH1;NFKBIA;CYLD;CXCL8;TRAF3;TRAF2;TMEM173;NFKB1
81,BioPlanet_2019,Viral myocarditis,8 of 71,3.883135171872669e-05,0.00040772919304663023,0,0,7.103492063492063,72.14507286947499,CD40;HLA-B;HLA-C;RAC1;HLA-A;HLA-F;ICAM1;HLA-E
82,BioPlanet_2019,Allograft rejection,6 of 37,4.588659538436371e-05,0.0004670466887074467,0,0,10.78317448680352,107.71676951922544,CD40;HLA-B;HLA-C;HLA-A;HLA-F;HLA-E
83,BioPlanet_2019,Interleukin-23-mediated signaling events,6 of 37,4.588659538436371e-05,0.0004670466887074467,0,0,10.78317448680352,107.71676951922544,NFKBIA;SOCS3;ITGA3;STAT1;STAT3;NFKB1
84,BioPlanet_2019,Modulation of interferon signaling by chaperones,5 of 23,4.610797739852842e-05,0.0004670466887074467,0,0,15.442241107963488,154.18343587276942,NFKBIA;IFNGR2;TAX1BP3;NFKB1;TNFRSF1A
85,BioPlanet_2019,Cell cycle checkpoints,10 of 117,4.868812255251101e-05,0.000487447366485023,0,0,5.246267053389193,52.09582765901055,CDKN1A;PSMA3;PSMA4;UBB;PSMB2;PSME1;PSME2;PSMB10;PSMB8;PSMB9
86,BioPlanet_2019,NF-kappaB signaling pathway,5 of 24,5.7391021021956365e-05,0.0005679732080448785,0,0,14.62874608617862,142.85881477951213,NFKBIA;TNFAIP3;MAP3K14;NFKB1;TNFRSF1A
87,BioPlanet_2019,Death receptor signaling,4 of 13,6.35182868561859e-05,0.000607658277590845,0,0,24.649089767733837,238.21330718846437,TNFSF10;TRAF2;CFLAR;TNFRSF1A
88,BioPlanet_2019,Interleukin-22 soluble receptor signaling pathway,4 of 13,6.35182868561859e-05,0.000607658277590845,0,0,24.649089767733837,238.21330718846437,SOCS3;STAT1;STAT3;JAK1
89,BioPlanet_2019,TACI and BCMA stimulation of B cell immune responses,4 of 13,6.35182868561859e-05,0.000607658277590845,0,0,24.649089767733837,238.21330718846437,TRAF3;TRAF2;MAP3K14;NFKB1
90,BioPlanet_2019,Keratinocyte differentiation,7 of 57,6.802010283448369e-05,0.0006435748191262687,0,0,7.814472934472935,74.98539472165217,NFKBIA;JUN;TRAF2;MAP3K14;NFKB1;TNFRSF1A;BIRC3
91,BioPlanet_2019,Senescence and autophagy,9 of 99,7.1662853006027e-05,0.0006706708308498831,0,0,5.602292263610315,53.46568929417263,JUN;CDKN1A;MAP1LC3B;CXCL8;KMT2A;IRF1;INHBA;SLC39A1;SQSTM1
92,BioPlanet_2019,HIV-1 Nef as negative effector of Fas and TNF,7 of 58,7.618112814627829e-05,0.0007052897992897377,0,0,7.6608569353667395,72.64328519776492,NFKBIA;TRAF2;CFLAR;MAP3K14;NFKB1;TNFRSF1A;BIRC3
93,BioPlanet_2019,Caspase cascade in apoptosis,7 of 59,8.512360152514236e-05,0.0007796959671611444,0,0,7.513149243918475,70.40877357213915,CFL2;CASP4;TNFSF10;TRAF2;TOP1;TNFRSF1A;BIRC3
94,BioPlanet_2019,MAP kinase signaling pathway,8 of 81,0.00010053911314558316,0.0009112018570352328,0,0,6.127279843444227,56.40138866517411,NFKBIA;JUN;STAT1;MAP3K8;TRAF2;RAC1;MAP3K14;NFKB1
95,BioPlanet_2019,Phagosome,11 of 154,0.0001065448081028009,0.0009555737476719956,0,0,4.322544890268233,39.53808005982603,TUBA1C;ATP6V0E1;TUBA1A;HLA-B;HLA-C;TAP1;HLA-A;RAC1;HLA-F;CTSS;HLA-E
96,BioPlanet_2019,NF-kappaB activation,3 of 6,0.00010927988141868188,0.0009699997721802588,0,0,55.32112676056338,504.6170928954336,NFKBIA;SQSTM1;NFKB1
97,BioPlanet_2019,p75 neurotrophin receptor signaling via NF-kB,4 of 16,0.0001549490548095813,0.0013613381243984,0,0,18.483992467043315,162.14923750481628,NFKBIA;UBB;SQSTM1;NFKB1
98,BioPlanet_2019,ATM pathway,6 of 48,0.0002052771361391009,0.0017852890324824,0,0,7.954545454545454,67.54323551971234,NFKBIA;CDKN1A;JUN;RBBP8;NBN;NFKB1
99,BioPlanet_2019,Epithelial cell signaling in Helicobacter pylori infection,7 of 68,0.00021080816136744964,0.0018150582693737,0,0,6.401709401709402,54.18766630244211,NFKBIA;JUN;CXCL8;ATP6V0E1;RAC1;MAP3K14;NFKB1
100,BioPlanet_2019,Innate immune system,16 of 319,0.00022123865470760623,0.001886004769339,0,0,2.985968772315828,25.13071508032017,JUN;TNFAIP3;UBE2L6;TRAF2;CTSS;NFKB1;NFKB2;IFIH1;NFKBIA;CYLD;PPP2R1B;UBB;TRAF3;IRF1;CASP4;BIRC3
101,BioPlanet_2019,HIV infection,12 of 200,0.00027134446656854733,0.0022787900154992,0,0,3.5888574591071207,29.472133320539218,PSMA3;PSMA4;PSMB2;UBB;PSME1;PSME2;HLA-A;RAC1;B2M;PSMB8;PSMB10;PSMB9
102,BioPlanet_2019,Pathways in cancer,16 of 325,0.0002726078648042068,0.0022787900154992,0,0,2.927080376237249,24.02394248844277,JUN;CDKN1A;HSP90AA1;CXCL8;EPAS1;STAT1;ITGA3;STAT3;TRAF2;NFKB1;NFKB2;NFKBIA;TRAF3;RAC1;JAK1;BIRC3
103,BioPlanet_2019,Autoimmune thyroid disease,6 of 52,0.0003207154826481949,0.0026551541400009,0,0,7.261363636363637,58.41735222355795,CD40;HLA-B;HLA-C;HLA-A;HLA-F;HLA-E
104,BioPlanet_2019,RANKL regulation of apoptosis and immune response,7 of 74,0.00035709535893467634,0.0029281819432643,0,0,5.826636050516648,46.24896851601998,EGR1;JUN;ITGA3;TRAF3;HLA-C;ICAM1;RELB
105,BioPlanet_2019,Interleukin-2/PI3K pathway,5 of 35,0.00037298573251784087,0.003029629393376,0,0,9.259678942398487,73.09563138918563,UGCG;HSP90AA1;RAC1;NFKB1;JAK1
106,BioPlanet_2019,4-1BB-dependent immune response,4 of 20,0.0003897867011616559,0.0031365079411232,0,0,13.860169491525424,108.80109540873288,NFKBIA;JUN;TRAF2;NFKB1
107,BioPlanet_2019,Integrated breast cancer pathway,10 of 152,0.0004219894435525912,0.0033641936194331,0,0,3.946090335114133,30.6632143558013,JUN;GRN;RRAS;RASGEF1A;STAT1;AHR;RAC1;NFKB1;RASGRP3;JAK1
108,BioPlanet_2019,"cAMP receptor, G-protein-independent pathways inferred from amoeba model",3 of 9,0.0004409519207588695,0.0034831156309485,0,0,27.656338028169014,213.6887620262189,KLF6;STAT1;STAT3
109,BioPlanet_2019,Mitochondrial pathway of apoptosis: caspases,7 of 77,0.0004558701822423888,0.0035682202446426,0,0,5.576068376068376,42.89838064978562,ACHE;HSP90AA1;HSPB1;TRAF2;HSPA2;PTMA;BIRC3
110,BioPlanet_2019,Chagas disease,8 of 104,0.0005643611511815187,0.0043385263497079,0,0,4.653809523809524,34.80963973955927,NFKBIA;JUN;CXCL8;PPP2R1B;IFNGR2;CFLAR;NFKB1;TNFRSF1A
111,BioPlanet_2019,Interleukin-4 signaling pathway,8 of 104,0.0005643611511815187,0.0043385263497079,0,0,4.653809523809524,34.80963973955927,NFKBIA;SOCS3;SOCS1;STAT1;STAT3;PARP14;NFKB1;JAK1
112,BioPlanet_2019,Cell adhesion molecules (CAMs),9 of 133,0.0006628858309350439,0.0050508380569475,0,0,4.059108974951474,29.708244270067485,CLDN4;CD40;HLA-B;HLA-C;HLA-A;HLA-F;PTPRF;ICAM1;HLA-E
113,BioPlanet_2019,Interleukin-11 pathway,4 of 23,0.0006828437859397919,0.0051124217364709,0,0,11.66993755575379,85.06502746751937,SOCS3;JUN;TIMP1;ICAM1
114,BioPlanet_2019,Signaling events mediated by PRL,4 of 23,0.0006828437859397919,0.0051124217364709,0,0,11.66993755575379,85.06502746751937,EGR1;CDKN1A;ITGA1;RAC1
115,BioPlanet_2019,Graft-versus-host disease,5 of 41,0.0007886932929597547,0.0058540079761926,0,0,7.714038401007239,55.11783066254957,HLA-B;HLA-C;HLA-A;HLA-F;HLA-E
116,BioPlanet_2019,Interferon alpha signaling regulation,4 of 25,0.000948363078576226,0.0069789795782404,0,0,10.55743879472693,73.48793633414614,SOCS3;SOCS1;STAT1;JAK1
117,BioPlanet_2019,Growth hormone receptor signaling,5 of 43,0.0009839229227073885,0.0071189717348828,0,0,7.307290890114805,50.595411713654514,SOCS2;SOCS3;SOCS1;STAT1;STAT3
118,BioPlanet_2019,Type 1 diabetes mellitus,5 of 43,0.0009839229227073885,0.0071189717348828,0,0,7.307290890114805,50.595411713654514,HLA-B;HLA-C;HLA-A;HLA-F;HLA-E
119,BioPlanet_2019,Fas signaling pathway,8 of 115,0.0010941189125805,0.0077674500114131,0,0,4.173030707610147,28.450913319385137,CXCL8;HSPB1;TRAF2;CFLAR;MAP3K14;NFKB1;NFKB2;BIRC3
120,BioPlanet_2019,Interleukin-9 regulation of target genes,4 of 26,0.0011051125116299,0.0077674500114131,0,0,10.07704160246533,68.60256573467454,SOCS2;SOCS3;BCL3;JUNB
121,BioPlanet_2019,Physiological and pathological hypertrophy  of the heart,4 of 26,0.0011051125116299,0.0077674500114131,0,0,10.07704160246533,68.60256573467454,JUN;STAT3;RAC1;CALM2
122,BioPlanet_2019,SODD/TNFR1 signaling pathway,3 of 12,0.0011096357159161,0.0077674500114131,0,0,18.43474178403756,125.42488591795234,TRAF2;BIRC3;TNFRSF1A
123,BioPlanet_2019,Integrin-linked kinase signaling,5 of 45,0.0012129236076747,0.0083546178096639,0,0,6.941218130311615,46.60834751129824,HSP90AA1;JUN;ACTN1;ILK;RAC1
124,BioPlanet_2019,Wnt interactions in lipid metabolism and immune response,5 of 45,0.0012129236076747,0.0083546178096639,0,0,6.941218130311615,46.60834751129824,IL32;KLF10;RBP1;HES1;IFI30
125,BioPlanet_2019,Adipocytokine signaling pathway,6 of 67,0.0012561325004995,0.0085835720867469,0,0,5.471590909090909,36.54868276557082,NFKBIA;SOCS3;STAT3;TRAF2;NFKB1;TNFRSF1A
126,BioPlanet_2019,Oxidative stress,4 of 27,0.0012791672278578,0.0086721494739023,0,0,9.638418079096043,64.20676555554516,SOD2;JUNB;NFKB1;NFE2L2
127,BioPlanet_2019,DNA replication,11 of 207,0.0013136567812906,0.0088363944429006,0,0,3.145121449156031,20.86769397761227,CDKN1A;PSMA3;PSMA4;PPP2R1B;PSMB2;UBB;PSME1;PSME2;PSMB8;PSMB10;PSMB9
128,BioPlanet_2019,Immunoregulatory interactions between a lymphoid and a non-lymphoid cell,8 of 119,0.0013641971011676,0.0091052225124442,0,0,4.021827541827542,26.532757334523488,CD40;HLA-B;HLA-C;HLA-A;HLA-F;B2M;ICAM1;HLA-E
129,BioPlanet_2019,CTL mediated immune response against target cells,3 of 13,0.0014234726795118,0.009355801351601,0,0,16.590422535211268,108.74451002328112,HLA-A;B2M;ICAM1
130,BioPlanet_2019,Double stranded RNA-induced gene expression,3 of 13,0.0014234726795118,0.009355801351601,0,0,16.590422535211268,108.74451002328112,NFKBIA;MAP3K14;NFKB1
131,BioPlanet_2019,Notch signaling pathway,8 of 121,0.0015177814960833,0.0099000747585434,0,0,3.9502402022756007,25.639055965960075,CDKN1A;DTX3L;STAT3;RBBP8;HES1;CFLAR;NFKB1;BIRC3
132,BioPlanet_2019,Diurnally regulated genes with circadian orthologs,5 of 48,0.0016272255701603,0.0105341444805119,0,0,6.455958890572502,41.45292969413092,DNAJA1;BTG1;PSMA4;G0S2;GFRA1
133,BioPlanet_2019,Influence of Ras and Rho proteins on G1 to S transition,4 of 29,0.0016831122962457,0.0108146245303548,0,0,8.866440677966102,56.63093761219123,NFKBIA;CDKN1A;RAC1;NFKB1
134,BioPlanet_2019,Ceramide signaling pathway,5 of 49,0.0017859524249055,0.0113904076877309,0,0,6.308910636106104,39.921546392200185,NFKBIA;TRAF2;NFKB1;TNFRSF1A;BIRC3
135,BioPlanet_2019,Leishmaniasis,6 of 72,0.0018253268780593,0.0115559297206549,0,0,5.055785123966942,31.881761763173177,NFKBIA;JUN;STAT1;IFNGR2;NFKB1;JAK1
136,BioPlanet_2019,PDGFA signaling pathway,4 of 30,0.001914948587632,0.011947614014139,0,0,8.524989135158627,53.34993190286471,JUN;STAT1;STAT3;JAK1
137,BioPlanet_2019,TNFR1 signaling pathway,4 of 30,0.001914948587632,0.011947614014139,0,0,8.524989135158627,53.34993190286471,JUN;TRAF2;TNFRSF1A;BIRC3
138,BioPlanet_2019,NF-kappaB activation by non-typeable Hemophilus influenzae,4 of 31,0.0021679783256438,0.0134289880458943,0,0,8.20883029922578,50.35263828532401,NFKBIA;CXCL8;MAP3K14;NFKB1
139,BioPlanet_2019,AKAP95 role in mitosis and chromosome dynamics,3 of 15,0.0022052639362332,0.0135623732078345,0,0,13.82394366197183,84.55979265952955,DDX5;H3F3B;H3F3A
140,BioPlanet_2019,Disease,23 of 674,0.0024954914740098,0.0152384266604433,0,0,2.0028566843203337,12.003660050465289,CDKN1A;HSP90AA1;ATP6V0E1;CXCL8;STAT1;H3F3A;STAT3;RAB27A;HLA-A;PSMB10;PSMB8;PSMB9;PSMA3;PSMA4;PSMB2;UBB;KIF5B;PSME1;PSME2;STX4;RAC1;B2M;ATF3
141,BioPlanet_2019,Androgen receptor regulation of biosynthesis and transcription,5 of 53,0.0025358504283821,0.0153758254847675,0,0,5.781987724268178,34.5602486493994,DNAJA1;EGR1;HSP90AA1;JUN;ZMIZ2
142,BioPlanet_2019,Acetylation and deacetylation of RelA in the nucleus,3 of 16,0.002678415700234,0.0159042477096657,0,0,12.759913326110508,75.57096712206703,NFKBIA;NFKB1;TNFRSF1A
143,BioPlanet_2019,Interleukin-10 anti-inflammatory signaling pathway,3 of 16,0.002678415700234,0.0159042477096657,0,0,12.759913326110508,75.57096712206703,STAT1;STAT3;JAK1
144,BioPlanet_2019,Interleukin-9 signaling pathway,3 of 16,0.002678415700234,0.0159042477096657,0,0,12.759913326110508,75.57096712206703,STAT1;STAT3;JAK1
145,BioPlanet_2019,Amino acid metabolism,10 of 195,0.0027836186907618,0.0164157239229173,0,0,3.022211867039453,17.78270523488003,PSMA3;PSMA4;PSMB2;PSME1;PSME2;INHBA;GLUL;PSMB8;PSMB10;PSMB9
146,BioPlanet_2019,ERBB1 downstream pathway,7 of 106,0.0029753787269547,0.0174272182578778,0,0,3.936832714610493,22.90206742776695,EGR1;ZFP36;JUN;STAT1;STAT3;RAC1;YWHAZ
147,BioPlanet_2019,EPO receptor signaling,4 of 34,0.0030636765060644,0.0177035266558486,0,0,7.386817325800377,42.7559299674016,JUN;SOCS1;STAT1;STAT3
148,BioPlanet_2019,N-cadherin signaling events,4 of 34,0.0030636765060644,0.0177035266558486,0,0,7.386817325800377,42.7559299674016,GAP43;KIF5B;CTNND1;RAC1
149,BioPlanet_2019,Atypical NF-kappaB pathway,3 of 17,0.0032095551107824,0.0180616140547951,0,0,11.84788732394366,68.02610172335068,NFKBIA;BCL3;NFKB1
150,BioPlanet_2019,Cadmium-induced DNA biosynthesis and proliferation in macrophages,3 of 17,0.0032095551107824,0.0180616140547951,0,0,11.84788732394366,68.02610172335068,NFKBIA;JUN;NFKB1
151,BioPlanet_2019,Post-chaperonin tubulin folding pathway,3 of 17,0.0032095551107824,0.0180616140547951,0,0,11.84788732394366,68.02610172335068,TUBA1C;TUBA1A;TBCB
152,BioPlanet_2019,Zinc transporters,3 of 17,0.0032095551107824,0.0180616140547951,0,0,11.84788732394366,68.02610172335068,SLC30A2;SLC39A14;SLC39A1
153,BioPlanet_2019,Natural killer cell-mediated cytotoxicity,8 of 137,0.0032993313572844,0.0184462616793627,0,0,3.457452934662237,19.756008635520185,IFNGR2;TNFSF10;HLA-B;HLA-C;HLA-A;RAC1;ICAM1;HLA-E
154,BioPlanet_2019,fMLP induced chemokine gene expression in HMC-1 cells,4 of 35,0.00341086367259,0.0189467975619354,0,0,7.148168398031712,40.60724171918002,NFKBIA;RAC1;CALM2;NFKB1
155,BioPlanet_2019,Endocytosis,10 of 201,0.0034572321174115,0.0190812618787904,0,0,2.926370584341337,16.584581899944595,EHD1;RAB11FIP1;HLA-B;HLA-C;CHMP4B;HLA-A;HSPA2;HLA-F;HLA-E;CHMP5
156,BioPlanet_2019,Corticosteroids and cardioprotection,3 of 18,0.0038008197098911,0.0208439857975557,0,0,11.057464788732394,61.61814849510802,HSP90AA1;CALM2;NFKB1
157,BioPlanet_2019,Small cell lung cancer,6 of 84,0.0039731451737717,0.0216511265482118,0,0,4.27534965034965,23.634976234271107,NFKBIA;ITGA3;TRAF3;TRAF2;NFKB1;BIRC3
158,BioPlanet_2019,FRA pathway,4 of 37,0.0041835639239999,0.0226543933243015,0,0,6.714261256634138,36.771268022409856,JUN;CXCL8;JUND;JUNB
159,BioPlanet_2019,Calcineurin in effects in keratinocyte differentiation,3 of 19,0.0044541753760506,0.0236731172764171,0,0,10.365845070422536,56.11978686532731,CDKN1A;MARCKS;CALM2
160,BioPlanet_2019,STAT3 pathway,3 of 19,0.0044541753760506,0.0236731172764171,0,0,10.365845070422536,56.11978686532731,STAT3;RAC1;JAK1
161,BioPlanet_2019,TP53 network,3 of 19,0.0044541753760506,0.0236731172764171,0,0,10.365845070422536,56.11978686532731,CDKN1A;TNFSF10;BBC3
162,BioPlanet_2019,Signal transduction through IL-1R,4 of 38,0.0046108155855113,0.0243552896878852,0,0,6.516450648055833,35.054272188850554,NFKBIA;JUN;MAP3K14;NFKB1
163,BioPlanet_2019,CXCR4 signaling pathway,7 of 116,0.0048956120542934,0.0257019632850405,0,0,3.573825766486317,19.010665871212765,ITGA3;STAT1;ITGA1;STAT3;RAC1;NFKB1;RHOB
164,BioPlanet_2019,ID regulation of gene expression,3 of 20,0.0051714231074298,0.0269854260333159,0,0,9.755592377796187,51.35936348969903,CDKN1A;CXCL8;ICAM1
165,BioPlanet_2019,Cytosolic sensors of pathogen-associated DNA,3 of 21,0.0059542055912545,0.0306980300243723,0,0,9.213145539906105,47.20500212478504,NFKBIA;NFKB1;NFKB2
166,BioPlanet_2019,Oxidative stress-induced gene expression via Nrf2,3 of 21,0.0059542055912545,0.0306980300243723,0,0,9.213145539906105,47.20500212478504,JUN;FXYD2;NFE2L2
167,BioPlanet_2019,LPA receptor mediated events,5 of 65,0.0061344840885331,0.0314392309537325,0,0,4.62275731822474,23.547536662823813,NFKBIA;JUN;CXCL8;RAC1;NFKB1
168,BioPlanet_2019,Activation of PKC through G-protein coupled receptors,2 of 7,0.0063223463582161,0.0320208247907301,0,0,22.064044943820225,111.72492950405196,NFKBIA;NFKB1
169,BioPlanet_2019,Interleukin-1 processing,2 of 7,0.0063223463582161,0.0320208247907301,0,0,22.064044943820225,111.72492950405196,NFKB1;NFKB2
170,BioPlanet_2019,Semaphorin interactions,5 of 66,0.0065421610472385,0.0329403547466223,0,0,4.546742209631728,22.86778416726115,HSP90AA1;RRAS;ITGA1;RAC1;RHOB
171,BioPlanet_2019,Signaling events mediated by T cell protein tyrosine phosphatase (TC-PTP),4 of 42,0.0066118839894987,0.0330978611334793,0,0,5.829319060362772,29.25669157931348,STAT1;ITGA1;STAT3;JAK1
172,BioPlanet_2019,AKT signaling pathway,3 of 22,0.0068040135682485,0.0338627496084507,0,0,8.727798369162343,43.553831315838615,NFKBIA;HSP90AA1;NFKB1
173,BioPlanet_2019,G alpha 13 pathway,5 of 67,0.0069684547652342,0.0342793919271319,0,0,4.47317920131591,22.21542620595102,NFKBIA;MAP3K14;NFKB1;SLC9B2;NFKB2
174,BioPlanet_2019,Telomerase regulation,5 of 67,0.0069684547652342,0.0342793919271319,0,0,4.47317920131591,22.21542620595102,HSP90AA1;JUN;IRF1;NBN;NFKB1
175,BioPlanet_2019,p75 neurotrophin receptor-mediated signaling,7 of 124,0.0070071695460803,0.0342793919271319,0,0,3.3280979862176445,16.51009982186657,NFKBIA;UBB;RAC1;SQSTM1;NFKB1;RHOB;BIRC3
176,BioPlanet_2019,CD8/T cell receptor downstream pathway,5 of 68,0.0074137861562854,0.0360636716415918,0,0,4.4019515265974185,21.58899277316315,EGR1;JUN;HLA-A;B2M;JUNB
177,BioPlanet_2019,Hypoxia and p53 in the cardiovascular system,3 of 23,0.0077221920021533,0.0373528500778315,0,0,8.290985915492957,40.32451182694169,CDKN1A;HSP90AA1;ABCB1
178,BioPlanet_2019,Cell cycle,16 of 453,0.007929808392331,0.0381428213731676,0,0,2.0560172360726376,9.945215263811942,CDKN1A;HSP90AA1;GADD45B;HSPA2;YWHAZ;PSMB10;PSMB8;PSMB9;PSMA3;PSMA4;TUBA1A;PSMB2;UBB;PPP2R1B;PSME1;PSME2
179,BioPlanet_2019,Proepithelin conversion to epithelin and wound repair control,2 of 8,0.0083304978380388,0.0389228765918929,0,0,18.38576779026217,88.02796847611599,GRN;CXCL8
180,BioPlanet_2019,Sema4D-mediated inhibition of cell attachment and migration,2 of 8,0.0083304978380388,0.0389228765918929,0,0,18.38576779026217,88.02796847611599,RRAS;RAC1
181,BioPlanet_2019,Transcription factor regulation of microRNAs related to cardiac hypertrophy,2 of 8,0.0083304978380388,0.0389228765918929,0,0,18.38576779026217,88.02796847611599,STAT3;NFKB1
182,BioPlanet_2019,MicroRNA regulation of DNA damage response,5 of 70,0.0083632197090594,0.0389228765918929,0,0,4.266071039442144,20.40850755693065,CDKN1A;GADD45B;SESN1;NBN;BBC3
183,BioPlanet_2019,Pancreatic cancer,5 of 70,0.0083632197090594,0.0389228765918929,0,0,4.266071039442144,20.40850755693065,STAT1;STAT3;RAC1;NFKB1;JAK1
184,BioPlanet_2019,Signaling events mediated by HDAC class I,5 of 70,0.0083632197090594,0.0389228765918929,0,0,4.266071039442144,20.40850755693065,NFKBIA;STAT3;CHD4;NFKB1;TNFRSF1A
185,BioPlanet_2019,Interleukin-3 signaling pathway,4 of 45,0.0084411355532769,0.0390742887708142,0,0,5.401956731431721,25.79239023516725,JUN;CXCL8;STAT3;JAK1
186,BioPlanet_2019,PDGFB signaling pathway,7 of 129,0.0086311011100412,0.0392631599521906,0,0,3.190883190883191,15.164299640986918,SLC9A3R1;JUN;JUND;STAT1;STAT3;RAC1;YWHAZ
187,BioPlanet_2019,Plexin D1 signaling,3 of 24,0.0087099460521119,0.0392631599521906,0,0,7.895774647887324,37.451946418123256,RRAS;ITGA3;ITGA1
188,BioPlanet_2019,Proteasome complex,3 of 24,0.0087099460521119,0.0392631599521906,0,0,7.895774647887324,37.451946418123256,PSMA3;PSMA4;PSMB2
189,BioPlanet_2019,Ras-independent pathway in NK cell-mediated cytotoxicity,3 of 24,0.0087099460521119,0.0392631599521906,0,0,7.895774647887324,37.451946418123256,HLA-A;RAC1;B2M
190,BioPlanet_2019,TAK1 activates NF-kappaB by phosphorylation and activation of IKK complex,3 of 24,0.0087099460521119,0.0392631599521906,0,0,7.895774647887324,37.451946418123256,NFKBIA;NFKB1;NFKB2
191,BioPlanet_2019,Mitochondrial pathway of apoptosis: multidomain Bcl-2 family,5 of 71,0.0088681368122655,0.0397680510175035,0,0,4.201218988754399,19.85198042684503,DNAJA1;BCL2L13;UBB;UBD;HSPA2
192,BioPlanet_2019,Costimulation by the CD28 family,5 of 72,0.0093937208503155,0.0419067028607341,0,0,4.138302820176737,19.316413213608783,PPP2R1B;MAP3K8;TNFRSF14;RAC1;MAP3K14
193,BioPlanet_2019,Metal ion solute carrier family (SLC) transporters,3 of 25,0.0097683468581021,0.0426738189609463,0,0,7.536491677336747,34.88346591964326,SLC30A2;SLC39A1;SLC39A14
194,BioPlanet_2019,TPO signaling pathway,3 of 25,0.0097683468581021,0.0426738189609463,0,0,7.536491677336747,34.88346591964326,JUN;STAT1;STAT3
195,BioPlanet_2019,Delta Np63 pathway,4 of 47,0.0098278603261855,0.0426738189609463,0,0,5.150177374852188,23.80687020797391,GPX2;CEBPD;ITGA3;HES1
196,BioPlanet_2019,"Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways",4 of 47,0.0098278603261855,0.0426738189609463,0,0,5.150177374852188,23.80687020797391,CYLD;CASP4;TNFAIP3;BIRC3
197,BioPlanet_2019,Regulation of NFAT transcription factors,4 of 47,0.0098278603261855,0.0426738189609463,0,0,5.150177374852188,23.80687020797391,EGR1;JUN;CXCL8;JUNB
198,BioPlanet_2019,Jak-STAT signaling pathway,9 of 199,0.009863054556595,0.0426738189609463,0,0,2.6401447745438094,12.194721432880335,SOCS2;SOCS3;SOCS1;CXCL8;STAT1;IFNGR2;STAT3;PTPRF;JAK1
199,BioPlanet_2019,Membrane trafficking,7 of 133,0.0101170155514759,0.0433370666160239,0,0,3.088952200063311,14.189214877282463,VAMP8;UBB;FTH1;CHMP4B;STX4;FTL;CHMP5
200,BioPlanet_2019,Tight junction,7 of 133,0.0101170155514759,0.0433370666160239,0,0,3.088952200063311,14.189214877282463,RAB3B;CLDN4;PPP2R1B;RRAS;ACTN1;EPB41L3;RAB13
201,BioPlanet_2019,Activation of pro-caspase 8,2 of 9,0.0105846621370872,0.0451158123763964,0,0,15.758426966292134,71.67483016562745,TNFSF10;TRAF2
202,BioPlanet_2019,Inhibition of activated T cell apoptosis by neuropeptides VIP and PACAP,3 of 26,0.0108983371437915,0.0459973935333554,0,0,7.208450704225352,32.57603436863024,NFKBIA;CALM2;NFKB1
203,BioPlanet_2019,Interleukin-27-mediated signaling events,3 of 26,0.0108983371437915,0.0459973935333554,0,0,7.208450704225352,32.57603436863024,STAT1;STAT3;JAK1
204,BioPlanet_2019,Interleukin-5 signaling pathway,4 of 49,0.0113544804501307,0.0476888178905492,0,0,4.920778405524168,22.0359486805384,JUN;STAT1;STAT3;JAK1
861,Panther_2016,Apoptosis signaling pathway Homo sapiens P00006,14 of 102,3.855938991384499e-09,2.2750040049168546e-07,0,0,9.043208245243129,175.19996301438704,JUN;TRAF2;HSPA2;CFLAR;NFKB1;NFKB2;TNFRSF1A;RELB;NFKBIA;TNFSF10;MAP3K14;ATF3;MCL1;BIRC3
862,Panther_2016,JAK/STAT signaling pathway Homo sapiens P00038,4 of 14,8.767281583182024e-05,0.0024608042863825,0,0,22.183050847457626,207.2318133048188,SOCS1;STAT1;STAT3;JAK1
863,Panther_2016,Interferon-gamma signaling pathway Homo sapiens P00035,5 of 28,0.00012512564168046863,0.0024608042863825,0,0,12.082152974504249,108.5725487223611,SOCS2;SOCS3;STAT1;IFNGR2;JAK1
864,Panther_2016,CCKR signaling map ST Homo sapiens P06959,11 of 165,0.00019603623380480385,0.0028915344486208,0,0,4.011527377521614,34.247255852622494,NFKBIA;CHGA;JUN;CXCL8;STAT3;HSPB1;RAC1;MAP3K14;IER3;MCL1;BIRC3
865,Panther_2016,Inflammation mediated by chemokine and cytokine signaling pathway Homo sapiens P00031,11 of 188,0.0005976263726346672,0.007051991197089,0,0,3.486136211921393,25.8760021916854,JUN;JUND;CXCL8;RRAS;GNG5;MYO3A;STAT3;RAC1;JUNB;NFKB2;RELB
866,Panther_2016,Toll receptor signaling pathway Homo sapiens P00054,5 of 49,0.0017859524249055,0.0165148668506913,0,0,6.308910636106104,39.921546392200185,NFKBIA;JUN;TNFAIP3;MAP3K8;NFKB2
867,Panther_2016,T cell activation Homo sapiens P00053,6 of 73,0.0019593909822854,0.0165148668506913,0,0,4.980071234735414,31.051349612428748,NFKBIA;CD74;JUN;RAC1;NFKB1;NFKB2
868,Panther_2016,Parkinson disease Homo sapiens P00049,6 of 81,0.0033166139933006,0.0244600282005923,0,0,4.447045454545455,25.387341554911597,PSMA3;PSMA4;UBE2L6;HSPA2;YWHAZ;PSMB10
869,Panther_2016,Muscarinic acetylcholine receptor 2 and 4 signaling pathway Homo sapiens P00043,4 of 39,0.0050664628090973,0.0332134784151938,0,0,6.329943502824859,33.454462743970545,VAMP8;ACHE;CACNA2D1;STX4
870,Panther_2016,Ras Pathway Homo sapiens P04393,5 of 69,0.0078785710198733,0.0464835690172525,0,0,4.332949716713881,20.98711309277931,JUN;STAT1;STAT3;RAC1;RHOB
920,KEGG_2019_Human,Epstein-Barr virus infection,27 of 201,3.4098979604716674e-16,8.251953064341436e-14,0,0,9.126575684967184,325.0400644906369,CD40;CDKN1A;TNFAIP3;ICAM1;RELB;HES1;RAC1;B2M;JAK1;JUN;GADD45B;STAT1;STAT3;HLA-B;HLA-C;TAP1;TRAF2;HLA-A;HLA-F;NFKB1;HLA-E;NFKB2;TAPBP;NFKBIA;OAS1;TRAF3;MAP3K14
921,KEGG_2019_Human,Antigen processing and presentation,16 of 77,4.037628613282237e-13,4.885530622071507e-11,0,0,15.017543859649123,428.5698957590476,CD74;HSP90AA1;HLA-B;TAP1;HLA-C;HLA-A;HSPA2;IFI30;HLA-F;CTSS;TAPBP;HLA-E;RFX5;PSME1;PSME2;B2M
922,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,22 of 186,2.768259175534093e-12,2.233062401597501e-10,0,0,7.776495354239256,206.954334613976,JUN;CDKN1A;CXCL8;STAT1;STAT3;HLA-B;HLA-C;TRAF2;HLA-A;HLA-F;NFKB1;ICAM1;HLA-E;TNFRSF1A;NFKBIA;ZFP36;UBB;GNG5;TRAF3;RAC1;CALM2;JAK1
923,KEGG_2019_Human,Osteoclast differentiation,18 of 127,1.2872425412317714e-11,7.787817374452216e-10,0,0,9.487155963302753,237.89929353271543,JUN;JUND;STAT1;IFNGR2;TRAF2;NFKB1;NFKB2;TNFRSF1A;RELB;NFKBIA;SOCS3;CYLD;SOCS1;RAC1;JUNB;SQSTM1;MAP3K14;JAK1
924,KEGG_2019_Human,Necroptosis,19 of 162,1.0140808285642228e-10,4.833975408869523e-09,0,0,7.642407739752873,175.86608051948386,HSP90AA1;STAT1;IFNGR2;PLA2G4C;STAT3;TNFAIP3;TRAF2;CFLAR;TNFRSF1A;CYLD;FTH1;TNFSF10;CHMP4B;GLUL;SQSTM1;FTL;JAK1;CHMP5;BIRC3
925,KEGG_2019_Human,TNF signaling pathway,16 of 110,1.2073883200612079e-10,4.833975408869523e-09,0,0,9.729003359462483,222.18505683701304,JUN;TNFAIP3;TRAF2;CFLAR;NFKB1;ICAM1;TNFRSF1A;NFKBIA;SOCS3;TRAF3;IRF1;BCL3;MAP3K8;JUNB;MAP3K14;BIRC3
926,KEGG_2019_Human,NF-kappa B signaling pathway,15 of 95,1.3982573496730023e-10,4.833975408869523e-09,0,0,10.693513119533527,242.6424877751895,CD40;CXCL8;GADD45B;TNFAIP3;TRAF2;CFLAR;NFKB1;ICAM1;TNFRSF1A;RELB;NFKB2;NFKBIA;TRAF3;MAP3K14;BIRC3
927,KEGG_2019_Human,Human cytomegalovirus infection,20 of 225,4.560466051024633e-09,1.3795409804349517e-07,0,0,5.610333381440324,107.75117096211976,CDKN1A;CXCL8;STAT3;HLA-B;HLA-C;TAP1;TRAF2;HLA-A;HLA-F;TMEM173;NFKB1;HLA-E;TNFRSF1A;TAPBP;NFKBIA;GNG5;RAC1;B2M;CALM2;JAK1
928,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,19 of 219,1.6571826741775728e-08,4.4559800794552513e-07,0,0,5.44834808259587,97.61021660547496,EGR1;JUN;CD40;CDKN1A;HLA-B;HLA-C;HLA-A;HLA-F;NFKB1;ICAM1;HLA-E;RELB;NFKB2;TNFRSF1A;NFKBIA;ZFP36;B2M;MAP3K14;JAK1
929,KEGG_2019_Human,Viral carcinogenesis,18 of 201,2.4280818308684352e-08,5.875958030701613e-07,0,0,5.629411764705883,98.70373684759583,JUN;CDKN1A;ACTN1;STAT3;HLA-B;HLA-C;CHD4;TRAF2;HLA-A;HLA-F;YWHAZ;NFKB1;HLA-E;NFKB2;NFKBIA;TRAF3;RAC1;JAK1
930,KEGG_2019_Human,Apoptosis,15 of 143,4.4540691104864246e-08,9.798952043070131e-07,0,0,6.667046282798834,112.85217676838954,JUN;GADD45B;TRAF2;CFLAR;NFKB1;CTSS;BBC3;TNFRSF1A;NFKBIA;TUBA1C;TUBA1A;TNFSF10;MAP3K14;MCL1;BIRC3
931,KEGG_2019_Human,Human immunodeficiency virus 1 infection,18 of 212,5.526233004283192e-08,1.1144569891971103e-06,0,0,5.307216494845361,88.68982017580947,JUN;HLA-B;HLA-C;TAP1;TRAF2;HLA-A;HLA-F;TMEM173;NFKB1;HLA-E;TNFRSF1A;TAPBP;NFKBIA;GNG5;CFL2;RAC1;B2M;CALM2
932,KEGG_2019_Human,Hepatitis C,15 of 155,1.3058069570098353e-07,2.407702942227873e-06,0,0,6.091836734693878,96.5633759461778,CDKN1A;STAT1;STAT3;TRAF2;CFLAR;YWHAZ;NFKB1;TNFRSF1A;NFKBIA;SOCS3;CLDN4;PPP2R1B;OAS1;TRAF3;JAK1
933,KEGG_2019_Human,NOD-like receptor signaling pathway,16 of 178,1.3928859996359598e-07,2.407702942227873e-06,0,0,5.6255866002454695,88.8095481036478,GSDMD;JUN;HSP90AA1;CXCL8;STAT1;TNFAIP3;TRAF2;TMEM173;NFKB1;NFKBIA;OAS1;TRAF3;NAMPT;CASP4;JAK1;BIRC3
934,KEGG_2019_Human,C-type lectin receptor signaling pathway,12 of 104,3.551987169844215e-07,5.730539300682e-06,0,0,7.369942196531792,109.44797837201511,NFKBIA;CYLD;JUN;RRAS;STAT1;IRF1;BCL3;CALM2;MAP3K14;NFKB1;NFKB2;RELB
935,KEGG_2019_Human,Influenza A,15 of 171,4.7084177426426886e-07,7.121481835747065e-06,0,0,5.462547656425207,79.58245694730475,JUN;CXCL8;STAT1;IFNGR2;ADAR;HSPA2;NFKB1;ICAM1;TNFRSF1A;NFKBIA;IFIH1;SOCS3;OAS1;TNFSF10;JAK1
936,KEGG_2019_Human,Herpes simplex virus 1 infection,26 of 492,9.756108991918573e-07,1.3888108094378202e-05,0,0,3.222607166864885,44.601534152460246,IFIH1;SOCS3;TNFRSF14;B2M;ZNF267;ZNF641;JAK1;CD74;STAT1;IFNGR2;HLA-B;HLA-C;TAP1;TRAF2;HLA-A;HLA-F;TMEM173;NFKB1;HLA-E;TAPBP;TNFRSF1A;NFKBIA;OAS1;TRAF3;SRSF5;BIRC3
937,KEGG_2019_Human,Proteasome,8 of 45,1.1788009461870603e-06,1.5640377237931217e-05,0,0,12.111196911196911,165.33010385718686,PSMA3;PSMA4;PSMB2;PSME1;PSME2;PSMB10;PSMB8;PSMB9
938,KEGG_2019_Human,Measles,13 of 138,1.2279635021516245e-06,1.5640377237931217e-05,0,0,5.883385507246377,80.07377955945823,JUN;STAT1;STAT3;TNFAIP3;ADAR;HSPA2;NFKB1;BBC3;NFKBIA;IFIH1;OAS1;TRAF3;JAK1
939,KEGG_2019_Human,Toxoplasmosis,11 of 113,5.912889446249398e-06,7.086828477086834e-05,0,0,6.072780697293327,73.10641702321699,NFKBIA;CD40;SOCS1;STAT1;IFNGR2;STAT3;HSPA2;NFKB1;JAK1;TNFRSF1A;BIRC3
940,KEGG_2019_Human,Cellular senescence,13 of 160,6.408858892588802e-06,7.086828477086834e-05,0,0,4.997239475500345,59.75613673297213,CDKN1A;CXCL8;GADD45B;HLA-B;HLA-C;HLA-A;HLA-F;NFKB1;HLA-E;RRAS;NBN;SQSTM1;CALM2
941,KEGG_2019_Human,IL-17 signaling pathway,10 of 93,6.442571342806213e-06,7.086828477086834e-05,0,0,6.771569034759729,80.9377397140839,NFKBIA;HSP90AA1;JUN;CXCL8;JUND;TRAF3;TNFAIP3;TRAF2;IL17RB;NFKB1
942,KEGG_2019_Human,MAPK signaling pathway,18 of 295,6.811131207668874e-06,7.166494575025511e-05,0,0,3.70110426842217,44.03186109347964,DUSP5;JUN;JUND;GADD45B;CACNA2D1;PLA2G4C;HSPB1;TRAF2;HSPA2;NFKB1;RELB;RASGRP3;NFKB2;TNFRSF1A;RRAS;MAP3K8;RAC1;MAP3K14
943,KEGG_2019_Human,Human papillomavirus infection,19 of 330,8.706997881455318e-06,8.779556197134112e-05,0,0,3.483756841096852,40.590586981359984,CDKN1A;ATP6V0E1;STAT1;ITGA3;ITGA1;HLA-B;HLA-C;CHD4;HLA-A;HLA-F;NFKB1;HLA-E;TNFRSF1A;SLC9A3R1;PPP2R1B;TRAF3;IRF1;HES1;JAK1
944,KEGG_2019_Human,Viral myocarditis,8 of 59,9.751742853459832e-06,9.439687082149117e-05,0,0,8.780280112044817,101.3074385657631,CD40;HLA-B;HLA-C;RAC1;HLA-A;HLA-F;ICAM1;HLA-E
945,KEGG_2019_Human,Pathways in cancer,25 of 530,1.153075488297822e-05,0.00010732471852618188,0,0,2.8449736865578448,32.348752690098465,CDKN1A;CXCL8;EPAS1;BBC3;RASGRP3;GNG5;HES1;RAC1;JAK1;JUN;HSP90AA1;GADD45B;STAT1;GSTO1;ITGA3;IFNGR2;STAT3;TRAF2;NFKB1;NFKB2;NFKBIA;TRAF3;CALM2;BIRC3;NFE2L2
946,KEGG_2019_Human,RIG-I-like receptor signaling pathway,8 of 70,3.499478877659868e-05,0.000313656995701366,0,0,7.218433179723502,74.06337224158348,IFIH1;NFKBIA;CYLD;CXCL8;TRAF3;TRAF2;TMEM173;NFKB1
947,KEGG_2019_Human,Fluid shear stress and atherosclerosis,11 of 139,4.203765928718023e-05,0.0003633254838392005,0,0,4.832807997118156,48.69993889274073,NPPC;JUN;HSP90AA1;GSTO1;RAC1;SQSTM1;CALM2;NFKB1;ICAM1;NFE2L2;TNFRSF1A
948,KEGG_2019_Human,Allograft rejection,6 of 38,5.367554451024529e-05,0.000447913164533771,0,0,10.445667613636363,102.70758115923874,CD40;HLA-B;HLA-C;HLA-A;HLA-F;HLA-E
949,KEGG_2019_Human,Phagosome,11 of 152,9.477681098819746e-05,0.0007645329419714594,0,0,4.384307233225009,40.61615990081389,TUBA1C;ATP6V0E1;TUBA1A;HLA-B;TAP1;HLA-C;HLA-A;RAC1;HLA-F;CTSS;HLA-E
950,KEGG_2019_Human,Toll-like receptor signaling pathway,9 of 104,0.00010518903268165652,0.0008211530938374478,0,0,5.306077514703665,48.6023515549206,NFKBIA;JUN;CD40;CXCL8;TRAF3;STAT1;MAP3K8;RAC1;NFKB1
951,KEGG_2019_Human,Th17 cell differentiation,9 of 107,0.0001309852442237088,0.0009905759094417975,0,0,5.142857142857143,45.9793331003371,NFKBIA;JUN;HSP90AA1;STAT1;IFNGR2;STAT3;AHR;NFKB1;JAK1
952,KEGG_2019_Human,Transcriptional misregulation in cancer,12 of 186,0.00013826652884964277,0.0010139545448973,0,0,3.880406617500498,34.48256352028157,DDX5;CD40;CDKN1A;CXCL8;SPINT1;KMT2A;GADD45B;H3F3B;H3F3A;NFKBIZ;NFKB1;BIRC3
953,KEGG_2019_Human,Hepatitis B,11 of 163,0.00017618165529509377,0.0012539988406297,0,0,4.064727741544062,35.13548612326358,NFKBIA;IFIH1;JUN;CDKN1A;CXCL8;TRAF3;STAT1;STAT3;YWHAZ;NFKB1;JAK1
954,KEGG_2019_Human,Epithelial cell signaling in Helicobacter pylori infection,7 of 68,0.00021080816136744964,0.0014575878585977,0,0,6.401709401709402,54.18766630244211,NFKBIA;JUN;CXCL8;ATP6V0E1;RAC1;MAP3K14;NFKB1
955,KEGG_2019_Human,Prolactin signaling pathway,7 of 70,0.0002528395538911503,0.0016996436678238,0,0,6.1978474200696425,51.335254464334135,SOCS2;SOCS3;SOCS1;STAT1;IRF1;STAT3;NFKB1
956,KEGG_2019_Human,Small cell lung cancer,8 of 93,0.0002644143614711624,0.0017294128507032,0,0,5.259025210084034,43.32381357351309,NFKBIA;CDKN1A;GADD45B;ITGA3;TRAF3;TRAF2;NFKB1;BIRC3
957,KEGG_2019_Human,Mineral absorption,6 of 51,0.0002879973107367167,0.0018340881367969,0,0,7.42310606060606,60.51731320732944,MT2A;FTH1;FXYD2;MT1F;ATP1B1;FTL
958,KEGG_2019_Human,Autoimmune thyroid disease,6 of 53,0.00035627557603656293,0.0022107356256627,0,0,7.106503868471954,56.42426231383742,CD40;HLA-B;HLA-C;HLA-A;HLA-F;HLA-E
959,KEGG_2019_Human,Pancreatic cancer,7 of 75,0.0003878977912666489,0.0023467816371632,0,0,5.7406569465393,45.0915323726032,CDKN1A;GADD45B;STAT1;STAT3;RAC1;NFKB1;JAK1
960,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,8 of 100,0.000433664222864976,0.0025156713882584,0,0,4.857142857142857,37.61002287338196,EGR1;JUN;CXCL8;STAT1;STAT3;RAC1;NFKB1;ICAM1
961,KEGG_2019_Human,Legionellosis,6 of 55,0.00043660412523493066,0.0025156713882584,0,0,6.815746753246753,52.729913423639765,NFKBIA;BCL2L13;CXCL8;HSPA2;NFKB1;NFKB2
962,KEGG_2019_Human,Endocytosis,13 of 244,0.0004812777134114921,0.00270858620106,0,0,3.1663592446201143,24.188027527086827,HLA-B;HLA-C;HLA-A;HSPA2;HLA-F;HLA-E;EHD1;RAB11FIP1;UBB;KIF5B;CHMP4B;SNX6;CHMP5
963,KEGG_2019_Human,Chagas disease (American trypanosomiasis),8 of 103,0.0005290400861567291,0.002909720473862,0,0,4.703037593984963,35.481814818050175,NFKBIA;JUN;CXCL8;PPP2R1B;IFNGR2;CFLAR;NFKB1;TNFRSF1A
964,KEGG_2019_Human,Graft-versus-host disease,5 of 41,0.0007886932929597547,0.0042414172643613,0,0,7.714038401007239,55.11783066254957,HLA-B;HLA-C;HLA-A;HLA-F;HLA-E
965,KEGG_2019_Human,Type I diabetes mellitus,5 of 43,0.0009839229227073885,0.005176290158591,0,0,7.307290890114805,50.595411713654514,HLA-B;HLA-C;HLA-A;HLA-F;HLA-E
966,KEGG_2019_Human,Mitophagy,6 of 65,0.0010711800552969,0.005515437731529,0,0,5.657646379044684,38.69261180609238,BCL2L13;JUN;RRAS;UBB;SQSTM1;OPTN
967,KEGG_2019_Human,Cell adhesion molecules (CAMs),9 of 145,0.0012253915515034,0.00617801573883,0,0,3.6986768919602224,24.79776018201365,CLDN4;CD40;HLA-B;HLA-C;HLA-A;HLA-F;PTPRF;ICAM1;HLA-E
968,KEGG_2019_Human,Adipocytokine signaling pathway,6 of 69,0.0014645545003233,0.007233105899556,0,0,5.297348484848484,34.57157781468001,NFKBIA;SOCS3;STAT3;TRAF2;NFKB1;TNFRSF1A
969,KEGG_2019_Human,Leishmaniasis,6 of 74,0.0021007704881382,0.010167729162589,0,0,4.90658422459893,30.25130511672078,NFKBIA;JUN;STAT1;IFNGR2;NFKB1;JAK1
970,KEGG_2019_Human,Pertussis,6 of 76,0.0024064821663153,0.0114189938087905,0,0,4.765909090909091,28.73647436342828,JUN;CXCL8;CFL2;IRF1;CALM2;NFKB1
971,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,8 of 131,0.0025031698493578,0.0116493673758574,0,0,3.627224157955865,21.727788758368703,IFNGR2;TNFSF10;HLA-B;HLA-C;HLA-A;RAC1;ICAM1;HLA-E
972,KEGG_2019_Human,JAK-STAT signaling pathway,9 of 162,0.0026240913386826,0.0119817000747397,0,0,3.284847463340637,19.52191614103571,SOCS2;SOCS3;CDKN1A;SOCS1;STAT1;IFNGR2;STAT3;MCL1;JAK1
973,KEGG_2019_Human,Tight junction,9 of 170,0.0036174219842439,0.0162114096330933,0,0,3.1203438395415475,17.54255330132892,SLC9A3R1;TUBA1C;CLDN4;JUN;TUBA1A;PPP2R1B;ACTN1;RAB13;RAC1
974,KEGG_2019_Human,Tuberculosis,9 of 179,0.0050643489027287,0.0222831351720065,0,0,2.9537839204449687,15.612312632604374,CD74;STAT1;IFNGR2;RFX5;CALM2;NFKB1;CTSS;JAK1;TNFRSF1A
975,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),8 of 149,0.0054698091651807,0.0235687905843217,0,0,3.161256332320162,16.465440121588877,SOCS3;JUN;CXCL8;COX4I1;TRAF2;RAC1;NFKB1;TNFRSF1A
976,KEGG_2019_Human,Ferroptosis,4 of 40,0.0055513267078774,0.0235687905843217,0,0,6.1537978656622725,31.9610927944753,MAP1LC3B;FTH1;SLC39A14;FTL
977,KEGG_2019_Human,Inflammatory bowel disease (IBD),5 of 65,0.0061344840885331,0.0253944909853198,0,0,4.62275731822474,23.547536662823813,JUN;STAT1;IFNGR2;STAT3;NFKB1
978,KEGG_2019_Human,Th1 and Th2 cell differentiation,6 of 92,0.0061912188765862,0.0253944909853198,0,0,3.876057082452432,19.70829015773234,NFKBIA;JUN;STAT1;IFNGR2;NFKB1;JAK1
979,KEGG_2019_Human,B cell receptor signaling pathway,5 of 71,0.0088681368122655,0.0357681518094712,0,0,4.201218988754399,19.85198042684503,NFKBIA;JUN;RAC1;NFKB1;RASGRP3
980,KEGG_2019_Human,p53 signaling pathway,5 of 72,0.0093937208503155,0.0372668925537109,0,0,4.138302820176737,19.316413213608783,CDKN1A;CD82;GADD45B;SESN1;BBC3
1162,Reactome_2022,Cytokine Signaling In Immune System R-HSA-1280215,61 of 702,4.904429302938007e-25,4.664112267094045e-22,0,0,6.088240701345225,340.786159662504,CD40;CDKN1A;CXCL8;UBE2L6;ADAR;IFI30;ICAM1;IL18BP;MT2A;PPP2R1B;MAP3K8;TIMP1;B2M;JAK1;HSP90AA1;TNFRSF12A;GSTO1;IFNGR2;HLA-B;HLA-C;HLA-A;HLA-F;YWHAZ;IL17RB;HLA-E;TNFRSF1A;PSMA3;PSMA4;OAS1;TRAF3;IRF1;PSME1;PSME2;SQSTM1;BIRC3;CEBPD;PSMB10;RELB;SOCS2;SOCS3;SOCS1;PSMB2;UBB;STX4;TNFRSF14;N4BP1;MCL1;GSDMD;IL32;EGR1;JUN;STAT1;STAT3;PSMB8;NFKB1;PSMB9;NFKB2;NFKBIA;TNIP2;HNRNPA2B1;MAP3K14
1163,Reactome_2022,Immune System R-HSA-168256,95 of 1943,2.905781380986551e-20,1.3816990466591052e-17,0,0,3.478079271805508,156.46139439975474,CD40;CDKN1A;CXCL8;B4GALT1;RNF19B;TNFAIP3;UBE2L6;ADAR;IFI30;UBE2Z;CTSS;ICAM1;IL18BP;IFIH1;MT2A;PPP2R1B;FTH1;KIF5B;CASP4;MAP3K8;TIMP1;B2M;GYG1;JAK1;SERPINB1;HSP90AA1;ATP6V0E1;TNFRSF12A;DTX3L;DYNLT1;GSTO1;IFNGR2;HLA-B;HLA-C;HLA-A;HLA-F;YWHAZ;IL17RB;HLA-E;TAPBP;TNFRSF1A;VAMP8;PSMA3;PSMA4;OAS1;TRAF3;IRF1;PSME1;PSME2;SQSTM1;FTL;BIRC3;TRIM56;CSTB;GRN;CEBPD;PSMB10;RELB;RASGRP3;SOCS2;SOCS3;SDCBP;RNF213;SOCS1;PSMB2;UBB;STX4;TNFRSF14;S100A11;N4BP1;MCL1;CHGA;GSDMD;IL32;EGR1;CD74;JUN;GCA;UBE2B;BTN2A2;STAT1;STAT3;CMTM6;RAB27A;PSMB8;NFKB1;PSMB9;NFKB2;NFKBIA;CYLD;KLHL5;TNIP2;QPCT;HNRNPA2B1;MAP3K14
1164,Reactome_2022,Signaling By Interleukins R-HSA-449147,40 of 453,7.535061769504254e-17,2.3886145809328485e-14,0,0,5.856518494829976,217.41961545054912,CDKN1A;CXCL8;CEBPD;PSMB10;ICAM1;IL18BP;SOCS2;SOCS3;SOCS1;PSMB2;UBB;PPP2R1B;STX4;MAP3K8;TIMP1;N4BP1;JAK1;MCL1;GSDMD;IL32;JUN;HSP90AA1;STAT1;GSTO1;STAT3;YWHAZ;IL17RB;PSMB8;NFKB1;PSMB9;NFKB2;TNFRSF1A;NFKBIA;PSMA3;PSMA4;TNIP2;HNRNPA2B1;PSME1;PSME2;SQSTM1
1165,Reactome_2022,ER-Phagosome Pathway R-HSA-1236974,18 of 89,2.2199694570607078e-14,5.277977384161833e-12,0,0,14.593123446561725,458.7887989315416,HLA-B;HLA-C;HLA-A;HLA-F;PSMB10;PSMB8;HLA-E;TAPBP;PSMB9;VAMP8;PSMA3;PSMA4;PSMB2;UBB;PSME1;PSME2;STX4;B2M
1166,Reactome_2022,Antigen processing-Cross Presentation R-HSA-1236975,19 of 104,2.982283009434269e-14,5.672302283943979e-12,0,0,12.8954711087975,401.6101326426562,HLA-B;HLA-C;HLA-A;HLA-F;CTSS;PSMB10;PSMB8;HLA-E;TAPBP;PSMB9;VAMP8;PSMA3;PSMA4;UBB;PSMB2;PSME1;PSME2;STX4;B2M
1167,Reactome_2022,TNFR2 Non-Canonical NF-kB Pathway R-HSA-5668541,18 of 100,1.8779815898894133e-13,2.97660081997472e-11,0,0,12.628407460545194,370.05538417797067,CD40;TNFRSF12A;PSMB10;PSMB8;NFKB2;TNFRSF1A;RELB;PSMB9;PSMA3;PSMA4;UBB;PSMB2;TRAF3;PSME1;PSME2;TNFRSF14;MAP3K14;BIRC3
1168,Reactome_2022,Interferon Gamma Signaling R-HSA-877300,16 of 89,4.291067815420916e-12,5.375844490737909e-10,0,0,12.541216053833214,328.2598778278889,STAT1;IFNGR2;HLA-B;HLA-C;HLA-A;IFI30;HLA-F;ICAM1;HLA-E;SOCS3;MT2A;SOCS1;OAS1;IRF1;B2M;JAK1
1169,Reactome_2022,Innate Immune System R-HSA-168249,53 of 1035,4.522266658875213e-12,5.375844490737909e-10,0,0,3.3019932556508964,86.2546934957155,B4GALT1;TNFAIP3;UBE2L6;CTSS;IFIH1;PPP2R1B;FTH1;CASP4;MAP3K8;B2M;GYG1;SERPINB1;HSP90AA1;ATP6V0E1;DYNLT1;HLA-B;HLA-C;HLA-A;HLA-E;VAMP8;PSMA3;PSMA4;TRAF3;PSME1;PSME2;FTL;BIRC3;TRIM56;CSTB;GRN;PSMB10;RELB;SDCBP;SOCS1;PSMB2;UBB;S100A11;N4BP1;CHGA;GSDMD;JUN;GCA;CMTM6;RAB27A;PSMB8;NFKB1;PSMB9;NFKB2;NFKBIA;CYLD;TNIP2;QPCT;MAP3K14
1170,Reactome_2022,Programmed Cell Death R-HSA-5357801,22 of 208,2.609892896531364e-11,2.6129228444991647e-09,0,0,6.848950332821301,166.9029393694217,GSDMD;HSP90AA1;STAT3;CFLAR;YWHAZ;PSMB8;PSMB10;BBC3;PSMB9;SDCBP;PSMA3;PSMA4;PSMB2;FNTA;UBB;IRF1;CASP4;TNFSF10;PSME1;PSME2;CHMP4B;BIRC3
1171,Reactome_2022,Adaptive Immune System R-HSA-1280218,42 of 733,2.996642589508881e-11,2.6129228444991647e-09,0,0,3.645157449302973,88.32560419463786,CD40;RNF19B;UBE2L6;IFI30;UBE2Z;PSMB10;CTSS;ICAM1;RASGRP3;SOCS3;RNF213;SOCS1;PSMB2;UBB;PPP2R1B;KIF5B;STX4;MAP3K8;TNFRSF14;B2M;CD74;UBE2B;BTN2A2;DTX3L;HLA-B;HLA-C;HLA-A;HLA-F;YWHAZ;PSMB8;NFKB1;PSMB9;HLA-E;TAPBP;VAMP8;NFKBIA;PSMA3;PSMA4;KLHL5;PSME1;PSME2;MAP3K14
1172,Reactome_2022,Interferon Alpha/Beta Signaling R-HSA-909733,14 of 72,3.1463268807898354e-11,2.6129228444991647e-09,0,0,13.74178027265437,332.30648330779115,EGR1;STAT1;HLA-B;HLA-C;ADAR;HLA-A;HLA-F;PSMB8;HLA-E;SOCS3;SOCS1;OAS1;IRF1;JAK1
1173,Reactome_2022,Interleukin-1 Family Signaling R-HSA-446652,19 of 152,3.2970635261819106e-11,2.6129228444991647e-09,0,0,8.221238938053098,198.4229214334871,GSDMD;STAT3;NFKB1;PSMB10;PSMB8;NFKB2;IL18BP;PSMB9;NFKBIA;PSMA3;PSMA4;UBB;PSMB2;TNIP2;PSME1;PSME2;MAP3K8;SQSTM1;N4BP1
1174,Reactome_2022,Interferon Signaling R-HSA-913531,21 of 200,8.557879898045451e-11,6.260418294647097e-09,0,0,6.775574822207118,157.0685537651937,EGR1;STAT1;IFNGR2;HLA-B;HLA-C;UBE2L6;ADAR;HLA-A;IFI30;HLA-F;PSMB8;ICAM1;HLA-E;SOCS3;MT2A;SOCS1;UBB;OAS1;IRF1;B2M;JAK1
1175,Reactome_2022,Endosomal/Vacuolar Pathway R-HSA-1236977,7 of 11,1.7231392660653362e-10,1.1705038871629537e-08,0,0,97.9102564102564,2201.189319759644,HLA-B;HLA-C;HLA-A;HLA-F;B2M;CTSS;HLA-E
1176,Reactome_2022,Interleukin-1 Signaling R-HSA-9020702,16 of 114,2.0903334427301907e-10,1.3252714026909409e-08,0,0,9.32999164578112,207.95177382963675,NFKB1;PSMB10;PSMB8;NFKB2;PSMB9;NFKBIA;PSMA3;PSMA4;UBB;PSMB2;TNIP2;PSME1;PSME2;MAP3K8;SQSTM1;N4BP1
1177,Reactome_2022,Class I MHC Mediated Antigen Processing And Presentation R-HSA-983169,28 of 378,2.522380087704032e-10,1.499239664629084e-08,0,0,4.676848484848485,103.36138208916164,RNF19B;UBE2L6;UBE2Z;PSMB10;CTSS;SOCS3;RNF213;SOCS1;PSMB2;UBB;STX4;B2M;UBE2B;DTX3L;HLA-B;HLA-C;HLA-A;HLA-F;PSMB8;PSMB9;HLA-E;TAPBP;VAMP8;PSMA3;PSMA4;KLHL5;PSME1;PSME2
1178,Reactome_2022,NIK To Noncanonical NF-kB Signaling R-HSA-5676590,12 of 58,3.832596668620715e-10,2.143999665799e-08,0,0,14.77456647398844,320.34670639758383,PSMA3;PSMA4;PSMB2;UBB;PSME1;PSME2;MAP3K14;PSMB10;PSMB8;RELB;NFKB2;PSMB9
1179,Reactome_2022,Dectin-1 Mediated Noncanonical NF-kB Signaling R-HSA-5607761,12 of 61,7.134521895130093e-10,3.7694057345937336e-08,0,0,13.867877786952931,292.07006618657783,PSMA3;PSMA4;PSMB2;UBB;PSME1;PSME2;MAP3K14;PSMB10;PSMB8;RELB;NFKB2;PSMB9
1180,Reactome_2022,CLEC7A (Dectin-1) Signaling R-HSA-5607764,14 of 99,2.586701071603984e-09,1.2947119574186258e-07,0,0,9.363816689466484,185.149647064621,NFKB1;PSMB10;PSMB8;NFKB2;RELB;PSMB9;NFKBIA;PSMA3;PSMA4;UBB;PSMB2;PSME1;PSME2;MAP3K14
1181,Reactome_2022,Role Of GTSE1 In G2/M Progression After G2 Checkpoint R-HSA-8852276,11 of 59,6.733656189403862e-09,3.201853518061537e-07,0,0,12.940321805955811,243.48700474861,CDKN1A;HSP90AA1;PSMA3;PSMA4;PSMB2;UBB;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1182,Reactome_2022,SARS-CoV Infections R-HSA-9679506,25 of 369,1.4338815081515853e-08,6.493434829772178e-07,0,0,4.211624415112787,76.06318204257516,DDX5;CHD4;IFIH1;MAP1LC3B;FNTA;UBB;B2M;JAK1;HSP90AA1;STAT1;IFNGR2;HLA-B;HLA-C;HLA-A;HLA-F;PARP14;PARP9;ATP1B1;YWHAZ;HLA-E;FXYD3;TRAF3;FXYD2;CHMP4B;NFE2L2
1183,Reactome_2022,Downstream Signaling Events Of B Cell Receptor (BCR) R-HSA-1168372,12 of 79,1.570984878439188e-08,6.790939179071217e-07,0,0,10.132861703045466,182.0771691220341,NFKBIA;PSMA3;PSMA4;PSMB2;UBB;PSME1;PSME2;PSMB10;NFKB1;PSMB8;RASGRP3;PSMB9
1184,Reactome_2022,GSK3B And BTRC:CUL1-mediated-degradation Of NFE2L2 R-HSA-9762114,10 of 51,1.9828509353488462e-08,8.198657563116315e-07,0,0,13.737734791141015,243.6544571685544,PSMA3;PSMA4;PSMB2;UBB;PSME1;PSME2;PSMB10;PSMB8;PSMB9;NFE2L2
1185,Reactome_2022,Activation Of NF-kappaB In B Cells R-HSA-1169091,11 of 66,2.3107802149435823e-08,9.156466601713946e-07,0,0,11.289337175792507,198.50149393139463,NFKBIA;PSMA3;PSMA4;PSMB2;UBB;PSME1;PSME2;PSMB10;NFKB1;PSMB8;PSMB9
1186,Reactome_2022,KEAP1-NFE2L2 Pathway R-HSA-9755511,13 of 100,2.7257088278095398e-08,1.0368596380987489e-06,0,0,8.4695985340663,147.52306266827085,PSMB10;PSMB8;PSMB9;MAP1LC3B;PSMA3;PSMA4;UBB;PSMB2;SESN1;PSME1;PSME2;SQSTM1;NFE2L2
1187,Reactome_2022,Negative Regulation Of NOTCH4 Signaling R-HSA-9604323,10 of 53,2.9312520804723825e-08,1.0721618186650908e-06,0,0,13.097433841218926,227.17827849252063,PSMA3;PSMA4;PSMB2;UBB;PSME1;PSME2;YWHAZ;PSMB10;PSMB8;PSMB9
1188,Reactome_2022,Cellular Response To Chemical Stress R-HSA-9711123,17 of 182,3.203961074343882e-08,1.1285062895189008e-06,0,0,5.884812938771884,101.55005552072292,GPX2;COX4I1;STAT3;PSMB10;PSMB8;PSMB9;MAP1LC3B;PSMA3;PSMA4;UBB;PSMB2;SESN1;PSME1;PSME2;STAP2;SQSTM1;NFE2L2
1189,Reactome_2022,AUF1 (hnRNP D0) Binds And Destabilizes mRNA R-HSA-450408,10 of 54,3.5407566170614646e-08,1.202592693866233e-06,0,0,12.799111807732498,219.585917788146,PSMA3;PSMA4;PSMB2;UBB;PSME1;HSPB1;PSME2;PSMB10;PSMB8;PSMB9
1190,Reactome_2022,Regulation Of mRNA Stability By Proteins That Bind AU-rich Elements R-HSA-450531,12 of 88,5.453463013283562e-08,1.7883597674595407e-06,0,0,8.928810465470033,149.32926491466873,ZFP36;PSMA3;PSMA4;PSMB2;UBB;PSME1;HSPB1;PSME2;YWHAZ;PSMB10;PSMB8;PSMB9
1191,Reactome_2022,Regulated Necrosis R-HSA-5218859,10 of 57,6.092043546018954e-08,1.931177804088008e-06,0,0,11.980313034971877,199.03729265555216,GSDMD;SDCBP;HSP90AA1;UBB;IRF1;CASP4;TNFSF10;CHMP4B;CFLAR;BIRC3
1192,Reactome_2022,MAPK6/MAPK4 Signaling R-HSA-5687128,12 of 90,7.04358404705145e-08,2.1607898157244933e-06,0,0,8.69897732325478,143.25966135287726,MOV10;PSMA3;JUN;PSMA4;PSMB2;UBB;PSME1;HSPB1;PSME2;PSMB10;PSMB8;PSMB9
1193,Reactome_2022,SCF(Skp2)-mediated Degradation Of P27/P21 R-HSA-187577,10 of 59,8.586486756745699e-08,2.551796533020362e-06,0,0,11.490147783251231,186.950347059464,CDKN1A;PSMA3;PSMA4;PSMB2;UBB;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1194,Reactome_2022,Infectious Disease R-HSA-5663205,42 of 961,8.94383916831139e-08,2.577451833049737e-06,0,0,2.707834602829162,43.94738606379876,DDX5;CEBPD;CHD4;PSMB10;IFIH1;MAP1LC3B;RNF213;GNG5;PSMB2;FNTA;UBB;B2M;JAK1;CHGA;GSDMD;JUN;HSP90AA1;STAT1;IFNGR2;HLA-B;HLA-C;HLA-A;HLA-F;PARP14;PARP9;ATP1B1;YWHAZ;PSMB8;NFKB1;PSMB9;HLA-E;NFKB2;PSMA3;PSMA4;FXYD3;TRAF3;FXYD2;PSME1;PSME2;CHMP4B;CHMP5;NFE2L2
1195,Reactome_2022,FCERI Mediated NF-kB Activation R-HSA-2871837,11 of 78,1.381735780353426e-07,3.679540515704994e-06,0,0,9.26168867478171,146.28610471144918,NFKBIA;PSMA3;PSMA4;PSMB2;UBB;PSME1;PSME2;PSMB10;NFKB1;PSMB8;PSMB9
1196,Reactome_2022,Nuclear Events Mediated By NFE2L2 R-HSA-9759194,11 of 78,1.381735780353426e-07,3.679540515704994e-06,0,0,9.26168867478171,146.28610471144918,PSMA3;PSMA4;PSMB2;UBB;PSME1;PSME2;SQSTM1;PSMB10;PSMB8;PSMB9;NFE2L2
1197,Reactome_2022,Apoptosis R-HSA-109581,16 of 178,1.3928859996359598e-07,3.679540515704994e-06,0,0,5.6255866002454695,88.8095481036478,GSDMD;STAT3;CFLAR;YWHAZ;PSMB10;PSMB8;BBC3;PSMB9;PSMA3;PSMA4;FNTA;UBB;PSMB2;TNFSF10;PSME1;PSME2
1198,Reactome_2022,Regulation Of TNFR1 Signaling R-HSA-5357905,8 of 35,1.5044219975193102e-07,3.866771134164498e-06,0,0,16.605291005291004,260.8639222664848,CLIP3;CYLD;UBB;SPPL2A;TNFAIP3;CFLAR;TNFRSF1A;BIRC3
1199,Reactome_2022,Regulation Of Activated PAK-2p34 By Proteasome Mediated Degradation R-HSA-211733,9 of 49,1.8647669798891202e-07,4.662817486462342e-06,0,0,12.637392550143266,195.81588637471077,PSMA3;PSMA4;PSMB2;UBB;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1200,Reactome_2022,Oxygen-dependent Proline Hydroxylation Of Hypoxia-inducible Factor Alpha R-HSA-1234176,10 of 64,1.91219644555238e-07,4.662817486462342e-06,0,0,10.423584504044276,161.2512167975299,PSMA3;PSMA4;PSMB2;UBB;EPAS1;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1201,Reactome_2022,p53-Dependent G1 DNA Damage Response R-HSA-69563,10 of 65,2.2242965488033019e-07,5.288265044779849e-06,0,0,10.233542319749215,156.7641036425632,CDKN1A;PSMA3;PSMA4;PSMB2;UBB;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1202,Reactome_2022,C-type Lectin Receptors (CLRs) R-HSA-5621481,14 of 141,2.498254801904716e-07,5.654784278687688e-06,0,0,6.253662332906061,95.07132189095957,NFKB1;PSMB10;PSMB8;NFKB2;RELB;PSMB9;NFKBIA;PSMA3;PSMA4;UBB;PSMB2;PSME1;PSME2;MAP3K14
1203,Reactome_2022,Autodegradation Of E3 Ubiquitin Ligase COP1 R-HSA-349425,9 of 51,2.6757654315556885e-07,5.654784278687688e-06,0,0,12.034383954154729,182.12668398107613,PSMA3;PSMA4;PSMB2;UBB;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1204,Reactome_2022,Ubiquitin Mediated Degradation Of Phosphorylated Cdc25A R-HSA-69601,9 of 51,2.6757654315556885e-07,5.654784278687688e-06,0,0,12.034383954154729,182.12668398107613,PSMA3;PSMA4;PSMB2;UBB;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1205,Reactome_2022,Ubiquitin-dependent Degradation Of Cyclin D R-HSA-75815,9 of 51,2.6757654315556885e-07,5.654784278687688e-06,0,0,12.034383954154729,182.12668398107613,PSMA3;PSMA4;PSMB2;UBB;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1206,Reactome_2022,Vpu Mediated Degradation Of CD4 R-HSA-180534,9 of 51,2.6757654315556885e-07,5.654784278687688e-06,0,0,12.034383954154729,182.12668398107613,PSMA3;PSMA4;PSMB2;UBB;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1207,Reactome_2022,ABC-family Proteins Mediated Transport R-HSA-382556,12 of 102,2.8664376618395584e-07,5.9260482965422175e-06,0,0,7.534489402697496,113.5072759226483,PSMA3;ABCB1;PSMA4;UBB;ABCA5;PSMB2;PSME1;PSME2;PSMB10;PSMB8;ABCF1;PSMB9
1208,Reactome_2022,G1/S DNA Damage Checkpoints R-HSA-69615,10 of 67,2.9851746532144405e-07,6.040215096184964e-06,0,0,9.873462391611213,148.34321757994005,CDKN1A;PSMA3;PSMA4;PSMB2;UBB;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1209,Reactome_2022,Regulation Of Apoptosis R-HSA-169911,9 of 52,3.185242323088928e-07,6.310761352619939e-06,0,0,11.753914839741451,175.83347987466502,PSMA3;PSMA4;PSMB2;UBB;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1210,Reactome_2022,Vif-mediated Degradation Of APOBEC3G R-HSA-180585,9 of 53,3.776818524644209e-07,7.33011105497274e-06,0,0,11.486194321437877,169.8717819125697,PSMA3;PSMA4;PSMB2;UBB;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1211,Reactome_2022,Degradation Of AXIN R-HSA-4641257,9 of 54,4.461374814401442e-07,8.005221600935417e-06,0,0,11.230372492836675,164.217679182964,PSMA3;PSMA4;PSMB2;UBB;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1212,Reactome_2022,FBXL7 Down-Regulates AURKA During Mitotic Entry And In Early Mitosis R-HSA-8854050,9 of 54,4.461374814401442e-07,8.005221600935417e-06,0,0,11.230372492836675,164.217679182964,PSMA3;PSMA4;PSMB2;UBB;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1213,Reactome_2022,Regulation Of RUNX3 Expression And Activity R-HSA-8941858,9 of 54,4.461374814401442e-07,8.005221600935417e-06,0,0,11.230372492836675,164.217679182964,PSMA3;PSMA4;PSMB2;UBB;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1214,Reactome_2022,SCF-beta-TrCP Mediated Degradation Of Emi1 R-HSA-174113,9 of 54,4.461374814401442e-07,8.005221600935417e-06,0,0,11.230372492836675,164.217679182964,PSMA3;PSMA4;PSMB2;UBB;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1215,Reactome_2022,Cellular Responses To Stimuli R-HSA-8953897,34 of 736,4.724805489980175e-07,8.223240742999338e-06,0,0,2.83124054728993,41.23778090261875,PPP1R15A;CDKN1A;CXCL8;EPAS1;COX4I1;PSMB10;MT2A;MAP1LC3B;PSMB2;UBB;SESN1;STAP2;FNIP2;JUN;GPX2;HSP90AA1;ATP6V0E1;STAT3;HSPA2;PSMB8;NFKB1;PSMB9;DNAJA1;MOV10;PSMA3;PSMA4;DNAJC7;MT1F;PSME1;PSME2;SQSTM1;ATF3;FKBP5;NFE2L2
1216,Reactome_2022,"Antigen Presentation: Folding, Assembly, Peptide Loading Of Class I MHC R-HSA-983170",7 of 28,4.755817464405506e-07,8.223240742999338e-06,0,0,18.63342830009497,271.27899668146955,HLA-B;HLA-C;HLA-A;HLA-F;B2M;HLA-E;TAPBP
1217,Reactome_2022,Interleukin-4 And Interleukin-13 Signaling R-HSA-6785807,12 of 107,4.854572245544991e-07,8.244103938416584e-06,0,0,7.136111956191056,103.7460420057158,SOCS3;CDKN1A;HSP90AA1;SOCS1;CXCL8;CEBPD;STAT1;STAT3;TIMP1;ICAM1;MCL1;JAK1
1218,Reactome_2022,Degradation Of DVL R-HSA-4641258,9 of 55,5.25092508874193e-07,8.609706481713063e-06,0,0,10.98567335243553,158.8494463051507,PSMA3;PSMA4;PSMB2;UBB;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1219,Reactome_2022,Hh Mutants Are Degraded By ERAD R-HSA-5362768,9 of 55,5.25092508874193e-07,8.609706481713063e-06,0,0,10.98567335243553,158.8494463051507,PSMA3;PSMA4;PSMB2;UBB;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1220,Reactome_2022,Signaling By B Cell Receptor (BCR) R-HSA-983705,12 of 109,5.943616764306376e-07,9.450591122442788e-06,0,0,6.988260532745366,100.18215034569756,NFKBIA;PSMA3;PSMA4;UBB;PSMB2;PSME1;PSME2;NFKB1;PSMB10;PSMB8;RASGRP3;PSMB9
1221,Reactome_2022,Regulation Of RUNX2 Expression And Activity R-HSA-8939902,10 of 72,5.962518058323526e-07,9.450591122442788e-06,0,0,9.074898034853542,130.06690867640643,PSMA3;PSMA4;PSMB2;UBB;STAT1;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1222,Reactome_2022,Stabilization Of P53 R-HSA-69541,9 of 56,6.158701509892646e-07,9.60151661624247e-06,0,0,10.751386941413156,153.74730274270155,PSMA3;PSMA4;PSMB2;UBB;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1223,Reactome_2022,Cellular Response To Hypoxia R-HSA-1234174,10 of 73,6.800289783661622e-07,1.0430767071390647e-05,0,0,8.930395913154534,126.82171710459264,PSMA3;PSMA4;PSMB2;UBB;EPAS1;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1224,Reactome_2022,Hh Mutants Abrogate Ligand Secretion R-HSA-5387390,9 of 58,8.388489538644747e-07,1.266262468452564e-05,0,0,10.311502251330332,144.27065303516417,PSMA3;PSMA4;PSMB2;UBB;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1225,Reactome_2022,Downstream TCR Signaling R-HSA-202424,11 of 94,9.502327812841698e-07,1.3768025586590902e-05,0,0,7.470192007221971,103.58585708473576,NFKBIA;PSMA3;PSMA4;PSMB2;UBB;PSME1;PSME2;PSMB10;NFKB1;PSMB8;PSMB9
1226,Reactome_2022,Degradation Of GLI1 By Proteasome R-HSA-5610780,9 of 59,9.743874891952597e-07,1.3768025586590902e-05,0,0,10.104756446991404,139.86454962910312,PSMA3;PSMA4;PSMB2;UBB;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1227,Reactome_2022,Degradation Of GLI2 By Proteasome R-HSA-5610783,9 of 59,9.743874891952597e-07,1.3768025586590902e-05,0,0,10.104756446991404,139.86454962910312,PSMA3;PSMA4;PSMB2;UBB;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1228,Reactome_2022,GLI3 Is Processed To GLI3R By Proteasome R-HSA-5610785,9 of 59,9.743874891952597e-07,1.3768025586590902e-05,0,0,10.104756446991404,139.86454962910312,PSMA3;PSMA4;PSMB2;UBB;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1229,Reactome_2022,TNF Signaling R-HSA-75893,8 of 44,9.844645004081822e-07,1.3768025586590902e-05,0,0,12.448253968253969,172.17389191688872,CLIP3;CYLD;UBB;SPPL2A;TNFAIP3;CFLAR;TNFRSF1A;BIRC3
1230,Reactome_2022,Defective CFTR Causes Cystic Fibrosis R-HSA-5678895,9 of 60,1.128443000956844e-06,1.5552888317535632e-05,0,0,9.906118321254002,135.66103873259885,PSMA3;PSMA4;PSMB2;UBB;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1231,Reactome_2022,MAPK Family Signaling Cascades R-HSA-5683057,20 of 318,1.3196406197115048e-06,1.7855757481790557e-05,0,0,3.8409912235415593,51.99991962041569,DUSP5;JUN;HSPB1;GFRA1;PSMB8;PSMB10;PSMB9;RASGRP3;MOV10;PSMA3;PSMA4;PPP2R1B;PSMB2;FNTA;UBB;RASGEF1A;PEA15;PSME1;PSME2;JAK1
1232,Reactome_2022,PTEN Regulation R-HSA-6807070,13 of 139,1.3330796858119134e-06,1.7855757481790557e-05,0,0,5.836392914653784,78.95483271906612,EGR1;JUN;CHD4;PSMB10;PSMB8;PSMB9;MOV10;PSMA3;PSMA4;UBB;PSMB2;PSME1;PSME2
1233,Reactome_2022,Toll-like Receptor Cascades R-HSA-168898,14 of 162,1.3598952166730995e-06,1.796194932022386e-05,0,0,5.3605436832181015,72.41077571439102,GSDMD;JUN;NFKB1;CTSS;NFKB2;NFKBIA;SOCS1;PPP2R1B;UBB;TRAF3;TNIP2;MAP3K8;N4BP1;BIRC3
1234,Reactome_2022,Neddylation R-HSA-8951664,17 of 237,1.405105265733084e-06,1.830486448920771e-05,0,0,4.401146360970408,59.30720034803543,EPAS1;PSMB8;PSMB10;PSMB9;SOCS2;SOCS3;NUB1;PSMA3;PSMA4;PSMB2;KLHL5;UBB;UBD;PSME1;PSME2;SQSTM1;NFE2L2
1235,Reactome_2022,Asymmetric Localization Of PCP Proteins R-HSA-4608870,9 of 62,1.5005775743469774e-06,1.928444963789156e-05,0,0,9.53132940476834,127.8118911876468,PSMA3;PSMA4;PSMB2;UBB;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1236,Reactome_2022,Autodegradation Of Cdh1 By Cdh1:APC/C R-HSA-174084,9 of 63,1.723355639260827e-06,2.1852149505827288e-05,0,0,9.354345749761222,124.14374143356632,PSMA3;PSMA4;PSMB2;UBB;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1237,Reactome_2022,DDX58/IFIH1-mediated Induction Of Interferon-Alpha/Beta R-HSA-168928,10 of 81,1.8111129042308795e-06,2.2368420414591767e-05,0,0,7.9209163024121745,104.72694173198504,IFIH1;NFKBIA;CYLD;HSP90AA1;UBB;TRAF3;TNFAIP3;UBE2L6;NFKB1;NFKB2
1238,Reactome_2022,Signaling By NOTCH4 R-HSA-9013694,10 of 81,1.8111129042308795e-06,2.2368420414591767e-05,0,0,7.9209163024121745,104.72694173198504,PSMA3;PSMA4;PSMB2;UBB;PSME1;PSME2;YWHAZ;PSMB10;PSMB8;PSMB9
1239,Reactome_2022,Cross-presentation Of Soluble Exogenous Antigens (Endosomes) R-HSA-1236978,8 of 48,1.9693595323525587e-06,2.376381894009681e-05,0,0,11.201142857142855,147.15839903087925,PSMA3;PSMA4;PSMB2;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1240,Reactome_2022,Hedgehog Ligand Biogenesis R-HSA-5358346,9 of 64,1.9740711842982627e-06,2.376381894009681e-05,0,0,9.18379786402709,120.6329737809852,PSMA3;PSMA4;PSMB2;UBB;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1241,Reactome_2022,Cyclin E Associated Events During G1/S Transition R-HSA-69202,10 of 82,2.030248371241736e-06,2.4134577513136132e-05,0,0,7.810504469987229,102.37503468195844,CDKN1A;PSMA3;PSMA4;PSMB2;UBB;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1242,Reactome_2022,Regulation Of RAS By GAPs R-HSA-5658442,9 of 65,2.255587633762005e-06,2.648226962602057e-05,0,0,9.019340974212035,117.27037352873457,PSMA3;PSMA4;PSMB2;UBB;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1243,Reactome_2022,Toll Like Receptor 3 (TLR3) Cascade R-HSA-168164,11 of 103,2.378475045900083e-06,2.733157583748957e-05,0,0,6.736311239193084,87.2288378734483,NFKBIA;JUN;PPP2R1B;UBB;TRAF3;TNIP2;MAP3K8;N4BP1;NFKB1;NFKB2;BIRC3
1244,Reactome_2022,Signal Transduction R-HSA-162582,75 of 2465,2.3854056724622863e-06,2.733157583748957e-05,0,0,1.9130061948341883,24.766048610955576,ITSN2;CDKN1A;CXCL8;B4GALT1;SPPL2A;TNFAIP3;HSPB1;CHD4;SPINT2;FNBP1L;SLK;FNTA;RASGEF1A;PPP2R1B;KIF5B;PEA15;TNFSF10;SOX4;IER3;JAK1;PLEKHG3;DUSP5;HSP90AA1;ATP6V0E1;ITGA3;ACTN1;TMOD3;GFRA1;SSTR2;YWHAZ;RHOB;TNFRSF1A;CLIP3;PSMA3;PSMA4;SPINT1;ELF3;VGF;PSME1;PSME2;TAX1BP3;TRIB1;SQSTM1;RHOQ;FKBP5;BIRC3;PPP1R15A;DDX5;EPAS1;PSMB10;RASGRP3;SOCS3;SOCS1;GNG5;PSMB2;UBB;UBD;STAP2;BCL9L;CHGA;IL32;EGR1;JUN;JUND;STAT1;STAT3;INHBA;CFLAR;PSMB8;NFKB1;PSMB9;NFKBIA;MOV10;CYLD;CDC42SE2
1245,Reactome_2022,Cellular Responses To Stress R-HSA-2262752,32 of 722,2.5168144158630466e-06,2.807249180264854e-05,0,0,2.696114519427403,34.7597011346818,PPP1R15A;CDKN1A;CXCL8;EPAS1;COX4I1;PSMB10;MAP1LC3B;PSMB2;UBB;SESN1;STAP2;FNIP2;JUN;GPX2;HSP90AA1;ATP6V0E1;STAT3;HSPA2;PSMB8;NFKB1;PSMB9;DNAJA1;MOV10;PSMA3;PSMA4;DNAJC7;PSME1;PSME2;SQSTM1;ATF3;FKBP5;NFE2L2
1246,Reactome_2022,Cyclin A:Cdk2-associated Events At S Phase Entry R-HSA-69656,10 of 84,2.5386270189566505e-06,2.807249180264854e-05,0,0,7.598633115874495,97.89993168682253,CDKN1A;PSMA3;PSMA4;PSMB2;UBB;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1247,Reactome_2022,Degradation Of Beta-Catenin By Destruction Complex R-HSA-195253,10 of 84,2.5386270189566505e-06,2.807249180264854e-05,0,0,7.598633115874495,97.89993168682253,PSMA3;PSMA4;PPP2R1B;PSMB2;UBB;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1248,Reactome_2022,Regulation Of Ornithine Decarboxylase (ODC) R-HSA-350562,8 of 50,2.715986745065851e-06,2.9688544765030165e-05,0,0,10.666666666666666,136.70778910500502,PSMA3;PSMA4;PSMB2;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1249,Reactome_2022,APC/C:Cdc20 Mediated Degradation Of Securin R-HSA-174154,9 of 67,2.9236245246671226e-06,3.124007778604982e-05,0,0,8.707439976286928,110.95617727688575,PSMA3;PSMA4;PSMB2;UBB;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1250,Reactome_2022,Regulation Of PTEN Stability And Activity R-HSA-8948751,9 of 67,2.9236245246671226e-06,3.124007778604982e-05,0,0,8.707439976286928,110.95617727688575,PSMA3;PSMA4;PSMB2;UBB;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1251,Reactome_2022,Regulation Of IFNG Signaling R-HSA-877312,5 of 14,3.1324862027691997e-06,3.309993754259454e-05,0,0,30.898646521875985,391.5996682876792,SOCS3;SOCS1;STAT1;IFNGR2;JAK1
1252,Reactome_2022,MyD88-independent TLR4 Cascade R-HSA-166166,11 of 107,3.466984961970064e-06,3.623189778937946e-05,0,0,6.454310758885687,81.14504855703571,NFKBIA;JUN;PPP2R1B;UBB;TRAF3;TNIP2;MAP3K8;N4BP1;NFKB1;NFKB2;BIRC3
1253,Reactome_2022,Orc1 Removal From Chromatin R-HSA-68949,9 of 69,3.755140531804444e-06,3.8816724410282895e-05,0,0,8.416332378223496,105.14006307914237,PSMA3;PSMA4;PSMB2;UBB;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1254,Reactome_2022,SARS-CoV-2 Infection R-HSA-9694516,18 of 283,3.828865034730565e-06,3.915323277450288e-05,0,0,3.8710987791342952,48.28399106817474,DDX5;HSP90AA1;STAT1;HLA-B;HLA-C;HLA-A;HLA-F;PARP14;PARP9;YWHAZ;HLA-E;IFIH1;MAP1LC3B;UBB;TRAF3;CHMP4B;B2M;JAK1
1255,Reactome_2022,Fc Epsilon Receptor (FCERI) Signaling R-HSA-2454202,12 of 130,3.90655076151494e-06,3.952265717234795e-05,0,0,5.738414813363378,71.45965179818946,NFKBIA;JUN;PSMA3;PSMA4;UBB;PSMB2;PSME1;PSME2;NFKB1;PSMB10;PSMB8;PSMB9
1256,Reactome_2022,Signaling By NOTCH R-HSA-157118,15 of 203,4.078052314969755e-06,4.082345001617091e-05,0,0,4.525308603684635,56.158586772430624,JUN;B4GALT1;STAT1;YWHAZ;PSMB8;PSMB10;PSMB9;MOV10;PSMA3;PSMA4;PSMB2;UBB;ELF3;PSME1;PSME2
1257,Reactome_2022,Inactivation Of CSF3 (G-CSF) Signaling R-HSA-9705462,6 of 25,4.189780214094535e-06,4.150501024587399e-05,0,0,17.604366028708135,217.99244006506345,SOCS3;SOCS1;UBB;STAT1;STAT3;JAK1
1258,Reactome_2022,G2/M Transition R-HSA-69275,14 of 182,5.367979405240596e-06,5.168094103555331e-05,0,0,4.717538759689923,57.24761115947908,CDKN1A;HSP90AA1;PSMB10;PSMB8;PSMB9;PSMA3;TUBA1A;PSMA4;PPP2R1B;UBB;PSMB2;PSME1;PSME2;OPTN
1259,Reactome_2022,CDK-mediated Phosphorylation And Removal Of Cdc6 R-HSA-69017,9 of 72,5.38003487120902e-06,5.168094103555331e-05,0,0,8.01432664756447,97.2363481919235,PSMA3;PSMA4;PSMB2;UBB;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1260,Reactome_2022,Cdc20:Phospho-APC/C Mediated Degradation Of Cyclin A R-HSA-174184,9 of 72,5.38003487120902e-06,5.168094103555331e-05,0,0,8.01432664756447,97.2363481919235,PSMA3;PSMA4;PSMB2;UBB;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1261,Reactome_2022,APC/C:Cdh1 Mediated Degradation Of Cdc20 And APC/C:Cdh1 Targets In Late Mitosis/Early G1 R-HSA-174178,9 of 73,6.0409786522911366e-06,5.680075394255189e-05,0,0,7.888699856733524,94.7980685970588,PSMA3;PSMA4;PSMB2;UBB;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1262,Reactome_2022,APC:Cdc20 Mediated Degradation Of Cell Cycle Proteins Before Cycle Checkpoint Satisfied R-HSA-179419,9 of 73,6.0409786522911366e-06,5.680075394255189e-05,0,0,7.888699856733524,94.7980685970588,PSMA3;PSMA4;PSMB2;UBB;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1263,Reactome_2022,Mitotic G2-G2/M Phases R-HSA-453274,14 of 184,6.092194429169603e-06,5.680075394255189e-05,0,0,4.66155950752394,55.9783476385911,CDKN1A;HSP90AA1;PSMB10;PSMB8;PSMB9;PSMA3;TUBA1A;PSMA4;PPP2R1B;UBB;PSMB2;PSME1;PSME2;OPTN
1264,Reactome_2022,APC/C:Cdc20 Mediated Degradation Of Mitotic Proteins R-HSA-176409,9 of 75,7.573639144111028e-06,6.969904740664831e-05,0,0,7.648866892419901,90.18654179678865,PSMA3;PSMA4;PSMB2;UBB;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1265,Reactome_2022,TCR Signaling R-HSA-202403,11 of 116,7.6221881496229476e-06,6.969904740664831e-05,0,0,5.898366954851105,69.50899318327262,NFKBIA;PSMA3;PSMA4;UBB;PSMB2;PSME1;PSME2;NFKB1;PSMB10;PSMB8;PSMB9
1266,Reactome_2022,Transcriptional Regulation By RUNX3 R-HSA-8878159,10 of 95,7.806872304068138e-06,7.018050587454681e-05,0,0,6.6115618661257605,77.75531397150701,CDKN1A;PSMA3;PSMA4;PSMB2;UBB;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1267,Reactome_2022,Death Receptor Signaling R-HSA-73887,12 of 139,7.822432831442653e-06,7.018050587454681e-05,0,0,5.329297710618542,62.664626792782215,CLIP3;NFKBIA;CYLD;UBB;SPPL2A;TNFSF10;TNFAIP3;CFLAR;SQSTM1;NFKB1;TNFRSF1A;BIRC3
1268,Reactome_2022,Toll Like Receptor 4 (TLR4) Cascade R-HSA-166016,12 of 140,8.420215354707543e-06,7.401878993907213e-05,0,0,5.28739161849711,61.78251094963459,NFKBIA;JUN;SOCS1;PPP2R1B;UBB;TRAF3;TNIP2;MAP3K8;N4BP1;NFKB1;NFKB2;BIRC3
1269,Reactome_2022,Activation Of APC/C And APC/C:Cdc20 Mediated Degradation Of Mitotic Proteins R-HSA-176814,9 of 76,8.457182430267926e-06,7.401878993907213e-05,0,0,7.534319804986529,88.00458093704624,PSMA3;PSMA4;PSMB2;UBB;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1270,Reactome_2022,RAF/MAP Kinase Cascade R-HSA-5673001,17 of 271,8.534237711831505e-06,7.401878993907213e-05,0,0,3.8053432470501294,44.41377647647918,DUSP5;GFRA1;PSMB8;PSMB10;PSMB9;RASGRP3;PSMA3;PSMA4;PPP2R1B;PSMB2;FNTA;UBB;RASGEF1A;PEA15;PSME1;PSME2;JAK1
1271,Reactome_2022,Metabolism Of Polyamines R-HSA-351202,8 of 58,8.561584535539363e-06,7.401878993907213e-05,0,0,8.956342857142857,104.50462610309494,PSMA3;PSMA4;PSMB2;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1272,Reactome_2022,TNF Receptor Superfamily (TNFSF) Members Mediating Non-Canonical NF-kB Pathway R-HSA-5676594,5 of 17,9.262883188819511e-06,7.936037759069691e-05,0,0,23.170443814919736,268.5337473351387,CD40;TNFRSF12A;TRAF3;MAP3K14;BIRC3
1273,Reactome_2022,ABC Transporter Disorders R-HSA-5619084,9 of 77,9.427375633095598e-06,8.004851988458852e-05,0,0,7.423141749536491,85.89980056357322,PSMA3;PSMA4;PSMB2;UBB;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1274,Reactome_2022,Transcriptional Regulation By RUNX2 R-HSA-8878166,11 of 119,9.746896373934086e-06,8.202918983726828e-05,0,0,5.733642864766784,66.15799164123389,CDKN1A;PSMA3;PSMA4;UBB;PSMB2;STAT1;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1275,Reactome_2022,RUNX1 Regulates Transcription Of Genes Involved In Differentiation Of HSCs R-HSA-8939236,10 of 98,1.0319266208765842e-05,8.608440495207296e-05,0,0,6.385188087774295,73.31152364796269,PSMA3;PSMA4;KMT2A;UBB;PSMB2;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1276,Reactome_2022,Regulation Of Necroptotic Cell Death R-HSA-5675482,6 of 29,1.0578654971749069e-05,8.748087720115969e-05,0,0,14.539772727272728,166.5774110012359,SDCBP;HSP90AA1;UBB;TNFSF10;CFLAR;BIRC3
1277,Reactome_2022,MAPK1/MAPK3 Signaling R-HSA-5684996,17 of 277,1.136615125375252e-05,9.293987083913992e-05,0,0,3.716377171215881,42.31047396666487,DUSP5;GFRA1;PSMB8;PSMB10;PSMB9;RASGRP3;PSMA3;PSMA4;PPP2R1B;PSMB2;FNTA;UBB;RASGEF1A;PEA15;PSME1;PSME2;JAK1
1278,Reactome_2022,SARS-CoV-2 Activates/Modulates Innate And Adaptive Immune Responses R-HSA-9705671,11 of 121,1.1434242784626048e-05,9.293987083913992e-05,0,0,5.628818443804034,64.04975066113809,IFIH1;HSP90AA1;TRAF3;STAT1;HLA-B;HLA-C;HLA-A;HLA-F;B2M;HLA-E;JAK1
1279,Reactome_2022,Antigen Processing: Ubiquitination And Proteasome Degradation R-HSA-983168,18 of 307,1.1739672023200284e-05,9.461379740731754e-05,0,0,3.5452269489110524,40.247318978740175,UBE2B;DTX3L;RNF19B;UBE2L6;UBE2Z;PSMB8;PSMB10;PSMB9;SOCS3;PSMA3;RNF213;PSMA4;SOCS1;PSMB2;KLHL5;UBB;PSME1;PSME2
1280,Reactome_2022,Deubiquitination R-HSA-5688426,17 of 279,1.2481677157312668e-05,9.97485292151626e-05,0,0,3.687627319737637,41.63791760948528,TNFAIP3;PSMB8;PSMB10;PSMB9;IFIH1;NFKBIA;CYLD;PSMA3;PSMA4;PSMB2;UBB;TNIP1;TRAF3;TNIP2;PSME1;PSME2;BIRC3
1281,Reactome_2022,Regulation Of APC/C Activators Between G1/S And Early Anaphase R-HSA-176408,9 of 80,1.2928643333633689e-05,0.00010237097814257602,0,0,7.108398240445538,80.01259473455754,PSMA3;PSMA4;PSMB2;UBB;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1282,Reactome_2022,Signaling By CSF3 (G-CSF) R-HSA-9674555,6 of 30,1.3025119195848265e-05,0.00010237097814257602,0,0,13.933238636363637,156.7298575342338,SOCS3;SOCS1;UBB;STAT1;STAT3;JAK1
1283,Reactome_2022,Neutrophil Degranulation R-HSA-6798695,23 of 468,1.3558683031951648e-05,0.00010569104560152471,0,0,2.9618044608418583,33.197336138445095,GSDMD;CSTB;SERPINB1;GRN;HSP90AA1;B4GALT1;GCA;DYNLT1;CMTM6;HLA-B;HLA-C;RAB27A;HLA-A;CTSS;NFKB1;VAMP8;SDCBP;FTH1;QPCT;B2M;GYG1;S100A11;FTL
1284,Reactome_2022,RIPK1-mediated Regulated Necrosis R-HSA-5213460,6 of 31,1.5909134944240714e-05,0.0001230047750566904,0,0,13.375227272727273,147.77776461363348,SDCBP;HSP90AA1;UBB;TNFSF10;CFLAR;BIRC3
1285,Reactome_2022,G1/S Transition R-HSA-69206,11 of 129,2.098131198694258e-05,0.0001609131266095354,0,0,5.245054461974307,56.4990889802401,CDKN1A;PSMA3;PSMA4;PPP2R1B;UBB;PSMB2;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1286,Reactome_2022,Hedgehog On State R-HSA-5632684,9 of 85,2.122331083283524e-05,0.00016146694881621047,0,0,6.639043884783592,71.43883694873804,PSMA3;PSMA4;PSMB2;UBB;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1287,Reactome_2022,Host Interactions Of HIV Factors R-HSA-162909,11 of 130,2.255966109872905e-05,0.00017027172781659778,0,0,5.200711985082218,55.64422297462976,PSMA3;PSMA4;UBB;PSMB2;PSME1;PSME2;HLA-A;B2M;PSMB10;PSMB8;PSMB9
1288,Reactome_2022,APC/C-mediated Degradation Of Cell Cycle Proteins R-HSA-174143,9 of 87,2.56230901985086e-05,0.00019187054156521004,0,0,6.468150760414371,68.38139754753503,PSMA3;PSMA4;PSMB2;UBB;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1289,Reactome_2022,PCP/CE Pathway R-HSA-4086400,9 of 88,2.809840360368046e-05,0.00020876235802421965,0,0,6.385949004388669,66.92345429195194,PSMA3;PSMA4;PSMB2;UBB;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1290,Reactome_2022,PIP3 Activates AKT Signaling R-HSA-1257604,16 of 268,2.8774229605575857e-05,0.00021212629732482663,0,0,3.599740090968161,37.63899173960972,EGR1;JUN;CDKN1A;CHD4;PSMB8;PSMB10;PSMB9;MOV10;PSMA3;PSMA4;PPP2R1B;PSMB2;UBB;PSME1;PSME2;IER3
1291,Reactome_2022,Interleukin-6 Signaling R-HSA-1059683,4 of 11,3.016063972523326e-05,0.00021895243037173157,0,0,31.694915254237287,329.9115109064604,SOCS3;STAT1;STAT3;JAK1
1292,Reactome_2022,Pexophagy R-HSA-9664873,4 of 11,3.016063972523326e-05,0.00021895243037173157,0,0,31.694915254237287,329.9115109064604,MAP1LC3B;UBB;EPAS1;SQSTM1
1293,Reactome_2022,Negative Regulators Of DDX58/IFIH1 Signaling R-HSA-936440,6 of 35,3.3018440438896334e-05,0.0002378828549802304,0,0,11.52801724137931,118.95120438704096,IFIH1;CYLD;UBB;TRAF3;TNFAIP3;UBE2L6
1294,Reactome_2022,MyD88:MAL(TIRAP) Cascade Initiated On Plasma Membrane R-HSA-166058,10 of 112,3.34270936508604e-05,0.0002388950440763338,0,0,5.504845616407483,56.73373051764877,NFKBIA;JUN;SOCS1;PPP2R1B;UBB;TNIP2;MAP3K8;N4BP1;NFKB1;NFKB2
1295,Reactome_2022,Switching Of Origins To A Post-Replicative State R-HSA-69052,9 of 90,3.366134164692821e-05,0.0002388950440763338,0,0,6.227634511302133,64.13940743701582,PSMA3;PSMA4;PSMB2;UBB;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1296,Reactome_2022,Post-translational Protein Modification R-HSA-597592,46 of 1383,3.59176872361946e-05,0.0002530201523083042,0,0,2.018559538193046,20.658504929834717,RAB3B;DDX5;B4GALT1;EPAS1;TNFAIP3;UBE2Z;PSMB10;SOCS2;IFIH1;SOCS3;TUBA1C;NUB1;TUBA1A;PSMB2;UBB;UBD;RAB29;TIMP1;APOL1;CHGA;UBE2B;HLA-B;RAB27A;HLA-A;PSMB8;PSMB9;NFKB2;NFKBIA;CYLD;PSMA3;PSMA4;KLHL5;TNIP1;VGF;TRAF3;TNIP2;B3GNT5;RAB13;PSME1;PSME2;TOP1;B4GALT6;SQSTM1;LY6E;BIRC3;NFE2L2
1297,Reactome_2022,Disease R-HSA-1643685,54 of 1736,4.455433357934229e-05,0.0003115527296614302,0,0,1.896708179485575,19.0027420600094,CDKN1A;B4GALT1;CHD4;IFIH1;MAP1LC3B;FNTA;PPP2R1B;KIF5B;B2M;GYG1;JAK1;HSP90AA1;IFNGR2;HLA-B;HLA-C;HLA-A;HLA-F;PARP9;ATP1B1;YWHAZ;HLA-E;PSMA3;PSMA4;TRAF3;RBP1;PSME1;PSME2;CHMP4B;HPRT1;SQSTM1;CHMP5;DDX5;CEBPD;PSMB10;PAPSS2;RNF213;GNG5;PSMB2;UBB;RBBP8;CHGA;GSDMD;JUN;STAT1;STAT3;PARP14;PSMB8;NFKB1;PSMB9;NFKB2;NFKBIA;FXYD3;FXYD2;NFE2L2
1298,Reactome_2022,Beta-catenin Independent WNT Signaling R-HSA-3858494,11 of 142,5.114515994810928e-05,0.0003550295409536637,0,0,4.721407044019623,46.6514802996736,MOV10;PSMA3;PSMA4;UBB;GNG5;PSMB2;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1299,Reactome_2022,UCH Proteinases R-HSA-5689603,9 of 95,5.178519683549432e-05,0.0003568675521054717,0,0,5.864063437062704,57.86896012561752,PSMA3;PSMA4;PSMB2;UBB;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1300,Reactome_2022,SARS-CoV-2-host Interactions R-HSA-9705683,13 of 196,5.533587431814397e-05,0.000378592924291762,0,0,4.006763285024155,39.274650874343735,HSP90AA1;STAT1;HLA-B;HLA-C;HLA-A;HLA-F;YWHAZ;HLA-E;IFIH1;MAP1LC3B;TRAF3;B2M;JAK1
1301,Reactome_2022,MyD88 Cascade Initiated On Plasma Membrane R-HSA-975871,9 of 96,5.625493886911164e-05,0.00038213176331803694,0,0,5.796363995652603,56.72099642304534,NFKBIA;JUN;PPP2R1B;UBB;TNIP2;MAP3K8;N4BP1;NFKB1;NFKB2
1302,Reactome_2022,Growth Hormone Receptor Signaling R-HSA-982772,5 of 24,5.7391021021956365e-05,0.0003870841205097908,0,0,14.62874608617862,142.85881477951213,SOCS2;SOCS3;SOCS1;STAT1;STAT3
1303,Reactome_2022,Potential Therapeutics For SARS R-HSA-9679191,9 of 97,6.104552635038206e-05,0.00040841660104388967,0,0,5.730203177910914,55.60526497509957,HSP90AA1;FNTA;FXYD3;FXYD2;IFNGR2;CHD4;ATP1B1;NFE2L2;JAK1
1304,Reactome_2022,TCF Dependent Signaling In Response To WNT R-HSA-201681,13 of 198,6.141280120849235e-05,0.00040841660104388967,0,0,3.963039561300431,38.43313067098141,YWHAZ;PSMB8;PSMB10;PSMB9;PSMA3;PSMA4;PPP2R1B;PSMB2;UBB;PSME1;PSME2;SOX4;BCL9L
1305,Reactome_2022,Ovarian Tumor Domain Proteases R-HSA-5689896,6 of 39,6.24864921218571e-05,0.00041267120838809794,0,0,10.12861570247934,98.05067355047493,IFIH1;UBB;TNIP1;TNIP2;TRAF3;TNFAIP3
1306,Reactome_2022,NF-kB Is Activated And Signals Survival R-HSA-209560,4 of 13,6.35182868561859e-05,0.00041659235034643293,0,0,24.649089767733837,238.21330718846437,NFKBIA;UBB;SQSTM1;NFKB1
1307,Reactome_2022,Hedgehog Off State R-HSA-5610787,9 of 98,6.617517787519982e-05,0.0004310451654747604,0,0,5.665529120118476,54.52054884701519,PSMA3;PSMA4;UBB;PSMB2;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1308,Reactome_2022,Mitotic G1 Phase And G1/S Transition R-HSA-453279,11 of 147,7.009894290847845e-05,0.0004534972428977075,0,0,4.546660450923885,43.49154813916123,CDKN1A;PSMA3;PSMA4;PPP2R1B;UBB;PSMB2;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1309,Reactome_2022,Ub-specific Processing Proteases R-HSA-5689880,13 of 201,7.161354448825646e-05,0.0004601654108671074,0,0,3.899198273203824,37.21483083692405,PSMB8;PSMB10;PSMB9;IFIH1;NFKBIA;CYLD;PSMA3;PSMA4;PSMB2;UBB;PSME1;PSME2;BIRC3
1310,Reactome_2022,G2/M Checkpoints R-HSA-69481,11 of 148,7.453659683184891e-05,0.000475733581121398,0,0,4.513241759397547,42.89484404122889,PSMA3;PSMA4;UBB;PSMB2;PSME1;RBBP8;PSME2;YWHAZ;PSMB10;PSMB8;PSMB9
1311,Reactome_2022,Transport Of Small Molecules R-HSA-382551,28 of 706,7.804411090279328e-05,0.0004947996631237095,0,0,2.3732546705998034,22.446803632975456,ABCB1;SLC43A2;SLC2A6;PSMB10;GNG5;PSMB2;UBB;FTH1;SLC39A1;ATP9A;ABCF1;ATP6V0E1;ABCA5;SLC30A2;ANO9;LSR;ATP1B1;SLC39A14;PSMB8;PSMB9;SLC9B2;PSMA3;PSMA4;FXYD3;FXYD2;PSME1;PSME2;FTL
1312,Reactome_2022,TRAF6 Mediated Induction Of NFkB And MAP Kinases Upon TLR7/8 Or 9 Activation R-HSA-975138,9 of 101,8.379191287550902e-05,0.0005277225771166164,0,0,5.479942693409742,51.4411759029512,NFKBIA;JUN;PPP2R1B;UBB;TNIP2;MAP3K8;N4BP1;NFKB1;NFKB2
1313,Reactome_2022,MyD88 Dependent Cascade Initiated On Endosome R-HSA-975155,9 of 102,9.047506447479869e-05,0.000566064383654826,0,0,5.420741288473981,50.46946633441824,NFKBIA;JUN;PPP2R1B;UBB;TNIP2;MAP3K8;N4BP1;NFKB1;NFKB2
1314,Reactome_2022,Toll Like Receptor 7/8 (TLR7/8) Cascade R-HSA-168181,9 of 103,9.75998043479209e-05,0.0006066497642802142,0,0,5.362799487898555,49.52349621992423,NFKBIA;JUN;PPP2R1B;UBB;TNIP2;MAP3K8;N4BP1;NFKB1;NFKB2
1315,Reactome_2022,Metabolism Of Proteins R-HSA-392499,56 of 1890,0.00011767750461769192,0.0007266967979962663,0,0,1.8005156463272838,16.29027817854501,RAB3B;ACHE;B4GALT1;TNFAIP3;UBE2L6;UBE2Z;IFIH1;TUBA1C;NUB1;TUBA1A;KIF5B;TIMP1;B2M;HLA-B;HLA-A;PSMA3;PSMA4;VGF;PPA1;TRAF3;B3GNT5;PSME1;PSME2;TOP1;B4GALT6;SQSTM1;LY6E;BIRC3;DDX5;EPAS1;PSMB10;SOCS2;SOCS3;GNG5;PSMB2;UBB;UBD;RAB29;APOL1;CHGA;UBE2B;STAT3;RAB27A;TBCB;INHBA;PSMB8;PSMB9;NFKB2;NFKBIA;CYLD;EIF5;KLHL5;TNIP1;TNIP2;RAB13;NFE2L2
1316,Reactome_2022,Toll Like Receptor 9 (TLR9) Cascade R-HSA-168138,9 of 106,0.00012185673891884624,0.0007476500562053083,0,0,5.196142143975423,46.83108570485995,NFKBIA;JUN;PPP2R1B;UBB;TNIP2;MAP3K8;N4BP1;NFKB1;NFKB2
1317,Reactome_2022,Intracellular Signaling By Second Messengers R-HSA-9006925,16 of 306,0.00013786462329190135,0.0008404439535294755,0,0,3.121919741883444,27.75148867934957,EGR1;JUN;CDKN1A;CHD4;PSMB8;PSMB10;PSMB9;MOV10;PSMA3;PSMA4;PPP2R1B;PSMB2;UBB;PSME1;PSME2;IER3
1318,Reactome_2022,Interleukin-10 Signaling R-HSA-6783783,6 of 45,0.00014253136549978898,0.000863358780829932,0,0,8.567744755244755,75.8755060883081,CXCL8;STAT3;TIMP1;ICAM1;JAK1;TNFRSF1A
1319,Reactome_2022,MAP3K8 (TPL2)-dependent MAPK1/3 Activation R-HSA-5684264,4 of 16,0.0001549490548095813,0.0009267707617856088,0,0,18.483992467043315,162.14923750481628,UBB;TNIP2;MAP3K8;NFKB1
1320,Reactome_2022,p75NTR Signals Via NF-kB R-HSA-193639,4 of 16,0.0001549490548095813,0.0009267707617856088,0,0,18.483992467043315,162.14923750481628,NFKBIA;UBB;SQSTM1;NFKB1
1321,Reactome_2022,Assembly Of Pre-Replicative Complex R-HSA-68867,9 of 110,0.00016186794396234807,0.0009621025919262062,0,0,4.989333030724276,43.55053948771612,PSMA3;PSMA4;UBB;PSMB2;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1322,Reactome_2022,IkBA Variant Leads To EDA-ID R-HSA-5603029,3 of 7,0.0001887009637346243,0.0011146249472771,0,0,41.4887323943662,355.78027680424987,NFKBIA;NFKB1;NFKB2
1323,Reactome_2022,Interleukin-17 Signaling R-HSA-448424,7 of 69,0.00023105497665121665,0.0013563782888599,0,0,6.298134362650492,52.73336504327505,JUN;PPP2R1B;UBB;TNIP2;MAP3K8;IL17RB;NFKB1
1324,Reactome_2022,HIV Infection R-HSA-162906,13 of 229,0.00026217099288957535,0.0015295988603557,0,0,3.388862050456253,27.94629706374677,HLA-A;PSMB8;PSMB10;PSMB9;PSMA3;PSMA4;PSMB2;UBB;PSME1;PSME2;CHMP4B;B2M;CHMP5
1325,Reactome_2022,Signaling By WNT R-HSA-195721,15 of 294,0.0002883041704278376,0.0016718125980297,0,0,3.0350481206307407,24.740178025652597,YWHAZ;PSMB8;PSMB10;PSMB9;MOV10;PSMA3;PSMA4;PPP2R1B;PSMB2;UBB;GNG5;PSME1;PSME2;SOX4;BCL9L
1326,Reactome_2022,Synthesis Of DNA R-HSA-69239,9 of 119,0.0002930091173467716,0.0016887980036168,0,0,4.5790049492055225,37.25161024798072,PSMA3;PSMA4;UBB;PSMB2;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1327,Reactome_2022,Mitotic Anaphase R-HSA-68882,13 of 232,0.0002973556085827619,0.0017035252033867,0,0,3.3419231023757527,27.13835992248736,PSMB8;PSMB10;PSMB9;TUBA1C;PSMA3;TUBA1A;PSMA4;PPP2R1B;PSMB2;UBB;PSME1;PSME2;CHMP4B
1328,Reactome_2022,Mitotic Metaphase And Anaphase R-HSA-2555396,13 of 233,0.0003099454718838851,0.0017650188249196,0,0,3.3265612648221343,26.875668262328453,PSMB8;PSMB10;PSMB9;TUBA1C;PSMA3;TUBA1A;PSMA4;PPP2R1B;PSMB2;UBB;PSME1;PSME2;CHMP4B
1329,Reactome_2022,Nicotinamide Salvaging R-HSA-197264,4 of 19,0.0003162697998685528,0.0017903129742559,0,0,14.784934086629002,119.15052577779235,NNMT;NAMPT;PARP14;PARP9
1330,Reactome_2022,SARS-CoV-1 Infection R-HSA-9678108,6 of 52,0.0003207154826481949,0.0018047362366771,0,0,7.261363636363637,58.41735222355795,MAP1LC3B;DDX5;UBB;CHMP4B;PARP9;PARP14
1331,Reactome_2022,Transcriptional Regulation By RUNX1 R-HSA-8878171,12 of 204,0.00032513181884991305,0.0018188256454486,0,0,3.513367052023121,28.21683405063812,MOV10;SOCS3;PSMA3;PSMA4;PSMB2;KMT2A;UBB;PSME1;PSME2;PSMB8;PSMB10;PSMB9
1332,Reactome_2022,"Nucleotide-binding Domain, Leucine Rich Repeat Containing NLR Signaling Pathways R-HSA-168643",6 of 53,0.00035627557603656293,0.0019813922386594,0,0,7.106503868471954,56.42426231383742,CYLD;CASP4;TNFAIP3;NFKB1;BIRC3;NFKB2
1333,Reactome_2022,Interleukin-12 Family Signaling R-HSA-447115,6 of 54,0.0003948469846452413,0.0021831365255675,0,0,6.958096590909091,54.5306882110054,GSTO1;STAT1;STAT3;HNRNPA2B1;PSME2;JAK1
1334,Reactome_2022,Interleukin-1 Processing R-HSA-448706,3 of 9,0.0004409519207588695,0.0024100303255269,0,0,27.656338028169014,213.6887620262189,GSDMD;NFKB1;NFKB2
1335,Reactome_2022,Interleukin-9 Signaling R-HSA-8985947,3 of 9,0.0004409519207588695,0.0024100303255269,0,0,27.656338028169014,213.6887620262189,STAT1;STAT3;JAK1
1336,Reactome_2022,DNA Replication Pre-Initiation R-HSA-69002,9 of 127,0.000473962315920929,0.0025756466425188,0,0,4.266815599048128,32.65983968339676,PSMA3;PSMA4;UBB;PSMB2;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1337,Reactome_2022,Interleukin-21 Signaling R-HSA-9020958,3 of 10,0.000621589204756277,0.0033522220501078,0,0,23.70422535211268,175.01377443571445,STAT1;STAT3;JAK1
1338,Reactome_2022,NGF-stimulated Transcription R-HSA-9031628,5 of 39,0.0006239151449727453,0.0033522220501078,0,0,8.16863856023996,60.28043708754264,EGR1;JUND;VGF;CHD4;TRIB1
1339,Reactome_2022,S Phase R-HSA-69242,10 of 161,0.0006627135741756467,0.0035406775788822,0,0,3.709180178122859,27.14811166396061,CDKN1A;PSMA3;PSMA4;UBB;PSMB2;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1340,Reactome_2022,Signaling By Hedgehog R-HSA-5358351,9 of 135,0.0007380598661417785,0.0039212007413454,0,0,3.994269340974212,28.80461590374034,PSMA3;PSMA4;UBB;PSMB2;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1341,Reactome_2022,Nuclear Events (Kinase And Transcription Factor Activation) R-HSA-198725,6 of 61,0.0007644267867762571,0.0040387215234678,0,0,6.070351239669422,43.5631733520861,EGR1;JUND;PPP2R1B;VGF;CHD4;TRIB1
1342,Reactome_2022,Interleukin-6 Family Signaling R-HSA-6783589,4 of 24,0.000807935008445987,0.0042450065913377,0,0,11.08587570621469,78.94284170447463,SOCS3;STAT1;STAT3;JAK1
1343,Reactome_2022,MAP Kinase Activation R-HSA-450294,6 of 62,0.0008337718165895695,0.0043566867998718,0,0,5.961647727272728,42.26540437994125,JUN;PPP2R1B;UBB;TNIP2;MAP3K8;NFKB1
1344,Reactome_2022,Interleukin-27 Signaling R-HSA-9020956,3 of 11,0.0008433763317574951,0.0043827917568381,0,0,20.74014084507042,146.80073450100042,STAT1;STAT3;JAK1
1345,Reactome_2022,Interleukin-7 Signaling R-HSA-1266695,4 of 25,0.000948363078576226,0.0048488886436881,0,0,10.55743879472693,73.48793633414614,SOCS2;SOCS1;STAT3;JAK1
1346,Reactome_2022,Regulation Of IFNA/IFNB Signaling R-HSA-912694,4 of 25,0.000948363078576226,0.0048488886436881,0,0,10.55743879472693,73.48793633414614,SOCS3;SOCS1;STAT1;JAK1
1347,Reactome_2022,TRAF6 Mediated NF-kB Activation R-HSA-933542,4 of 25,0.000948363078576226,0.0048488886436881,0,0,10.55743879472693,73.48793633414614,IFIH1;NFKBIA;NFKB1;NFKB2
1348,Reactome_2022,Separation Of Sister Chromatids R-HSA-2467813,10 of 170,0.0010070087547006,0.0051212049503759,0,0,3.498922413793104,24.145262224423423,PSMA3;PSMA4;PPP2R1B;UBB;PSMB2;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1349,Reactome_2022,Interleukin-20 Family Signaling R-HSA-8854691,4 of 26,0.0011051125116299,0.0055249401352684,0,0,10.07704160246533,68.60256573467454,SOCS3;STAT1;STAT3;JAK1
1350,Reactome_2022,Pyroptosis R-HSA-5620971,4 of 26,0.0011051125116299,0.0055249401352684,0,0,10.07704160246533,68.60256573467454,GSDMD;IRF1;CASP4;CHMP4B
1351,Reactome_2022,TNFR1-induced NFkappaB Signaling Pathway R-HSA-5357956,4 of 26,0.0011051125116299,0.0055249401352684,0,0,10.07704160246533,68.60256573467454,CYLD;TNFAIP3;TNFRSF1A;BIRC3
1352,Reactome_2022,Interleukin-35 Signaling R-HSA-8984722,3 of 12,0.0011096357159161,0.0055249401352684,0,0,18.43474178403756,125.42488591795234,STAT1;STAT3;JAK1
1353,Reactome_2022,TAK1-dependent IKK And NF-kappa-B Activation R-HSA-445989,5 of 45,0.0012129236076747,0.005977139535845,0,0,6.941218130311615,46.60834751129824,NFKBIA;UBB;N4BP1;NFKB1;NFKB2
1354,Reactome_2022,Vesicle-mediated Transport R-HSA-5653656,23 of 637,0.0012130262149506,0.005977139535845,0,0,2.127687296416938,14.286647924926427,ITSN2;SCARB2;HSP90AA1;DENND4A;RAB3IP;RAB27A;FNBP1L;UBE2Z;YWHAZ;VAMP8;NECAP2;MAP1LC3B;UBB;FTH1;KIF5B;RAB13;CHMP4B;STX4;APOL1;OPTN;RHOQ;FTL;CHMP5
1355,Reactome_2022,Cell Cycle Checkpoints R-HSA-69620,13 of 271,0.0012668306153251,0.0062100820369807,0,0,2.8310526907089093,18.886623674769364,CDKN1A;YWHAZ;PSMB8;PSMB10;PSMB9;PSMA3;PSMA4;PPP2R1B;PSMB2;UBB;PSME1;RBBP8;PSME2
1356,Reactome_2022,TNFR1-induced Proapoptotic Signaling R-HSA-5357786,3 of 13,0.0014234726795118,0.006942166760081,0,0,16.590422535211268,108.74451002328112,CYLD;TNFAIP3;TNFRSF1A
1357,Reactome_2022,Immunoregulatory Interactions Between A Lymphoid And A non-Lymphoid Cell R-HSA-198933,8 of 123,0.0016847661562029,0.008174554155862,0,0,3.881142857142857,24.78547703007596,CD40;HLA-B;HLA-C;HLA-A;HLA-F;B2M;ICAM1;HLA-E
1358,Reactome_2022,Diseases Of Signal Transduction By Growth Factor Receptors And Second Messengers R-HSA-5663202,17 of 424,0.0017615485393353,0.008503719090903,0,0,2.356092429406212,14.941306230307353,CDKN1A;HSP90AA1;STAT1;STAT3;PSMB10;PSMB8;PSMB9;PSMA3;RNF213;PSMA4;PSMB2;UBB;PPP2R1B;KIF5B;PSME1;PSME2;SQSTM1
1359,Reactome_2022,DNA Replication R-HSA-69306,9 of 155,0.0019447156563948,0.009340528228442,0,0,3.4435765592495198,21.49700706617391,PSMA3;PSMA4;UBB;PSMB2;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1360,Reactome_2022,Diseases Associated With TLR Signaling Cascade R-HSA-5602358,4 of 31,0.0021679783256438,0.0103087369384363,0,0,8.20883029922578,50.35263828532401,NFKBIA;TRAF3;NFKB1;NFKB2
1361,Reactome_2022,Nicotinate Metabolism R-HSA-196807,4 of 31,0.0021679783256438,0.0103087369384363,0,0,8.20883029922578,50.35263828532401,NNMT;NAMPT;PARP14;PARP9
1362,Reactome_2022,Signaling By Non-Receptor Tyrosine Kinases R-HSA-9006927,5 of 52,0.002330229501821,0.0110251157026456,0,0,5.90531010788982,35.79674100498933,SOCS3;UBB;EPAS1;STAT3;STAP2
1363,Reactome_2022,NOD1/2 Signaling Pathway R-HSA-168638,4 of 33,0.0027414098205258,0.0129063402936637,0,0,7.641924800311709,45.081876739805,CYLD;CASP4;TNFAIP3;BIRC3
1364,Reactome_2022,Membrane Trafficking R-HSA-199991,21 of 599,0.0027720531095864,0.0129863177695405,0,0,2.0553017157290565,12.10195981680137,ITSN2;SCARB2;DENND4A;RAB3IP;RAB27A;FNBP1L;UBE2Z;YWHAZ;VAMP8;NECAP2;MAP1LC3B;UBB;FTH1;KIF5B;RAB13;CHMP4B;STX4;OPTN;RHOQ;FTL;CHMP5
1365,Reactome_2022,Signaling By MST1 R-HSA-8852405,2 of 5,0.0030830017920153,0.014372228942189,0,0,36.77715355805243,212.64004226086405,SPINT1;SPINT2
1366,Reactome_2022,RIP-mediated NFkB Activation Via ZBP1 R-HSA-1810476,3 of 17,0.0032095551107824,0.0147716870641832,0,0,11.84788732394366,68.02610172335068,NFKBIA;NFKB1;NFKB2
1367,Reactome_2022,Zinc Transporters R-HSA-435354,3 of 17,0.0032095551107824,0.0147716870641832,0,0,11.84788732394366,68.02610172335068,SLC30A2;SLC39A14;SLC39A1
1368,Reactome_2022,Regulation Of Expression Of SLITs And ROBOs R-HSA-9010553,9 of 167,0.0032152883515099,0.0147716870641832,0,0,3.1800805193863115,18.25314775837216,PSMA3;PSMA4;UBB;PSMB2;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1369,Reactome_2022,Senescence-Associated Secretory Phenotype (SASP) R-HSA-2559582,6 of 81,0.0033166139933006,0.0150913871178417,0,0,4.447045454545455,25.387341554911597,CDKN1A;JUN;CXCL8;UBB;STAT3;NFKB1
1370,Reactome_2022,TP53 Regulates Metabolic Genes R-HSA-5628897,6 of 81,0.0033166139933006,0.0150913871178417,0,0,4.447045454545455,25.387341554911597,MOV10;GPX2;COX4I1;SESN1;DDIT4;YWHAZ
1371,Reactome_2022,Signaling By NTRK1 (TRKA) R-HSA-187037,7 of 114,0.004452355976683,0.020162812065836,0,0,3.640999014830791,19.713540667254488,EGR1;JUND;PPP2R1B;VGF;STAT3;CHD4;TRIB1
1372,Reactome_2022,Disorders Of Transmembrane Transporters R-HSA-5619115,9 of 176,0.004539490007343,0.0204599762890198,0,0,3.0073091639071428,16.224254324430905,PSMA3;PSMA4;UBB;PSMB2;PSME1;PSME2;PSMB10;PSMB8;PSMB9
1373,Reactome_2022,MET Receptor Activation R-HSA-6806942,2 of 6,0.0045698705125402,0.02049974932748,0,0,27.581460674157302,148.61636837966284,SPINT1;SPINT2
1374,Reactome_2022,HSP90 Chaperone Cycle For Steroid Hormone Receptors (SHR) In Presence Of Ligand R-HSA-3371497,4 of 38,0.0046108155855113,0.0205863174733395,0,0,6.516450648055833,35.054272188850554,DNAJA1;HSP90AA1;HSPA2;FKBP5
1375,Reactome_2022,Selective Autophagy R-HSA-9663891,5 of 61,0.0046813658977604,0.0208036400409821,0,0,4.953966005665722,26.57389280822129,MAP1LC3B;HSP90AA1;UBB;EPAS1;SQSTM1
1376,Reactome_2022,Transcriptional Regulation By TP53 R-HSA-3700989,14 of 354,0.004901571314326,0.0216809038136005,0,0,2.310430916552668,12.28733242708146,JUN;BTG2;CDKN1A;GPX2;COX4I1;CHD4;YWHAZ;BBC3;MOV10;PPP2R1B;UBB;SESN1;DDIT4;RBBP8
1377,Reactome_2022,Cytosolic Sensors Of Pathogen-Associated DNA R-HSA-1834949,5 of 63,0.0053732732665175,0.0235483081864434,0,0,4.78265116733418,24.99565592814371,NFKBIA;UBB;NFKB1;TRIM56;NFKB2
1378,Reactome_2022,Signaling By MET R-HSA-6806834,5 of 63,0.0053732732665175,0.0235483081864434,0,0,4.78265116733418,24.99565592814371,SPINT1;UBB;ITGA3;STAT3;SPINT2
1379,Reactome_2022,ZBP1(DAI) Mediated Induction Of Type I IFNs R-HSA-1606322,3 of 21,0.0059542055912545,0.0259745390701059,0,0,9.213145539906105,47.20500212478504,NFKBIA;NFKB1;NFKB2
1380,Reactome_2022,Binding And Uptake Of Ligands By Scavenger Receptors R-HSA-2173782,4 of 41,0.0060662075479197,0.0263422985300077,0,0,5.987173614292258,30.564650955275848,HSP90AA1;FTH1;APOL1;FTL
1381,Reactome_2022,DEx/H-box Helicases Activate Type I IFN And Inflammatory Cytokines Production R-HSA-3134963,2 of 7,0.0063223463582161,0.0272061148717809,0,0,22.064044943820225,111.72492950405196,NFKB1;NFKB2
1382,Reactome_2022,Modulation By Mtb Of Host Immune System R-HSA-9637628,2 of 7,0.0063223463582161,0.0272061148717809,0,0,22.064044943820225,111.72492950405196,UBB;B2M
1383,Reactome_2022,Deactivation Of Beta-Catenin Transactivating Complex R-HSA-3769402,4 of 42,0.0066118839894987,0.0283238814144744,0,0,5.829319060362772,29.25669157931348,UBB;YWHAZ;SOX4;BCL9L
1384,Reactome_2022,PINK1-PRKN Mediated Mitophagy R-HSA-5205685,3 of 22,0.0068040135682485,0.0290162192977773,0,0,8.727798369162343,43.553831315838615,MAP1LC3B;UBB;SQSTM1
1385,Reactome_2022,DAP12 Interactions R-HSA-2172127,4 of 43,0.00718911240498,0.0305216334693572,0,0,5.679559611763001,28.02969196162981,HLA-B;HLA-C;B2M;HLA-E
1386,Reactome_2022,Post-chaperonin Tubulin Folding Pathway R-HSA-389977,3 of 23,0.0077221920021533,0.0323515620883164,0,0,8.290985915492957,40.32451182694169,TUBA1C;TUBA1A;TBCB
1387,Reactome_2022,RAF-independent MAPK1/3 Activation R-HSA-112409,3 of 23,0.0077221920021533,0.0323515620883164,0,0,8.290985915492957,40.32451182694169,DUSP5;PEA15;JAK1
1388,Reactome_2022,RHOBTB2 GTPase Cycle R-HSA-9013418,3 of 23,0.0077221920021533,0.0323515620883164,0,0,8.290985915492957,40.32451182694169,HSP90AA1;ACTN1;TMOD3
1389,Reactome_2022,Interleukin-12 Signaling R-HSA-9020591,4 of 44,0.0077986262573073,0.0325284805732425,0,0,5.53728813559322,26.87693168808346,GSTO1;HNRNPA2B1;PSME2;JAK1
1390,Reactome_2022,Myoclonic Epilepsy Of Lafora R-HSA-3785653,2 of 8,0.0083304978380388,0.0344447975824999,0,0,18.38576779026217,88.02796847611599,UBB;GYG1
1391,Reactome_2022,TRAIL Signaling R-HSA-75158,2 of 8,0.0083304978380388,0.0344447975824999,0,0,18.38576779026217,88.02796847611599,TNFSF10;CFLAR
1392,Reactome_2022,Other Interleukin Signaling R-HSA-449836,3 of 24,0.0087099460521119,0.0358578298509026,0,0,7.895774647887324,37.451946418123256,IL32;STX4;JAK1
1393,Reactome_2022,M Phase R-HSA-68886,14 of 380,0.0089166949047016,0.0365507623033243,0,0,2.143410852713178,10.116534689415673,HSP90AA1;PSMB10;PSMB8;PSMB9;TUBA1C;PSMA3;PSMA4;TUBA1A;PSMB2;UBB;PPP2R1B;PSME1;PSME2;CHMP4B
1394,Reactome_2022,Muscle Contraction R-HSA-397014,9 of 196,0.0089824927290397,0.0366624488640207,0,0,2.6829137489848764,12.643171611353852,TMOD1;NPPC;FXYD3;FXYD2;TMOD3;TPM1;ITGA1;ANXA6;ATP1B1
1395,Reactome_2022,Signaling By NTRKs R-HSA-166520,7 of 132,0.0097292608544464,0.0395306292002346,0,0,3.113823361823362,14.425152134857004,EGR1;JUND;PPP2R1B;VGF;STAT3;CHD4;TRIB1
1396,Reactome_2022,Cell Recruitment (Pro-Inflammatory Response) R-HSA-9664424,3 of 25,0.0097683468581021,0.0395306292002346,0,0,7.536491677336747,34.88346591964326,GSDMD;NFKB1;NFKB2
1397,Reactome_2022,BH3-only Proteins Associate With And Inactivate Anti-Apoptotic BCL-2 Members R-HSA-111453,2 of 9,0.0105846621370872,0.0424726316133752,0,0,15.758426966292134,71.67483016562745,STAT3;BBC3
1398,Reactome_2022,RHO GTPases Activate Rhotekin And Rhophilins R-HSA-5666185,2 of 9,0.0105846621370872,0.0424726316133752,0,0,15.758426966292134,71.67483016562745,TAX1BP3;RHOB
1399,Reactome_2022,Attenuation Phase R-HSA-3371568,3 of 26,0.0108983371437915,0.0430054714678246,0,0,7.208450704225352,32.57603436863024,HSP90AA1;UBB;HSPA2
1400,Reactome_2022,Infection With Mycobacterium Tuberculosis R-HSA-9635486,3 of 26,0.0108983371437915,0.0430054714678246,0,0,7.208450704225352,32.57603436863024,RNF213;UBB;B2M
1401,Reactome_2022,Metal Ion SLC Transporters R-HSA-425410,3 of 26,0.0108983371437915,0.0430054714678246,0,0,7.208450704225352,32.57603436863024,SLC30A2;SLC39A1;SLC39A14
1402,Reactome_2022,N-glycan Antennae Elongation In medial/trans-Golgi R-HSA-975576,3 of 26,0.0108983371437915,0.0430054714678246,0,0,7.208450704225352,32.57603436863024,CHGA;B4GALT1;B4GALT6
1403,Reactome_2022,Protein Ubiquitination R-HSA-8852135,5 of 76,0.0117104681996223,0.0460192366026483,0,0,3.90436101025416,17.36375586452077,UBB;UBE2B;HLA-B;HLA-A;UBE2Z
2113,GO_Biological_Process_2023,Regulation Of I-kappaB kinase/NF-kappaB Signaling (GO:0043122),19 of 232,4.203431936631933e-08,6.527581824527986e-05,0,0,5.112399074881937,86.83297061719777,CD74;CD40;STAT1;HSPB1;TNFAIP3;TRAF2;CFLAR;TNFRSF1A;TNIP1;TRAF3;TNIP2;UBD;ZC3H12A;TNFSF10;SQSTM1;MAP3K14;OPTN;APOL2;BIRC3
2114,GO_Biological_Process_2023,Response To Cytokine (GO:0034097),14 of 125,5.480757199435756e-08,6.527581824527986e-05,0,0,7.160957469097004,119.72718068330482,CD74;CD40;GCH1;STAT1;ADAR;NFKB1;NFKB2;RELB;NUB1;PLSCR1;UBD;TIMP1;MCL1;TRIM56
2115,GO_Biological_Process_2023,Positive Regulation Of Transcription By RNA Polymerase II (GO:0045944),41 of 938,1.2866237168809662e-07,8.228236572004651e-05,0,0,2.7028229394159995,42.88318913695665,CSRNP1;CD40;KMT2A;EPAS1;AHR;PTMS;RELB;ZMIZ2;ZC3H12A;NAMPT;HES1;JUNB;SOX4;IER2;BCL9L;KLF10;EGR1;JUN;JUND;STAT1;STAT3;INHBA;ELL2;NFKB1;NFKB2;TNFRSF1A;NFKBIA;PLSCR1;KLF6;TNIP1;ELF3;TNIP2;IRF1;RFX5;BCL3;NCOA7;PTMA;SQSTM1;ATF3;RHOQ;NFE2L2
2116,GO_Biological_Process_2023,Regulation Of Innate Immune Response (GO:0045088),11 of 78,1.381735780353426e-07,8.228236572004651e-05,0,0,9.26168867478171,146.28610471144918,PLSCR1;IRF1;TNFAIP3;TRAFD1;PARP9;YWHAZ;N4BP1;HLA-E;BIRC3;TRIM56;NFE2L2
2117,GO_Biological_Process_2023,Regulation Of Apoptotic Process (GO:0042981),33 of 705,5.242281756027169e-07,0.00024974230285713435,0,0,2.8663461538461537,41.45120284249013,HSPB1;UBE2Z;PTMS;SOCS2;SOCS3;UBB;UBD;TNFSF10;PIM3;SOX4;IER3;TGM2;MCL1;EGR1;CD74;JUN;HSP90AA1;GADD45B;TSC22D1;TNFRSF12A;STAT1;ACTN1;TRAF2;CFLAR;YWHAZ;NFKB1;RHOB;CLIP3;DNAJA1;BCL3;PTMA;SQSTM1;BIRC3
2118,GO_Biological_Process_2023,Positive Regulation Of Extrinsic Apoptotic Signaling Pathway (GO:2001238),7 of 31,1.0084939988155333e-06,0.0003477216850000104,0,0,16.301756885090217,225.07921201639357,CYLD;PPP2R1B;TNFRSF12A;TNFSF10;G0S2;TRAF2;INHBA
2119,GO_Biological_Process_2023,NIK/NF-kappaB Signaling (GO:0038061),7 of 32,1.271146951008494e-06,0.0003477216850000104,0,0,15.648888888888887,212.44291444050896,NFKBIA;TRAF2;MAP3K14;NFKB1;RELB;NFKB2;BIRC3
2120,GO_Biological_Process_2023,Antigen Processing And Presentation Of Endogenous Peptide Antigen (GO:0002483),6 of 21,1.3638557291513614e-06,0.0003477216850000104,0,0,22.30340909090909,301.2118839092852,HLA-B;HLA-C;TAP1;HLA-A;HLA-F;HLA-E
2121,GO_Biological_Process_2023,Cellular Response To Tumor Necrosis Factor (GO:0071356),12 of 119,1.5335560926701877e-06,0.0003477216850000104,0,0,6.331910755766842,84.77112272398244,NFKBIA;ZFP36;CD40;CXCL8;TRAF3;STAT1;ZC3H12A;ILK;TRAF2;NFE2L2;TNFRSF1A;BIRC3
2122,GO_Biological_Process_2023,Positive Regulation Of Apoptotic Process (GO:0043065),18 of 270,1.9731869965734526e-06,0.0003477216850000104,0,0,4.073529411764706,53.5093143303379,JUN;GRN;BTG1;GADD45B;TNFRSF12A;CFLAR;UBE2Z;CTSS;RHOB;CLIP3;DNAJA1;UBD;ZC3H12A;TNFSF10;SQSTM1;SOX4;TGM2;MCL1
2123,GO_Biological_Process_2023,Antigen Processing And Presentation Of Endogenous Peptide Antigen Via MHC Class I Via ER Pathway (GO:0002484),5 of 13,2.0437042779177773e-06,0.0003477216850000104,0,0,34.76274787535411,455.4179501382452,HLA-B;HLA-C;HLA-A;HLA-F;HLA-E
2124,GO_Biological_Process_2023,"Antigen Processing And Presentation Of Endogenous Peptide Antigen Via MHC Class I Via ER Pathway, TAP-independent (GO:0002486)",5 of 13,2.0437042779177773e-06,0.0003477216850000104,0,0,34.76274787535411,455.4179501382452,HLA-B;HLA-C;HLA-A;HLA-F;HLA-E
2125,GO_Biological_Process_2023,Antigen Processing And Presentation Of Endogenous Peptide Antigen Via MHC Class Ib (GO:0002476),5 of 13,2.0437042779177773e-06,0.0003477216850000104,0,0,34.76274787535411,455.4179501382452,HLA-B;HLA-C;HLA-A;HLA-F;HLA-E
2126,GO_Biological_Process_2023,Antigen Processing And Presentation Of Peptide Antigen Via MHC Class Ib (GO:0002428),5 of 13,2.0437042779177773e-06,0.0003477216850000104,0,0,34.76274787535411,455.4179501382452,HLA-B;HLA-C;HLA-A;HLA-F;HLA-E
2127,GO_Biological_Process_2023,Positive Regulation Of DNA-templated Transcription (GO:0045893),46 of 1243,2.337947224879247e-06,0.00037126601931082446,0,0,2.271892337681811,29.457895097580263,CSRNP1;CD40;KMT2A;EPAS1;ILK;CHD4;AHR;PTMS;RELB;ZMIZ2;ZC3H12A;NAMPT;HES1;JUNB;SOX4;IER2;BCL9L;KLF10;EGR1;CD74;JUN;JUND;DTX3L;STAT1;TESC;STAT3;INHBA;PARP9;NFKB1;NFKB2;TNFRSF1A;NFKBIA;PLSCR1;KLF6;TNIP1;ELF3;TNIP2;IRF1;RFX5;BCL3;NCOA7;PTMA;SQSTM1;ATF3;RHOQ;NFE2L2
2128,GO_Biological_Process_2023,Positive Regulation Of Inflammatory Response (GO:0050729),11 of 104,2.617789291216324e-06,0.00038972338072983017,0,0,6.6635369216944005,85.64764201236095,GSDMD;NFKBIA;VAMP8;GRN;TNIP1;NINJ1;CASP4;NFKBIZ;C2CD4A;C2CD4B;TNFRSF1A
2129,GO_Biological_Process_2023,Tumor Necrosis Factor-Mediated Signaling Pathway (GO:0033209),7 of 38,4.345838727417393e-06,0.000608928696982837,0,0,12.616211745244003,155.76343142936346,NFKBIA;STAT1;TRAF3;ILK;TRAF2;TNFRSF1A;BIRC3
2130,GO_Biological_Process_2023,Type II Interferon-Mediated Signaling Pathway (GO:0060333),4 of 9,1.184797508480108e-05,0.0015634692740091,0,0,44.3774011299435,503.38855215170514,STAT1;IFNGR2;IRF1;JAK1
2131,GO_Biological_Process_2023,Antigen Processing And Presentation Of Peptide Antigen Via MHC Class I (GO:0002474),5 of 18,1.2637769416480022e-05,0.0015634692740091,0,0,21.387012421006755,241.220277443508,TAP1;HLA-A;IFI30;B2M;TAPBP
2132,GO_Biological_Process_2023,I-kappaB kinase/NF-kappaB Signaling (GO:0007249),7 of 45,1.4033201218349487e-05,0.0015634692740091,0,0,10.28849902534113,114.96455769678022,NFKBIA;BCL3;MAP3K14;NFKB1;RELB;NFKB2;BIRC3
2133,GO_Biological_Process_2023,Positive Regulation Of Apoptotic Signaling Pathway (GO:2001235),8 of 62,1.4191496786439671e-05,0.0015634692740091,0,0,8.291216931216931,92.55375676792012,SLC9A3R1;CYLD;TNFRSF12A;TNFSF10;G0S2;TRAF2;CTSS;BBC3
2134,GO_Biological_Process_2023,Positive Regulation Of Defense Response (GO:0031349),11 of 124,1.444010244676812e-05,0.0015634692740091,0,0,5.478539185432659,61.0610657770023,GSDMD;NFKBIA;PLSCR1;GRN;TNIP1;NINJ1;CASP4;NFKBIZ;OPTN;TNFRSF1A;TRIM56
2135,GO_Biological_Process_2023,Negative Regulation Of Cell Population Proliferation (GO:0008285),20 of 379,1.811374393628189e-05,0.0018759538285314,0,0,3.1782894628405662,34.70323276558436,KLF10;BTG2;CDKN1A;BTG1;CXCL8;TESC;ITGA1;TNFAIP3;INHBA;SOD2;PLAAT4;SLC9A3R1;FTH1;IRF1;HES1;INSM1;TRIB1;B2M;S100A11;SOX4
2136,GO_Biological_Process_2023,Positive Regulation Of Cytokine Production Involved In Immune Response (GO:0002720),6 of 33,2.3220179125165185e-05,0.0022474968506915,0,0,12.383207070707073,132.1348731914592,LACC1;TNFRSF14;TRAF2;HLA-A;HLA-F;HLA-E
2137,GO_Biological_Process_2023,Positive Regulation Of Response To External Stimulus (GO:0032103),12 of 155,2.3588338063513115e-05,0.0022474968506915,0,0,4.729132139536764,50.38775905442738,GSDMD;NFKBIA;PLSCR1;GRN;TNIP1;NINJ1;CASP4;NFKBIZ;STX4;OPTN;TNFRSF1A;TRIM56
2138,GO_Biological_Process_2023,Regulation Of Interferon-Beta Production (GO:0032648),7 of 50,2.860721810093305e-05,0.0026208612890931,0,0,9.089842973563904,95.09658726438764,IFIH1;HSP90AA1;OAS1;TRAF3;IRF1;TRIM56;RELB
2139,GO_Biological_Process_2023,Regulation Of Inflammatory Response (GO:0050727),15 of 240,3.0095450155821407e-05,0.0026550874915246,0,0,3.773955296404276,39.29116394426944,GSDMD;GRN;STAT3;TNFAIP3;AHR;TNFRSF1A;NFKBIA;CYLD;LACC1;TNIP1;NINJ1;CASP4;NFKBIZ;SNX6;BIRC3
2140,GO_Biological_Process_2023,Regulation Of Endopeptidase Activity (GO:0052548),8 of 69,3.148016331871646e-05,0.002678062465185,0,0,7.337142857142857,76.05794504682741,SERPINB1;PSMA3;PSME1;PSME2;TIMP1;PSMB8;BIRC3;PSMB9
2141,GO_Biological_Process_2023,Plasma Membrane Organization (GO:0007009),8 of 72,4.301279383099919e-05,0.003532981893291,0,0,6.992142857142857,70.2990948729161,SLC9A3R1;UGCG;PLSCR1;EPB41L3;ANXA6;STX4;FNBP1L;CHMP5
2142,GO_Biological_Process_2023,Regulation Of Defense Response To Virus By Host (GO:0050691),6 of 37,4.588659538436371e-05,0.0036433956735184,0,0,10.78317448680352,107.71676951922544,HSP90AA1;DTX3L;STAT1;ZC3H12A;TNFAIP3;PARP9
2143,GO_Biological_Process_2023,Regulation Of Cell Population Proliferation (GO:0042127),30 of 766,5.432714738052324e-05,0.0041744279051743,0,0,2.3494664634146343,23.07290369603263,BTG2;CDKN1A;BTG1;CXCL8;COX17;SDCBP;SLC9A3R1;BCL7A;FTH1;NAMPT;HES1;STX4;TIMP1;JUNB;S100A11;SOX4;KLF10;JUN;JUND;TSC22D1;STAT1;TESC;STAT3;ITGA1;NAP1L1;INHBA;SOD2;PLAAT4;IRF1;INSM1
2144,GO_Biological_Process_2023,Positive Regulation Of Angiogenesis (GO:0045766),10 of 119,5.627396925251844e-05,0.0041888935862343,0,0,5.149478013286934,50.389076425777255,CD40;GRN;BTG1;CXCL8;RRAS;ZC3H12A;NINJ1;HSPB1;JAK1;RHOB
2145,GO_Biological_Process_2023,Regulation Of Defense Response (GO:0031347),9 of 97,6.104552635038206e-05,0.0044063770838366,0,0,5.730203177910914,55.60526497509957,CYLD;LACC1;GRN;TRAF3;IRF1;CASP4;N4BP1;NFE2L2;BIRC3
2146,GO_Biological_Process_2023,Cytokine-Mediated Signaling Pathway (GO:0019221),15 of 257,6.585947523680452e-05,0.0045471820078969,0,0,3.505770667180686,33.753515281207214,EGR1;CXCL8;STAT1;STAT3;ILK;TRAF2;TNFRSF1A;NFKBIA;UGCG;SOCS1;OAS1;TRAF3;TNIP2;JAK1;BIRC3
2147,GO_Biological_Process_2023,Apoptotic Process (GO:0006915),14 of 228,6.681417727808316e-05,0.0045471820078969,0,0,3.69474027385351,35.51973760300384,PPP1R15A;CSRNP1;EMP3;AHR;CFLAR;BBC3;RHOB;NFKBIA;BCL2L13;PLSCR1;IRF1;DDIT4;CASP4;IER3
2148,GO_Biological_Process_2023,Positive Regulation Of Peptidase Activity (GO:0010952),5 of 25,7.069143450609182e-05,0.004677416583153,0,0,13.896600566572236,132.81239839846188,GRN;CLDN4;PSME1;PSME2;CTSS
2149,GO_Biological_Process_2023,Defense Response To Symbiont (GO:0140546),11 of 148,7.453659683184891e-05,0.0047985452338774,0,0,4.513241759397547,42.89484404122889,IFIH1;MOV10;CD40;PLSCR1;OAS1;TRAF3;STAT1;IRF1;DDIT4;MAP3K14;TRIM56
2150,GO_Biological_Process_2023,Regulation Of Extrinsic Apoptotic Signaling Pathway (GO:2001236),7 of 60,9.490321468302786e-05,0.0059394231653324,0,0,7.371015427619201,68.27515800517779,CYLD;TNFRSF12A;TNFSF10;G0S2;TRAF2;STX4;CFLAR
2151,GO_Biological_Process_2023,Positive Regulation Of Vasculature Development (GO:1904018),9 of 104,0.00010518903268165652,0.0059394231653324,0,0,5.306077514703665,48.6023515549206,CD40;GRN;BTG1;CXCL8;RRAS;ZC3H12A;NINJ1;HSPB1;RHOB
2152,GO_Biological_Process_2023,Negative Regulation Of Viral Process (GO:0048525),7 of 61,0.00010557818418349624,0.0059394231653324,0,0,7.23414582673842,66.23626453717962,IFIH1;ZFP36;PLSCR1;OAS1;TNIP1;STAT1;N4BP1
2153,GO_Biological_Process_2023,Cellular Response To Interleukin-9 (GO:0071355),3 of 6,0.00010927988141868188,0.0059394231653324,0,0,55.32112676056338,504.6170928954336,STAT1;STAT3;JAK1
2154,GO_Biological_Process_2023,Interleukin-9-Mediated Signaling Pathway (GO:0038113),3 of 6,0.00010927988141868188,0.0059394231653324,0,0,55.32112676056338,504.6170928954336,STAT1;STAT3;JAK1
2155,GO_Biological_Process_2023,Regulation Of Phosphorylation (GO:0042325),8 of 82,0.00010969654696141568,0.0059394231653324,0,0,6.044169884169884,55.10948785575327,SDCBP;CDKN1A;SOCS1;HSPB1;ILK;PLXNB2;INHBA;FNIP2
2156,GO_Biological_Process_2023,Positive Regulation Of T Cell Mediated Immunity (GO:0002711),6 of 43,0.00010993929521832562,0.0059394231653324,0,0,9.031787469287467,82.33000114481173,HLA-B;HLA-C;TRAF2;HLA-A;HLA-F;HLA-E
2157,GO_Biological_Process_2023,Negative Regulation Of Cellular Process (GO:0048523),23 of 537,0.00011220572730476828,0.0059394231653324,0,0,2.5549915790696325,23.238099420492844,KLF10;BTG2;CDKN1A;BTG1;CXCL8;TESC;ITGA1;SPINT2;INHBA;SOD2;PLAAT4;RHOB;VAMP8;SLC9A3R1;BCL7A;FTH1;IRF1;ANXA6;PLXNB2;INSM1;S100A11;SOX4;CHMP5
2158,GO_Biological_Process_2023,Regulation Of Transcription By RNA Polymerase II (GO:0006357),59 of 2028,0.00012417405498868625,0.0062228849304894,0,0,1.7711093861203164,15.929050190027498,CSRNP1;CD40;CHD4;AHR;PTMS;ZFP36;BCL7A;ZMIZ2;ZC3H12A;NAMPT;BBX;JUNB;SOX4;IER2;ZNF641;KLF10;ARID5B;PARP9;YWHAZ;TNFRSF1A;PLSCR1;ELF3;IRF1;RFX5;LCOR;NCOA7;PTMA;SQSTM1;ATF3;RHOQ;DDX5;KMT2A;CEBPD;EPAS1;RELB;SDCBP;RBBP8;CAMTA1;HES1;FNIP2;BCL9L;EGR1;JUN;JUND;STAT1;STAT3;ZBTB10;INHBA;SOD2;NFKB1;NFKB2;NFKBIA;KLF6;TNIP1;TNIP2;BHLHE40;BCL3;INSM1;NFE2L2
2159,GO_Biological_Process_2023,Positive Regulation Of Defense Response To Virus By Host (GO:0002230),5 of 28,0.00012512564168046863,0.0062228849304894,0,0,12.082152974504249,108.5725487223611,HSP90AA1;DTX3L;STAT1;ZC3H12A;PARP9
2160,GO_Biological_Process_2023,Positive Regulation Of Cytokine-Mediated Signaling Pathway (GO:0001961),6 of 44,0.00012539818499726762,0.0062228849304894,0,0,8.79366028708134,79.00238826661534,CD74;RBM47;CASP4;PARP14;PARP9;TRIM56
2161,GO_Biological_Process_2023,Response To Tumor Necrosis Factor (GO:0034612),9 of 108,0.00014067832124838915,0.0067067769206349,0,0,5.090648606407918,45.149139052006205,NFKBIA;NUB1;ZFP36;CD40;CXCL8;GCH1;UBD;ZC3H12A;NFE2L2
2162,GO_Biological_Process_2023,Positive Regulation Of Programmed Cell Death (GO:0043068),14 of 245,0.000143306571802889,0.0067067769206349,0,0,3.4198379140239608,30.26735877807284,JUN;GADD45B;TNFRSF12A;CFLAR;UBE2Z;RHOB;CLIP3;DNAJA1;UBD;TNFSF10;SQSTM1;SOX4;TGM2;MCL1
2163,GO_Biological_Process_2023,Positive Regulation Of Type I Interferon Production (GO:0032481),7 of 64,0.0001435959794090598,0.0067067769206349,0,0,6.852351676913081,60.63308109635359,IFIH1;HSP90AA1;OAS1;TRAF3;STAT1;IRF1;TRIM56
2164,GO_Biological_Process_2023,Cellular Response To Cytokine Stimulus (GO:0071345),16 of 308,0.00014855268848222152,0.006804855845474,0,0,3.1002162941600577,27.327076200172684,EGR1;CD40;CXCL8;STAT1;STAT3;NFKB1;TNFRSF1A;NFKBIA;MT2A;ZFP36;SOCS1;OAS1;IRF1;ZC3H12A;JAK1;NFE2L2
2165,GO_Biological_Process_2023,Negative Regulation Of Natural Killer Cell Mediated Cytotoxicity (GO:0045953),4 of 16,0.0001549490548095813,0.006834974973267,0,0,18.483992467043315,162.14923750481628,HLA-B;HLA-A;HLA-F;HLA-E
2166,GO_Biological_Process_2023,Negative Regulation Of Receptor Signaling Pathway Via JAK-STAT (GO:0046426),4 of 16,0.0001549490548095813,0.006834974973267,0,0,18.483992467043315,162.14923750481628,SOCS3;SOCS1;BCL3;PARP14
2167,GO_Biological_Process_2023,Regulation Of Tyrosine Phosphorylation Of STAT Protein (GO:0042509),7 of 65,0.00015848619597967533,0.0068638930695197,0,0,6.733863837312113,58.92025176423052,SOCS3;CD40;SOCS1;HES1;PARP9;PARP14;TNFRSF1A
2168,GO_Biological_Process_2023,Negative Regulation Of Apoptotic Process (GO:0043066),21 of 482,0.00017595255769374684,0.0073625892023157,0,0,2.592744453098348,22.415043658584977,CD74;GRN;TSC22D1;HSPB1;CFLAR;UBE2Z;SOD2;YWHAZ;NFKB1;PTMS;SOCS2;DNAJA1;SOCS3;ZC3H12A;BCL3;PIM3;PTMA;IER3;SNX6;BIRC3;MCL1
2169,GO_Biological_Process_2023,Negative Regulation Of Peptidyl-Tyrosine Phosphorylation (GO:0050732),5 of 30,0.00017618286504281943,0.0073625892023157,0,0,11.11444759206799,96.07315268383154,SOCS3;SOCS1;MVP;PARP14;SAMSN1
2170,GO_Biological_Process_2023,T-helper 17 Cell Lineage Commitment (GO:0072540),3 of 7,0.0001887009637346243,0.0077497533726875,0,0,41.4887323943662,355.78027680424987,SOCS3;STAT3;JAK1
2171,GO_Biological_Process_2023,Regulation Of Viral Genome Replication (GO:0045069),7 of 67,0.0001920169306073485,0.0077522767577407,0,0,6.508736942070275,55.70129567477829,IFIH1;PLSCR1;CXCL8;OAS1;STAU1;TNIP1;N4BP1
2172,GO_Biological_Process_2023,Regulation Of Extrinsic Apoptotic Signaling Pathway Via Death Domain Receptors (GO:1902041),5 of 31,0.00020700493197987825,0.0079529959350979,0,0,10.686424057528871,90.6504553776893,PEA15;TNFAIP3;STX4;CFLAR;ICAM1
2173,GO_Biological_Process_2023,Antigen Processing And Presentation Of Exogenous Peptide Antigen (GO:0002478),5 of 31,0.00020700493197987825,0.0079529959350979,0,0,10.686424057528871,90.6504553776893,HLA-A;IFI30;HLA-F;CTSS;HLA-E
2174,GO_Biological_Process_2023,Regulation Of Response To Biotic Stimulus (GO:0002831),5 of 31,0.00020700493197987825,0.0079529959350979,0,0,10.686424057528871,90.6504553776893,TRAF3;IRF1;N4BP1;BIRC3;NFE2L2
2175,GO_Biological_Process_2023,Cellular Response To Molecule Of Bacterial Origin (GO:0071219),9 of 117,0.0002581159456740192,0.0097592409935795,0,0,4.664278892072589,38.536746433595496,ZFP36;CXCL8;TNIP1;TNIP2;ZC3H12A;TNFAIP3;AHR;NFKB1;CHMP5
2176,GO_Biological_Process_2023,Positive Regulation Of T Cell Mediated Cytotoxicity (GO:0001916),5 of 33,0.0002807942717613322,0.010450811802117,0,0,9.922096317280452,81.14179524298301,HLA-B;HLA-C;HLA-A;HLA-F;HLA-E
2177,GO_Biological_Process_2023,T-helper 17 Cell Differentiation (GO:0072539),3 of 8,0.00029791655006429263,0.0109174957269714,0,0,33.18929577464789,269.4538408175636,SOCS3;STAT3;JAK1
2178,GO_Biological_Process_2023,Regulation Of Protein Phosphorylation (GO:0001932),14 of 265,0.0003213381627155817,0.0115951909796366,0,0,3.1440980264986567,25.28803237686202,CD74;CD40;CDKN1A;HSP90AA1;HSPB1;ILK;CLIP3;SLC9A3R1;SOCS1;ZC3H12A;PLXNB2;RAC1;INSM1;FNIP2
2179,GO_Biological_Process_2023,Positive Regulation Of I-kappaB kinase/NF-kappaB Signaling (GO:0043123),11 of 175,0.00032614517029204654,0.0115951909796366,0,0,3.764989105222464,30.225964934691856,CD74;CD40;TNIP2;UBD;TNFSF10;TRAF2;CFLAR;MAP3K14;TNFRSF1A;BIRC3;APOL2
2180,GO_Biological_Process_2023,Regulation Of Cell Cycle (GO:0051726),15 of 298,0.00033278838377150946,0.0116573813256431,0,0,2.9915317969691664,23.956197860815468,PPP1R15A;JUN;CDKN1A;JUND;GADD45B;STAT3;RHOB;CYLD;SDCBP;IRF1;PIM3;NBN;INSM1;JUNB;BIRC3
2181,GO_Biological_Process_2023,Regulation Of Angiogenesis (GO:0045765),12 of 205,0.00033990813209850085,0.0117342198646178,0,0,3.494983377759142,27.9138561830312,CD40;GRN;BTG1;CXCL8;RRAS;STAT1;ZC3H12A;NINJ1;HSPB1;TNFAIP3;GLUL;RHOB
2182,GO_Biological_Process_2023,Negative Regulation Of Protein Ubiquitination (GO:0031397),6 of 54,0.0003948469846452413,0.0134360788203566,0,0,6.958096590909091,54.5306882110054,DNAJA1;DTX3L;TNFAIP3;SQSTM1;SOX4;N4BP1
2183,GO_Biological_Process_2023,Positive Regulation Of Interferon-Beta Production (GO:0032728),5 of 36,0.00042684996742098173,0.0140046330033016,0,0,8.960522708580829,69.52539435529154,IFIH1;HSP90AA1;OAS1;IRF1;TRIM56
2184,GO_Biological_Process_2023,Regulation Of T Cell Mediated Cytotoxicity (GO:0001914),5 of 36,0.00042684996742098173,0.0140046330033016,0,0,8.960522708580829,69.52539435529154,HLA-B;HLA-C;HLA-A;HLA-F;HLA-E
2185,GO_Biological_Process_2023,Negative Regulation Of Tyrosine Phosphorylation Of STAT Protein (GO:0042532),3 of 9,0.0004409519207588695,0.0140046330033016,0,0,27.656338028169014,213.6887620262189,SOCS3;SOCS1;PARP14
2186,GO_Biological_Process_2023,Phosphatidylethanolamine Acyl-Chain Remodeling (GO:0036152),3 of 9,0.0004409519207588695,0.0140046330033016,0,0,27.656338028169014,213.6887620262189,LPGAT1;PLA2G4C;PLAAT4
2187,GO_Biological_Process_2023,"Regulation Of CD8-positive, Alpha-Beta T Cell Activation (GO:2001185)",3 of 9,0.0004409519207588695,0.0140046330033016,0,0,27.656338028169014,213.6887620262189,IRF1;HLA-A;HLA-E
2188,GO_Biological_Process_2023,Regulation Of Immune Response (GO:0050776),7 of 77,0.0004558701822423888,0.0142879312381759,0,0,5.576068376068376,42.89838064978562,PLSCR1;IRF1;SPPL2A;AHR;N4BP1;BIRC3;NFE2L2
2189,GO_Biological_Process_2023,Regulation Of Response To External Stimulus (GO:0032101),9 of 127,0.000473962315920929,0.0146620550197877,0,0,4.266815599048128,32.65983968339676,CYLD;LACC1;GRN;TRAF3;IRF1;CASP4;N4BP1;NFE2L2;BIRC3
2190,GO_Biological_Process_2023,Negative Regulation Of Smooth Muscle Cell Proliferation (GO:0048662),5 of 37,0.0004863758109910232,0.0148531689971874,0,0,8.68006373937677,66.21611760389972,CDKN1A;TPM1;TNFAIP3;SOD2;TRIB1
2191,GO_Biological_Process_2023,Negative Regulation Of Programmed Cell Death (GO:0043069),17 of 381,0.0005501865800166919,0.0164339181212979,0,0,2.640311301601624,19.816204583611466,CD74;TSC22D1;HSPB1;CFLAR;UBE2Z;YWHAZ;NFKB1;PTMS;SOCS2;DNAJA1;SOCS3;BCL3;PIM3;PTMA;IER3;BIRC3;MCL1
2192,GO_Biological_Process_2023,Negative Regulation Of Epithelial Cell Apoptotic Process (GO:1904036),5 of 38,0.0005519367966850703,0.0164339181212979,0,0,8.416602283457808,63.141998551971945,CAST;TNIP2;TNFAIP3;ICAM1;NFE2L2
2193,GO_Biological_Process_2023,Regulation Of Protein Localization To Plasma Membrane (GO:1903076),7 of 80,0.0005753104679972535,0.0169183893181414,0,0,5.346095304999414,39.88508247386928,CLIP3;VAMP8;ITGA3;KIF5B;STX4;SQSTM1;RHOQ
2194,GO_Biological_Process_2023,Response To Lipopolysaccharide (GO:0032496),10 of 159,0.0006012585028482936,0.0171019217936519,0,0,3.759353544704158,27.88119140965599,ZFP36;CXCL8;GCH1;TNIP1;TNIP2;ZC3H12A;TNFAIP3;TRIB1;NFKB1;CHMP5
2195,GO_Biological_Process_2023,Intrinsic Apoptotic Signaling Pathway (GO:0097193),8 of 105,0.000601564984736179,0.0171019217936519,0,0,4.60559646539028,34.15499280966238,PPP1R15A;DDX5;CDKN1A;CASP4;TRAF2;FNIP2;MCL1;BBC3
2196,GO_Biological_Process_2023,T-helper Cell Lineage Commitment (GO:0002295),3 of 10,0.000621589204756277,0.0171019217936519,0,0,23.70422535211268,175.01377443571445,SOCS3;STAT3;JAK1
2197,GO_Biological_Process_2023,Regulation Of Programmed Necrotic Cell Death (GO:0062098),3 of 10,0.000621589204756277,0.0171019217936519,0,0,23.70422535211268,175.01377443571445,CYLD;CFLAR;BIRC3
2198,GO_Biological_Process_2023,Positive Regulation Of ATP-dependent Activity (GO:0032781),5 of 39,0.0006239151449727453,0.0171019217936519,0,0,8.16863856023996,60.28043708754264,VMP1;PLSCR1;FXYD2;TPM1;ATP1B1
2199,GO_Biological_Process_2023,Defense Response To Virus (GO:0051607),11 of 189,0.0006246293854104608,0.0171019217936519,0,0,3.4663730855163037,25.5761210220906,IFIH1;MOV10;CD40;PLSCR1;OAS1;TRAF3;STAT1;IRF1;DDIT4;MAP3K14;TRIM56
2200,GO_Biological_Process_2023,Negative Regulation Of Extrinsic Apoptotic Signaling Pathway Via Death Domain Receptors (GO:1902042),4 of 23,0.0006828437859397919,0.0184833397512339,0,0,11.66993755575379,85.06502746751937,PEA15;TNFAIP3;CFLAR;ICAM1
2201,GO_Biological_Process_2023,Regulation Of Interleukin-1 Beta Production (GO:0032651),7 of 84,0.0007718567521103533,0.0206580088036726,0,0,5.067340067340068,36.31616473745496,GSDMD;EGR1;SERPINB1;ZC3H12A;STAT3;HSPB1;TNFAIP3
2202,GO_Biological_Process_2023,Regulation Of Proteolysis Involved In Protein Catabolic Process (GO:1903050),4 of 24,0.000807935008445987,0.0213833465568704,0,0,11.08587570621469,78.94284170447463,NUB1;UBB;PSME1;PSME2
2203,GO_Biological_Process_2023,Positive Regulation Of Endothelial Cell Migration (GO:0010595),7 of 85,0.0008284367317709638,0.0216850142316311,0,0,5.002118489297977,35.49488318071302,CD40;GRN;RRAS;ZC3H12A;HSPB1;RAC1;RHOB
2204,GO_Biological_Process_2023,Regulation Of T-helper 17 Cell Differentiation (GO:2000319),3 of 11,0.0008433763317574951,0.0218361132852864,0,0,20.74014084507042,146.80073450100042,NFKBIZ;ZC3H12A;JUNB
2205,GO_Biological_Process_2023,Cellular Response To Lipid (GO:0071396),12 of 228,0.000874568255155767,0.022400232083667,0,0,3.119139370584457,21.964293910911767,ZFP36;CXCL8;TNIP1;TNIP2;TESC;ZC3H12A;TNFAIP3;LCOR;AHR;SSTR2;NFKB1;CHMP5
2206,GO_Biological_Process_2023,Regulation Of Protein Ubiquitination (GO:0031396),8 of 113,0.0009761300460498208,0.0242357715247128,0,0,4.252952380952381,29.48110328325804,DNAJA1;HSP90AA1;UBB;TNFAIP3;SQSTM1;SOX4;N4BP1;BIRC3
2207,GO_Biological_Process_2023,Regulation Of Endothelial Cell Apoptotic Process (GO:2000351),5 of 43,0.0009839229227073885,0.0242357715247128,0,0,7.307290890114805,50.595411713654514,CD40;TNIP2;TNFAIP3;ICAM1;NFE2L2
2208,GO_Biological_Process_2023,Regulation Of Cellular Component Size (GO:0032535),5 of 43,0.0009839229227073885,0.0242357715247128,0,0,7.307290890114805,50.595411713654514,PPP1R15A;RAB3B;SLC9A3R1;MYO3A;RAC1
2209,GO_Biological_Process_2023,Cellular Response To Virus (GO:0098586),6 of 64,0.0009869310822406172,0.0242357715247128,0,0,5.755485893416928,39.83320186865073,IFIH1;HSP90AA1;OAS1;IFNGR2;ZC3H12A;JAK1
2210,GO_Biological_Process_2023,Protein Localization To Cell Periphery (GO:1990778),9 of 142,0.0010578105797135,0.0256616725758477,0,0,3.7826873774694616,25.91728682338675,RAB3B;EHD1;SLC9A3R1;TESC;EPB41L3;RAB13;RAB29;ATP1B1;TNFRSF1A
2211,GO_Biological_Process_2023,Response To Unfolded Protein (GO:0006986),5 of 44,0.0010939906820579,0.0256616725758477,0,0,7.1195612697029125,48.54062118798805,DNAJA1;HSP90AA1;HSPB1;HSPA2;OPTN
2212,GO_Biological_Process_2023,Acute Inflammatory Response (GO:0002526),4 of 26,0.0011051125116299,0.0256616725758477,0,0,10.07704160246533,68.60256573467454,PLSCR1;C2CD4A;C2CD4B;APOL2
2213,GO_Biological_Process_2023,Negative Regulation Of Endothelial Cell Apoptotic Process (GO:2000352),4 of 26,0.0011051125116299,0.0256616725758477,0,0,10.07704160246533,68.60256573467454,TNIP2;TNFAIP3;ICAM1;NFE2L2
2214,GO_Biological_Process_2023,Cellular Response To Oxygen-Containing Compound (GO:1901701),17 of 406,0.0011088592720282,0.0256616725758477,0,0,2.467421541059488,16.789381056566217,EGR1;JUN;CXCL8;TESC;TPM1;TNFAIP3;AHR;SSTR2;NFKB1;ZFP36;TNIP1;TNIP2;ZC3H12A;LCOR;SQSTM1;CHMP5;TGM2
2215,GO_Biological_Process_2023,Positive Regulation Of Sodium Ion Transmembrane Transporter Activity (GO:2000651),3 of 12,0.0011096357159161,0.0256616725758477,0,0,18.43474178403756,125.42488591795234,FXYD2;TESC;ATP1B1
2216,GO_Biological_Process_2023,Regulation Of Neurogenesis (GO:0050767),6 of 67,0.0012561325004995,0.0284764143622183,0,0,5.471590909090909,36.54868276557082,DYNLT1;BHLHE40;HES1;NAP1L1;B2M;TGM2
2217,GO_Biological_Process_2023,Regulation Of Peptidase Activity (GO:0052547),4 of 27,0.0012791672278578,0.0284764143622183,0,0,9.638418079096043,64.20676555554516,CSTB;PSMA3;CTSS;PSMB8
2218,GO_Biological_Process_2023,Cortical Cytoskeleton Organization (GO:0030865),4 of 27,0.0012791672278578,0.0284764143622183,0,0,9.638418079096043,64.20676555554516,EPB41L3;RAB13;RAC1;RHOQ
2219,GO_Biological_Process_2023,Positive Regulation Of Calcium Ion Transmembrane Transporter Activity (GO:1901021),4 of 27,0.0012791672278578,0.0284764143622183,0,0,9.638418079096043,64.20676555554516,VMP1;GSTO1;ATP1B1;CALM2
2220,GO_Biological_Process_2023,Negative Regulation Of DNA-binding Transcription Factor Activity (GO:0043433),9 of 149,0.0014815137782342,0.0326756094421667,0,0,3.5922636103151864,23.402487019479956,NFKBIA;CYLD;TRAF3;ZC3H12A;BCL3;BHLHE40;TNFAIP3;HES1;TRIB1
2221,GO_Biological_Process_2023,Protein Transport (GO:0015031),14 of 313,0.0016216904962944,0.0352368300738365,0,0,2.632826475849732,16.91403068414127,GSDMD;RAB3B;CD74;ARRDC3;CMTM6;EHD1;VMP1;RAB13;RAB29;UNC119;STX4;TMED6;OPTN;SNX6
2222,GO_Biological_Process_2023,Cellular Response To Mechanical Stimulus (GO:0071260),5 of 48,0.0016272255701603,0.0352368300738365,0,0,6.455958890572502,41.45292969413092,CD40;IRF1;MAP3K14;NFKB1;TNFRSF1A
2223,GO_Biological_Process_2023,Response To Interferon-Beta (GO:0035456),4 of 29,0.0016831122962457,0.0357961918719399,0,0,8.866440677966102,56.63093761219123,PLSCR1;OAS1;STAT1;IRF1
2224,GO_Biological_Process_2023,Integrated Stress Response Signaling (GO:0140467),4 of 29,0.0016831122962457,0.0357961918719399,0,0,8.866440677966102,56.63093761219123,JUN;CEBPD;JUNB;NFE2L2
2225,GO_Biological_Process_2023,Cellular Response To Lipopolysaccharide (GO:0071222),8 of 124,0.0017735347627544,0.0367112119402062,0,0,3.847487684729064,24.372990662255106,ZFP36;CXCL8;TNIP1;TNIP2;ZC3H12A;TNFAIP3;NFKB1;CHMP5
2226,GO_Biological_Process_2023,Interferon-Mediated Signaling Pathway (GO:0140888),5 of 49,0.0017859524249055,0.0367112119402062,0,0,6.308910636106104,39.921546392200185,TRAF3;STAT1;IFNGR2;IRF1;JAK1
2227,GO_Biological_Process_2023,Positive Regulation Of miRNA Metabolic Process (GO:2000630),5 of 49,0.0017859524249055,0.0367112119402062,0,0,6.308910636106104,39.921546392200185,EGR1;JUN;ZC3H12A;STAT3;NFKB1
2228,GO_Biological_Process_2023,Negative Regulation Of Receptor Signaling Pathway Via STAT (GO:1904893),3 of 14,0.0017877836209336,0.0367112119402062,0,0,15.081434058898848,95.41689466727928,SOCS3;SOCS1;BCL3
2229,GO_Biological_Process_2023,Intrinsic Apoptotic Signaling Pathway In Response To Endoplasmic Reticulum Stress (GO:0070059),4 of 30,0.001914948587632,0.0389863891943549,0,0,8.524989135158627,53.34993190286471,PPP1R15A;CASP4;TRAF2;BBC3
2230,GO_Biological_Process_2023,Cellular Response To Reactive Oxygen Species (GO:0034614),6 of 73,0.0019593909822854,0.0395531298288462,0,0,4.980071234735414,31.051349612428748,JUN;TPM1;TNFAIP3;SQSTM1;RHOB;NFE2L2
2231,GO_Biological_Process_2023,Regulation Of Tumor Necrosis Factor Production (GO:0032680),8 of 127,0.0020621850009559,0.0412783585905632,0,0,3.7499159663865536,23.189439755401136,IFIH1;ZFP36;OAS1;ZC3H12A;STAT3;HSPB1;TNFAIP3;HLA-E
2232,GO_Biological_Process_2023,Positive Regulation Of Leukocyte Mediated Cytotoxicity (GO:0001912),5 of 51,0.0021370063687887,0.0417241735283189,0,0,6.0339943342776206,37.09910497653404,HLA-B;HLA-C;HLA-A;HLA-F;HLA-E
2233,GO_Biological_Process_2023,Positive Regulation Of Protein Localization To Cell Periphery (GO:1904377),5 of 51,0.0021370063687887,0.0417241735283189,0,0,6.0339943342776206,37.09910497653404,CLIP3;ITGA3;KIF5B;STX4;SQSTM1
2234,GO_Biological_Process_2023,Positive Regulation Of Protein Localization To Plasma Membrane (GO:1903078),5 of 51,0.0021370063687887,0.0417241735283189,0,0,6.0339943342776206,37.09910497653404,CLIP3;ITGA3;KIF5B;STX4;SQSTM1
2235,GO_Biological_Process_2023,Response To Estradiol (GO:0032355),4 of 31,0.0021679783256438,0.0419847509892972,0,0,8.20883029922578,50.35263828532401,SOCS2;STAT3;LCOR;SSTR2
2236,GO_Biological_Process_2023,3'-UTR-mediated mRNA Destabilization (GO:0061158),3 of 15,0.0022052639362332,0.0423624088395775,0,0,13.82394366197183,84.55979265952955,MOV10;ZFP36;ZC3H12A
2237,GO_Biological_Process_2023,Regulation Of Protein Localization To Nucleus (GO:1900180),5 of 52,0.002330229501821,0.044052433915378,0,0,5.90531010788982,35.79674100498933,DTX3L;PARP9;GLUL;YWHAZ;JAK1
2238,GO_Biological_Process_2023,Negative Regulation Of Innate Immune Response (GO:0045824),5 of 52,0.002330229501821,0.044052433915378,0,0,5.90531010788982,35.79674100498933,GRN;OAS1;TNFAIP3;TRAFD1;YWHAZ
2239,GO_Biological_Process_2023,Positive Regulation Of Peptidyl-Tyrosine Phosphorylation (GO:0050731),8 of 130,0.0023865843263507,0.0447625501210044,0,0,3.657142857142857,22.081433919653264,CD74;CD40;UNC119;TNFRSF14;HES1;PARP14;PARP9;TNFRSF1A
2240,GO_Biological_Process_2023,Positive Regulation Of Protein Modification Process (GO:0031401),11 of 225,0.002532412867891,0.0468247730264044,0,0,2.877912144146085,17.20583583770613,CLIP3;EGR1;CD74;CD40;CDKN1A;HSP90AA1;NNMT;CAMTA1;ILK;RAC1;CALM2
2241,GO_Biological_Process_2023,Negative Regulation Of Viral Genome Replication (GO:0045071),5 of 53,0.0025358504283821,0.0468247730264044,0,0,5.781987724268178,34.5602486493994,IFIH1;PLSCR1;OAS1;TNIP1;N4BP1
2242,GO_Biological_Process_2023,Positive Regulation Of Protein Dephosphorylation (GO:0035307),4 of 33,0.0027414098205258,0.0497029729803482,0,0,7.641924800311709,45.081876739805,PPP1R15A;ITGA1;CAMTA1;CALM2
2243,GO_Biological_Process_2023,Negative Regulation Of Protein Modification By Small Protein Conjugation Or Removal (GO:1903321),5 of 54,0.0027543209208253,0.0497029729803482,0,0,5.66369890732497,33.38515097892731,DNAJA1;TNFAIP3;SQSTM1;SOX4;N4BP1
2244,GO_Biological_Process_2023,Protein K63-linked Ubiquitination (GO:0070534),5 of 54,0.0027543209208253,0.0497029729803482,0,0,5.66369890732497,33.38515097892731,RNF213;UBE2B;TRAF3;TRAF2;TRIM56
